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Background: Depression is the most prevalent mental health problem among people with learning disabilities.
Objective: The trial investigated the clinical effectiveness and cost-effectiveness of behavioural activation
for depression experienced by people with mild to moderate learning disabilities. The intervention was
compared with a guided self-help intervention.
Design: A multicentre, single-blind, randomised controlled trial, with follow-up at 4, 8 and 12 months
post randomisation. There was a nested qualitative study.
Setting: Participants were recruited from community learning disability teams and services and from
Improving Access to Psychological Therapies services in Scotland, England and Wales.
Participants: Participants were aged ≥ 18 years, with clinically significant depression, assessed using the
Diagnostic Criteria for Psychiatric Disorders for use with Adults with Learning Disabilities. Participants had
to be able to give informed consent and a supporter could accompany them to therapy.
Interventions: BeatIt was a manualised behavioural activation intervention, adapted for people with
learning disabilities and depression. StepUp was an adapted guided self-help intervention.
Main outcome measures: The primary outcome measure was the Glasgow Depression Scale for people
with a Learning Disability (GDS-LD). Secondary outcomes included carer ratings of depressive symptoms
and aggressiveness, self-reporting of anxiety symptoms, social support, activity and adaptive behaviour,
relationships, quality of life (QoL) and life events, and resource and medication use.
Results: There were 161 participants randomised (BeatIt, n = 84; StepUp, n = 77). Participant retention
was strong, with 141 completing the trial. Most completed therapy (BeatIt: 86%; StepUp: 82%). At
baseline, 63% of BeatIt participants and 66% of StepUp participants were prescribed antidepressants.
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
vii
There was no statistically significant difference in GDS-LD scores between the StepUp (12.94 points) and
BeatIt (11.91 points) groups at the 12-month primary outcome point. However, both groups improved
during the trial. Other psychological and QoL outcomes followed a similar pattern. There were no treatment
group differences, but there was improvement in both groups. There was no economic evidence suggesting
that BeatIt may be more cost-effective than StepUp. However, treatment costs for both groups were
approximately only 4–6.5% of the total support costs. Results of the qualitative research with participants,
supporters and therapists were in concert with the quantitative findings. Both treatments were perceived
as active interventions and were valued in terms of their structure, content and perceived impact.
Limitations: A significant limitation was the absence of a treatment-as-usual (TAU) comparison.
Conclusions: Primary and secondary outcomes, economic data and qualitative results all clearly
demonstrate that there was no evidence for BeatIt being more effective than StepUp.
Future work: Comparisons against TAU are required to determine whether or not these interventions had
any effect.
Trial registration: Current Controlled Trials ISRCTN09753005.
Funding: This project was funded by the National Institute for Health Research Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 53.
See the NIHR Journals Library website for further project information.
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Glossary
BeatIt A behavioural activation intervention adapted for adults with learning disabilities and depression,
delivered to participants over 12 sessions by a therapist alongside a supporter, ordinarily within a
4-month period.
StepUp A guided self-help intervention.
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Plain English summary
Depression is as common among adults with learning disabilities as it is among the general populationand is the most frequent type of mental ill health they experience. Psychological (talking) therapies are
the recommended treatment for most people with depression. However, many adults with learning
disabilities do not have the verbal ability to participate in talking therapies. Behavioural activation is a
psychological therapy shown to be effective in treating depression. It relies less on talking, gets people
with depression involved in positive activities and helps them to engage in tasks that people with
depression tend to avoid. We wanted to see if a behavioural activation intervention adapted for adults
with learning disabilities and depression, called BeatIt, was effective.
To achieve this, we compared BeatIt to a guided self-help therapy, StepUp. Guided self-help is an
educational approach, helping people to have a better understanding of depression and the skills to cope
better. Adults with a learning disability were randomly assigned to either BeatIt or StepUp. They, and their
carers, were asked to rate their symptoms of depression before therapy, immediately following therapy
and 12 months later.
No difference was found between BeatIt and StepUp in terms of their clinical effectiveness in treating
depression. Although BeatIt was more expensive than StepUp, the cost of both interventions was small
compared with the participants’ overall support costs. Although we cannot say that BeatIt was more
effective than StepUp, they may be better than no treatment. However, this could be discovered only in a
future study making this comparison.
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Scientific summary
Background
Depression is at least as common in adults with learning disabilities as it is in the general population,
with a point prevalence of ≈5%. Indeed, depression is the most common type of mental ill health
experienced by adults with a learning disability. Depression is more enduring in such adults than in the
general population, suggesting that it is either a more severe disease or more poorly managed. For example,
a study with a British cohort found that adults with a learning disability were four times more likely than
adults with no learning disability to meet the criteria for chronic depression over a 28-year period.
In recent years there have been important innovations in the treatment of depression. A number of
high-intensity psychosocial interventions are as efficacious as, and longer lasting than, medications in the
treatment of non-psychotic depression. This was confirmed in a recent individual patient-level meta-analysis
with over 1700 patients treated in randomised controlled trials. In 2016, the National Institute for Health
and Care Excellence (NICE) identified that the only available evidence on psychological interventions for
depression in people with a learning disability was for cognitive–behavioural therapy (CBT), adapted for
people with a learning disability. However, it was of very low quality.
Behavioural activation has been shown to be at least as efficacious as antidepressant medications, and
superior or non-inferior to CBT, placebo pills and treatment as usual among people with more severe
depression, and to have effects as long lasting as CBT following treatment termination. Behavioural
activation is more accessible than CBT for people with learning disabilities as it focuses on behaviour more
than on cognition, and is therefore less reliant on expressive and receptive communicative abilities or the
ability to grasp abstract concepts. The emphasis is on increasing engagement with potential environmental
reinforcers. It is also possible to train non-specialist nurses to deliver behavioural activation.
Objectives
The primary objective was to measure the clinical effectiveness of behavioural activation (BeatIt) for adults
with a learning disability and depression, compared with a guided self-help intervention (StepUp), in
reducing self-reported depressive symptoms.
The secondary objectives concerned whether or not BeatIt had significantly better outcomes than StepUp
in relation to (1) carer-reported depressive symptoms, (2) self-reported anxiety symptoms, (3) carer-reported
aggressiveness, (4) improved levels of activity and quality of life (QoL) and (5) an improvement in the
carer’s relationship with the adult with a learning disability who they supported and a greater confidence
in supporting adults with learning disabilities who are depressed.
The trial was supplemented with an economic evaluation to consider the cost-effectiveness of providing
the intervention compared with the attention control. There was also a qualitative study to explore the
views and experiences of participants and their supporters and therapists, using a framework analysis.
Methods
This was a multicentre, single-blind randomised controlled trial (RCT) of an adapted behavioural activation
(BeatIt) compared with an adapted guided self-help intervention (StepUp). To ensure that it would be
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possible to recruit participants, there was an initial internal pilot phase in Scotland before opening study
sites in England and Wales.
The inclusion criteria for participants were: (1) mild to moderate learning disabilities, (2) aged ≥ 18 years,
(3) clinically significant depression as assessed using the Diagnostic Criteria for Psychiatric Disorders for
use with Adults with Learning Disabilities (DC-LD), (4) the ability to provide informed consent, (5) sufficient
communicative abilities to engage in therapy, (6) having a supporter who could accompany them to
therapy sessions and (7) having a carer who could provide information for baseline assessments.
The primary outcome was measured using the Glasgow Depression Scale for people with a Learning
Disability (GDS-LD) score at 12 months post randomisation. Secondary outcomes were emotional and
interpersonal difficulties (carer ratings of depressive symptoms and aggressiveness, self-report of anxiety
symptoms); QoL (including community involvement, domestic and leisure activity and perceived social
support); adaptive behaviour; carer self-efficacy and patient–carer relationships; life events; and resource
and medication use. The primary and secondary measures were collected at baseline and 4 and 12 months
post randomisation. Participants’ expectations of therapy were also assessed at baseline. Service use data
were collected from carers at 8 months. Participants and supporters taking part in the qualitative study
were interviewed after the 4-month follow-up to ensure that they could still recall their experience of
therapy. Therapist focus groups took place once all participants had completed therapy.
BeatIt was a 12-session manualised behavioural activation intervention, delivered to participants by
therapists alongside a supporter, ordinarily within a 4-month period. The focus was on increasing activity,
and involved formulating the participants’ difficulties, scheduling activity and addressing barriers to change.
The guided self-help intervention, StepUp, was chosen as the attention control because it was deemed
comparable to BeatIt in terms of therapist attention, the use of a structured, manualised approach and the
presence of a supporter. A series of four booklets concerning depression and factors linked to low mood,
such as sleep, provided a focus for the sessions. Both therapies were delivered on an outreach basis.
Results
In total, 161 participants were randomised, 84 to BeatIt and 77 to StepUp. Participant retention was good,
with 141 participants completing the trial. The majority of participants were recruited through specialist
learning disability, community health and social care services, with a small number recruited from
Improving Access to Psychological Therapies services.
The baseline data suggested that participants had severe/enduring difficulties, with 66% of those allocated to
StepUp and 63% of those allocated to BeatIt prescribed antidepressants. In addition, 18% of participants
allocated to StepUp and 20% allocated to BeatIt had received prior psychological therapy and participants
had extensive contacts with psychology, psychiatry and community nursing.
There was good adherence, with participants in the BeatIt arm attending an average of 9.9 sessions and
those in the StepUp arm attending an average of 7.1 sessions. Moreover, therapists from both arms of the
trial were rated strongly for non-specific components such as warmth and empathy, and delivered the
therapy with excellent fidelity to the manuals.
Primary outcome
Both groups improved during the trial, but there were no statistically significant group differences in the
effects of StepUp and BeatIt on depression scores (measured using the GDS-LD) at the 12-month primary
outcome point.
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Secondary outcomes
There were within-group reductions in both arms of the study on depression scores (measured using the
GDS-LD) at 12 months (–4.20 points for BeatIt and –4.46 points for StepUp). The reductions occurred
between baseline and the 4-month follow-up, immediately following the end of therapy, and there were
no changes between the 4-month and 12-month follow-ups. Other psychological outcomes followed a
similar pattern of results to the primary outcome. For carer-reported depression in the participants,
self-reported anxiety and carer-reported aggressive behaviour, there were no treatment group differences.
Within-group analyses showed reductions in carer-reported depression and self-reported anxiety from
baseline to both 4 and 12 months post randomisation, associated primarily with reductions from baseline
to 4 months that were maintained through to follow-up. Similar findings for carer-reported aggression
showed a reduction from baseline to 4 months, but for the BeatIt group only.
In terms of QoL outcomes, there was increased participation in domestic and leisure activities in the BeatIt
group at 12-month follow-up compared with the StepUp group. Although self-reported health-related
QoL [measured using the EuroQol-5 Dimensions – youth version (EQ-5D-Y)] followed a similar pattern of
within-group analysis findings (improvements compared with baseline in both treatment groups). Adaptive
behaviour skills showed no treatment group differences at 12 months.
Carers’ sense of self-efficacy in supporting adults with a learning disability and depression increased within
both treatment groups from baseline, but again there were no treatment group differences at either 4 or
12 months’ follow-up.
Given the lack of differences between the BeatIt and StepUp groups at the primary end point (12-month
follow-up), it is not surprising that there was also no economic evidence to suggest that BeatIt may be
more cost-effective than StepUp. No differences in resource use were found at 12 months. Overall,
the vast majority of the support costs for participants in both treatment groups were not related to the
treatments themselves; intervention costs were approximately 4–6.5% of the total support costs.
Exploratory analyses of predictors and potential moderators of outcomes suggested that the two treatments
worked equally across a variety of participant characteristics. Notably, intelligence quotient (IQ) scores were
unrelated to outcome. One interesting finding was that the participants’ positive expectation of change at
the outset predicted a better outcome.
Results of the qualitative research with participants, supporters and therapists were almost without
exception in concert with the quantitative findings. In particular, both treatments were perceived as active
interventions and both treatments were valued in terms of their structure, content and perceived effect/
outcomes. The qualitative data from supporters did offer additional insight in relation to the putative impact
on carer–participant relationships. Supporters reported understanding more about the person and/or their
depression following either treatment and reported more positive relationships with participants following
either treatment.
Implications for practice
Primary and secondary outcomes, economic data and qualitative results all clearly demonstrate that there
was no consistent evidence that BeatIt was more effective than StepUp. The improvement seen with both
BeatIt and StepUp may mean that they are effective, but in the absence of an inactive control, this cannot
be determined.
There is an absence of accessible psychosocial interventions for adults with learning disabilities who are
depressed. This research was unable to determine if these two interventions could fill that gap.
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Implications for future research
This study has shown that the intervention is acceptable and practical in routine settings. A further
evaluation of BeatIt against an inactive control would be needed to assess its clinical effectiveness.
Trial registration
This trial is registered as ISRCTN09753005.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
Depression and learning disabilities
Depression is common and places a significant burden on health services. For example, in 2011/12 the
cost of prescribed antidepressant medication alone was £31.4M in Scotland1 and in 2015 it was £284.7M
in England.2 From 2008–12, of all psychiatric hospital discharges, mood disorders were the most common
discharge diagnosis in women.3 Depression is clearly a major public health challenge: it is the third leading
contributor to the global burden of disease, and is expected to rise; the World Health Organization
predicts that it will be the second leading contributor to the global burden of disease by 2020.4
The term ‘learning disability’ refers to people who have significant impairments of both intellectual and
functional ability, with age at onset occurring before adulthood. A significant proportion of the UK
population has learning disabilities. Approximately 2% of adults and 3.5% of children have an intelligence
quotient (IQ) of < 70.5,6 Individuals with learning disabilities have higher levels of mental ill health than the
general population, with a point prevalence of 40% for adults.7
Depression is at least as common in adults with learning disabilities as in the general population, with a point
prevalence of ≈5%.8,9 Indeed, depression is the most common type of mental ill health experienced by adults
with learning disabilities;7 anxiety disorders are also common, with a point prevalence of ≈4%.10 Depression is
more enduring than for the general population,11 suggesting that it is either a more severe condition, or more
poorly managed. For example, a study with a British cohort found that adults with learning disabilities were
four times more likely than the population without a learning disability to meet criteria for chronic depression
over a 28-year period.12 The US 2000 incident cohort with learning disabilities has been calculated to have
lifetime costs (in excess of costs for people without learning disabilities) of US$44.1B.13 Poorly addressed
depression makes a clear contribution to these costs. Hence, as well as the human suffering that depression
brings to people with learning disabilities, their families, local communities and society more widely,
inadequately managed depression is a financial burden.
Psychological therapies for depression
In recent years there have been important innovations in the treatment of depression. A number of high-
intensity psychosocial interventions are as effective as, and longer lasting than, medications in the treatment
of non-psychotic depression.14 This was confirmed in a recent individual patient-level meta-analysis with over
1700 patients treated in randomised controlled trials (RCTs).15 The National Institute for Health and Care
Excellence (NICE) recommends cognitive–behavioural therapy (CBT) to treat mild to moderate depression,16
and high-intensity forms of CBT delivered by mental health experts are recommended to treat moderate and
severe levels of depression.17 There is now an increasing emphasis on low-intensity delivery, as used in the
Improving Access to Psychological Therapies (IAPT) programme in England. These include written self-help
books, computerised CBT and self-help groups.18–22 The evidence base for these approaches continues to
grow, given the attraction of therapies that are less resource intensive.
In behavioural activation, the focus is on behaviour more than on cognition, emphasising engagement
with potential environmental reinforcers. Behavioural activation also takes account of valued activities,23
emphasising the importance of purposeful routine activities such as household chores and self-care, as well
as achievement, pleasure and closeness to others. Avoidance is a key target for change, with the aim of
breaking the vicious cycle linked to mood and activity, whereby reduced activity lowers mood. In turn, the
worse people feel, the more withdrawn they become. Behavioural activation has been shown to be at
least as effective as antidepressant medications, and superior or non-inferior to CBT, placebo pills and
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treatment as usual (TAU) among patients with more severe depression,24–27 with effects as lasting as CBT
following treatment termination.28 Behavioural activation appears to be less complicated to learn than
CBT, it is possible to train non-specialist nurses to deliver it26 and it can be delivered as a high-intensity or
low-intensity therapy.29,30
Psychological therapies for depression in adults with learning disabilities
Although psychological therapies have become established first-line interventions for depression in the
general population, this has not been the case for adults with learning disabilities, owing to the additional
complexities involved in making these interventions accessible to adults with cognitive and verbal
communication impairments. Arguably, psychological therapies are more advisable than pharmacotherapy
for adults with learning disabilities than for the general population, as limitations in verbal communication
skills reduce their ability to report and describe adverse effects of drugs, which can be further disabling or
potentially have serious health effects. Perhaps more importantly, people with learning disabilities should
have the opportunity to access effective psychological therapies just like anyone else. Awareness of the
inequity in provision of psychological therapies has grown, but there remain considerable limitations in the
existing evidence base, and in its implementation. This was recently synthesised by the NICE guideline31 on
mental health problems in people with learning disabilities. A key point is the need for modifications to the
treatment interventions, depending on the type and extent of need of each adult with learning disabilities.32
In 2016, NICE identified that the only available evidence on psychological interventions for depression in
people with learning disabilities was for CBT, adapted for people with learning disabilities. Only three RCTs
(total participants, n = 130)33–35 and three controlled before-and-after studies (total participants, n = 130)36–38
were identified that explored the use of CBT for the treatment, or prevention, of depression in adults with
learning disabilities. These included only participants with mild, or mild and moderate, learning disabilities.
Only two studies reported outcomes beyond the immediate end of treatment.35,36 Although the trials had
variations in the adaptations made to the intervention – and suffered from inadequate power as a result of
the small size (being feasibility or pilot studies), leading to imprecise estimates – NICE concluded that CBT
may result in a clinically meaningful reduction in depressive symptoms over TAU at 38 weeks’ follow-up.
However, the combined evidence was assessed, using the Grading of Recommendations, Assessment,
Development and Evaluation (GRADE) approach, as being of very low quality. One feasibility RCT with
32 participants also evaluated the cost-effectiveness (from the perspective of the NHS and social care
services) of individual CBT constituting 16 weekly 1-hour sessions.35 The cost difference between the two
arms was £5650 but given the small size of the study, it is unclear whether or not CBT is a cost-effective
option for people with mild to moderate learning disabilities. NICE recommended adapted CBT for
depression be considered for adults with mild/moderate learning disabilities, but were not confident
enough in the evidence to make a strong recommendation.
There are possible advantages to considering the use of behavioural activation for people with learning
disabilities, given that it is less complicated to learn than CBT and can be delivered by non-specialists.
However, the only study on behavioural activation with people with learning disabilities and depression
was the feasibility study we undertook to inform the design of the study reported here. It was a pre–post
trial with 22 participants recruited over a 12-month period, at one site.39 Outcomes showed evidence of
positive change on depressive symptoms for those able to self-report on the Glasgow Depression Scale40
pre- and post-intervention, and at 3 months’ follow-up after end of treatment. We therefore used this
study to inform the design of the trial reported here.
INTRODUCTION
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Trial objectives
Primary objective
To measure the clinical effectiveness of BeatIt, a behavioural activation intervention adapted for adults with
learning disabilities and depression, compared with a guided self-help intervention (StepUp), in reducing
self-reported depressive symptoms.
Secondary objectives
1. Does BeatIt lead to a greater reduction in carer-reported depressive symptoms than StepUp?
2. Does BeatIt lead to a greater reduction in self-reported anxiety symptoms than StepUp?
3. Does BeatIt lead to a greater reduction in carer-reported aggressiveness than StepUp?
4. Does BeatIt lead to more significant and sustainable changes in participants’ activity levels than StepUp?
5. Does BeatIt lead to a significantly greater improvement in participants’ quality of life (QoL) than StepUp?
6. Does BeatIt improve carers’ sense of self-efficacy in supporting adults with learning disabilities who are
depressed, compared with StepUp?
7. Is BeatIt a cost-effective intervention for the management of depression experienced by adults with
learning disabilities, compared with StepUp?
8. Does BeatIt improve carers’ reported relationships with the adults with learning disabilities and
depression that they support, compared with StepUp?
In addition, qualitative methods were used to address process issues, which could help to inform the
future uptake of BeatIt or StepUp in practice. We explored the perspectives of:
l participants receiving BeatIt and StepUp
l carers supporting participants receiving BeatIt and StepUp
l therapists delivering BeatIt and StepUp.
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Chapter 2 Trial design and methods
Study design
This was the first large-scale RCT of an adapted individual psychological therapy for people with learning
disabilities and a mental health problem. The design was a multicentre, single-blind RCT of adapted
behavioural activation compared with an adapted, guided self-help intervention. The behavioural activation
intervention was referred to as ‘BeatIt’, and the guided self-help intervention was called ‘StepUp’.
To ensure that it would be possible to recruit to the study, there was an internal pilot phase. Consequently,
there were two phases of data collection:
l Phase 1 – there was an initial 7-month internal pilot phase in Scotland, in which the criterion for
success was to recruit a minimum of 20 participants (approximately three per month).
l Phase 2 – following the successful completion of the internal pilot phase, the study sites in England
and Wales were opened and recruitment continued at all three sites for an additional 11 months.
The trial was supplemented with an economic evaluation to consider the cost-effectiveness of providing
the intervention compared with the attention control (see Chapter 6). There was also a qualitative study to
explore the views and experiences of participants, their supporters and therapists who took part in the trial
(see Chapter 7). The trial protocol has been published.41 A description of all approved changes to the
original protocol that were submitted are shown in Table 1.
Ethics approval and research governance
Multicentre approval was granted by the West of Scotland Research Ethics Committee 3. Research and
development approval was granted in all study sites: Cumbria Partnership NHS Foundation Trust, Lancashire
Care NHS Foundation Trust, Betsi Cadwaladr University Health Board, South Staffordshire and Shropshire
Healthcare NHS Foundation Trust, NHS Lanarkshire, NHS Ayrshire and Arran, and NHS Greater Glasgow and
Clyde. The International Standard Randomised Controlled Trial Number (ISRCTN) reference for the study
is ISRCTN09753005.
Participants
A multipoint recruitment strategy was adopted with the aim of recruiting participants with mild to moderate
learning disabilities and clinical depression across three study sites: (1) Scotland (Greater Glasgow and Clyde,
Lanarkshire and Ayrshire), (2) England (Cumbria and Lancashire) and (3) North Wales (Betsi Cadwaladr
University Health Board). Participants were also recruited from Shropshire and Staffordshire specialist learning
disability services. For pragmatic reasons, Shropshire and Staffordshire were administered by the North Wales
site. The recruitment sites comprised both rural and urban areas.
Potential participants were screened by research assistants and considered eligible for recruitment if they
met all of the following inclusion criteria and did not meet any of the exclusion criteria.
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6TABLE 1 Summary of the approved changes made to the original BeatIt study protocolI
l
l
l
l
l
NVersionnclusion criteria
Had mild/modera
Intelligence™ (W
Community: Seco
Aged ≥ 18 years.
Had clinically sign
Disorders for use
assistants at scree
Gave informed co
Had a level of exp
treatment (readin
IHR Journals Library www.joChanges made to the protocolFrom version 1 to 2 The SSQ3 was added to the self-report measures
The Guernsey Community and Leisure Participation Assessment was removed
Proxy-reported measures of aggression (BPI-S) and of selected aspects of adaptive behaviour
(ABS-RC2) were added
An 8-month follow-up call to the carer was added, to collect data on service and medication use
A procedure and questionnaire for screening suicidal participants was added and suicidal intent
was added to the exclusion criteria
The separate consent forms for participation in the main study and participation in the qualitative
interviews were combined into one form
The Depression Carer Self-Efficacy Scale was removed and replaced with the EDSE scale
Activity data were to be collected from the participant and carer jointly, rather than from the
carer aloneFrom version 2 to 3 The timing of the qualitative interviews was changed from 12 months post randomisation to
between 4 and 8 months post randomisation, to allow better recall
Decision to accept self-referrals
Originally, it was specified that the supporter had to have known/worked with the participant
for a minimum of 6 months. This was changed to 6 months OR is able to obtain information for
the 4 months before randomisation
Exclusion criteria: factors that prevent the participant from interacting with the carer and
therapist or retaining information from the therapy – changed ‘dementia’ to ‘late-stage
dementia’
To carry out inter-rater reliability checks on the fidelity ratings
The need to communicate any potential risks to researchers and therapists was added to the
protocol:
Risk information regarding visiting participants at home will be communicated to researchers
and therapists by the referring individual/organisation. The participant should be informed of
this. If the allocated participant is not previously known to services, the therapist should
follow their service’s standard procedure for seeing new clients safelyThe period of time for follow-up interviews was amended to ‘between 2 weeks before and
4 weeks after the due date’ABS-RC2, Adaptive Behavior Scale – Residential and Community: Second Edition; BPI-S, Behavior Problems Inventory for
Individuals with Intellectual Disabilities – Short Form; EDSE, Emotional Difficulties Self-Efficacy; SSQ3, Social Support
Questionnaire – three questions.te learning disabilities as assessed using the Wechsler Abbreviated Scale of
ASI™)42 and a modified version of the Adaptive Behavior Scale – Residential and
nd Edition (ABS-RC2)43 to assess adaptive behaviour skills.
ificant unipolar depression as determined using the Diagnostic Criteria for Psychiatric
with Adults with Learning Disabilities (DC-LD),44 which was assessed by research
ning who were trained in the use of the diagnostic assessment.
nsent to participate.
ressive and receptive communication skills in English to allow for participation in
g skills were not required).
urnalslibrary.nihr.ac.uk
l Had a family member, paid carer or other support person who could complete screening and baseline
visits and had supported them ideally for a minimum of 6 months OR who was able to obtain information
for the 4 months before randomisation.
l Had a carer or other named individual who could accompany the participant to weekly or fortnightly
treatment sessions with the therapist and who was providing them with a minimum of 2 hours support
per week.
Exclusion criteria
l Was suicidal as assessed during the screening process.
l Had a measured IQ of > 75.
l Experienced difficulties that prevented them from interacting with the carer and therapist or retaining
information from the therapy (e.g. late-stage dementia, significant agitation, withdrawal arising
from psychosis).
l Did not consent to have their general practitioner (GP) contacted about their participation in the study.
Additional participants
As stated in the inclusion criteria above, a support person who had known the participant for at least
4 months was also recruited to take part in the trial as an informant for each individual participant.
Recruitment procedure
Although a multipoint recruitment strategy was adopted, most participants were recruited through specialist
community health teams for people with learning disabilities. A smaller number of participants were recruited
through social work colleagues, third sector organisations working alongside the community teams and IAPT
services in Lancashire, which are open to anyone with mental health problems.
The approach to recruitment was for members of the research team to meet with members of the community
teams or other organisations and provide an explanation about the study and suitable participants. This was a
critical task, as few people with learning disabilities self-refer or are given psychological help for depression.
Most receive help because their difficulties have become a problem for someone else. Referrals to health
services are often for behavioural difficulties such as anger management problems or anxiety disorders that are
proving disruptive or difficult for others to manage or support. Therefore, when describing who might be
suitable participants, members of the research team highlighted that it would be important to bear in mind
individuals whose depressive symptoms might be overshadowed by other presenting problems. Members of
the community teams or other organisations were then able to identify potential participants, provide them
with a brief explanation of the study and give them an information pack. These packs contained a letter,
information sheets and a Freepost envelope that they could return if they were interested in finding out more
about the study. It was suggested to participants that they might find it useful to discuss the study information
with a friend or supporter.
Adults with learning disabilities are often supported by several people. For example, they may have
multiple paid carers working in shifts or different supporters in their home and day-centre environments.
This means that the potential participant may not have known who they could discuss the study with.
This could have created a situation in which information sheets went missing before potential participants
were able to discuss the study with supporters and make an informed decision about whether or not they
wanted to participate. To take account of this, as in previous studies, the member of staff who gave out
the information sheet was asked to notify a NHS secretary in the learning disabilities team (who was
independent of the research study) that an information sheet had been handed out. After 2 weeks, if no
tear off reply slip had been received, the NHS secretary contacted the individual once, by telephone,
to check that they still had the information pack. If the information pack had gone missing, a second
information pack was sent out.
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On receiving a reply slip, a member of the research team arranged to meet the potential participant at their
home or another convenient location for them. The participant was also asked if they would like someone
to support them when they met to discuss the research project. When the member of the research team
met with the participant, they talked through the information sheet and invited questions. If the participant
was satisfied with the responses obtained, they would then be invited to participate in the study.
Advice about the information sheets and the approach taken to recruitment was provided by the Trial
Steering Committee. The views of the Committee members with intellectual disabilities and a family
member proved particularly helpful.
Informed consent
Individuals who chose to take part in the study were asked to complete a written consent form by members
of the research team. The consent form was read to the individual with learning disabilities, they were asked
to sign it, and this was witnessed by a carer or another individual who was independent of the study. Those
who did not have the capacity to consent to participate were excluded from the study. The researchers all
received training on assessing capacity to consent in adults with learning disabilities based on the relevant
UK legislation45,46 and established best practice.
Randomisation, concealment and blinding
Participants who provided informed consent were screened and provided baseline data before being
randomised. The flow diagram for the study is shown in Figure 1. Individuals were allocated to the
BeatIt arm or the StepUp arm in a 1 : 1 ratio, using a blocked randomisation within each study centre.
Mixed block sizes of length four and six were used at random. The randomisation was stratified by study
centre and the use of antidepressants. At the design stage, several potential stratification variables were
considered but ultimately not used, including the use by participants of other drugs that may have some
mood-stabilising properties and are commonly prescribed in this population. For example, an estimated
25% of the population have comorbid epilepsy and may be taking carbamazepine, sodium valproate,
lamotrigine or pindolol. Changes in the prescription of antidepressants and other mood-stabilising drugs
were monitored over the duration of the study.
To conceal the allocation of participants from the research team, researchers randomised each participant
to a treatment arm using an automated system run by the Robertson Centre for Biostatistics (RCB). The
system did not reveal the random allocation to the researcher but notified the study coordinator, who then
contacted the clinicians to arrange subsequent treatment visits. Thus, the researchers collecting outcome
data remained unaware of the study arm to which participants had been assigned.
Interventions
Therapists
To avoid contamination, there were separate therapists for the behavioural activation (BeatIt) and the
guided self-help intervention (StepUp). BeatIt and StepUp therapists were recruited from specialist
community teams for people with a learning disability and, in Lancashire, they were also recruited from
mainstream mental health IAPT services. Hence, the therapists were assistant and trainee psychologists,
community nurses and occupational therapists who all had prior training and experience of working with
people who have learning disabilities and mental health problems. The IAPT therapists who worked on the
trial were low-intensity workers, who were trained to deliver brief, manualised psychological interventions
for depression and anxiety disorders but did not necessarily have experience of working with adults with
learning disabilities.
TRIAL DESIGN AND METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
8
Baseline assessment
(n = 166)
Primary outcome: self-reported depression – GDS-LD
Secondary outcomes:
Self-reports
Anxiety – GAS-ID
QoL – EQ-5D-Y, SSQ3
Life events – BLESID
Proxy (carer) reports
Depressive symptoms – IDDS
Aggression – BPI-S
Activity – ICI, IPDL, ABS-RC2
Patient–carer relationship – Expressed Emotion (5-minute speech sample)
Carer efficacy – EDSE scale
Use of services – CSRI, medication inventory
Setting: community, with carer support of ≥ 2 hours per week
Multipoint recruitment: specialist learning disability services, social
services, care providers, IAPT
Consent/screening visit
Information and discussion about study ± consent
Examine inclusion/exclusion criteria
Screening measures
Learning disability: WASI, ABS-RC2
Depression: DC-LD criteria
Randomisation
Qualitative interviews
20 patients and 20 carers from
both groups
Qualitative interviews
6 BeatIt and 6 attention
control therapists
20 patients and 20 carers
from the BeatIt group
BeatIt
(n = 83)
8 – 12 sessions of supervised
behavioural activation
treatment with fidelity checks
12-month post-randomisation
assessment
Repeat of all outcome measures
4-month post-randomisation
assessment
Repeat of all outcome measures
StepUp
(n = 83)
8 sessions of supervised
guided self-help
with fidelity checks
12-month post-randomisation
assessment
Repeat of all outcome measures
4-month post-randomisation
assessment
Repeat of all outcome measures
Train therapists
Qualitative and quantitative
data analyses/report writing
Train therapists
Monitoring of
treatment fidelity by
independent RAs
8-month post-randomisation
assessment
Carer report: remedication/
use of services
FIGURE 1 Flow chart showing BeatIt study design and participant follow-up. BLESID, Bangor Life Events Schedule for
Intellectual Disabilities; BPI-S, Behavior Problems Inventory for Individuals with Intellectual Disabilities – Short Form;
CSRI, Client Service Receipt Inventory; EDSE, Emotional Difficulties Self-Efficacy; EQ-5D-Y, EuroQol-5 Dimensions –
youth version; GAS-ID, Glasgow Anxiety Scale for people with an Intellectual Disability; GDS-LD, Glasgow Depression
Scale for People with Learning Disabilities; ICI, Index of Community Involvement; IDDS, Intellectual Disabilities
Depression Scale; IPDL, Index of Participation in Domestic Life; RA, research assistant; SSQ3, Social Support
Questionnaire – three questions.
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The therapists received 1–2 days of training about the delivery of the intervention and were given a manual
and packs of materials for use in each treatment session. The training was delivered separately for BeatIt
and StepUp therapists. All trainers completed an initial training course in collaboration with the curriculum
developer (AJ) before training independently. The training provided (1) a background to the interventions
and the underpinning theory, (2) an overview of the content and structure of the interventions, (3) an
introduction to each of the exercises and self-report materials, and training and practice in their delivery and
use, (4) how to deal with potential barriers to progress and (5) how to work alongside both clients with
learning disabilities and their carers.
Supervisors
The supervisors were clinical psychologists with experience of delivering psychological therapies to people
with learning disabilities. They all received 2 days of training in the intervention they supervised. The training
followed the same format as the therapists’ training but included further guidance about supervision of
participants. Time was spent highlighting issues that could cause confusion or may need particular support
from the supervisor (e.g. producing the BeatIt formulation; delivery of the problem-solving StepUp booklet).
Finally, care was taken to emphasise the limits of each intervention to avoid contamination and ensure that
the core ingredients of BeatIt and StepUp remained distinct. For example, the StepUp therapy did not include
homework tasks, with the exception of the problem-solving booklet. Hence, the therapists needed to be
reminded to avoid following up on plans discussed in previous sessions.
Supporters
Table 2 shows the relationship of the supporters to the participants. Of the 161 participants at the outset,
both residential (n = 49) and non-residential (n = 33) support workers featured most commonly, while
parents were the next largest group (n = 34). The friends were other individuals with learning disabilities.
When possible, participants chose who they wanted to support them in therapy sessions but some individuals
had very limited formal or informal support, and in certain instances a visiting professional offered to help.
TABLE 2 Relationship of the supporters to participants
Relationship
Site (n)
All (n)Scotland England Wales and SSSFT
Parent 15 13 6 34
Sibling 6 1 1 8
Other family member 2 1 1 4
Support worker (residential) 22 8 19 49
Visiting social care assistant 3 0 1 4
Visiting professional (community nurse) 7 5 2 14
Spouse or partner 3 2 2 7
Support worker (non-residential) 13 13 7 33
Grandparent 1 0 0 1
Advocate 1 0 0 1
Social worker 1 0 0 1
Housing officer 0 1 0 1
Friend 0 1 2 3
Supervisor 0 1 0 1
Total 74 46 41 161
SSSFT, South Staffordshire and Shropshire Healthcare NHS Foundation Trust.
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Behavioural activation (BeatIt)
BeatIt was adapted from Lejeuz et al.’s47 behavioural activation intervention. The underpinning theory
of behavioural activation is that a negative cycle of withdrawal and avoidance of activity plays a key
role in the development and maintenance of depression and low mood. Consequently, the main goal
of the intervention was to break this negative cycle and bring the individual into contact with positive
environmental contingencies that produce a corresponding improvement in mood. The focus was not on
pleasurable activity but rather on regular activities that were purposeful, sustainable and consistent with
life goals. For example, volunteering for a charity might provide someone with a reason to get up in the
morning and take care of their personal appearance, as well as bringing them into contact with others
and providing them with a valued social role.
BeatIt was delivered on an outreach basis, face to face at the participant’s home, except when participants
chose to meet elsewhere or their living circumstances made it impossible to deliver the intervention at
home. Sessions were scheduled to last for between 1 and 2 hours and were delivered on a weekly to
fortnightly basis, to help build rapport and ensure continuity across sessions. When it was anticipated
that sessions would last > 1 hour, a break was scheduled. The sessions were delivered to the participant
alongside someone who provided regular support in their life. The participants were asked to choose who
they would like to join them during sessions. A meeting was held with the supporter before starting therapy
proper, to help them understand what the therapy involved and what their role in the sessions would be.
The overarching aim in the BeatIt intervention was to foster a collaborative approach, with an agenda
agreed by the client and the supporter at the beginning of each session. The repetition and structure was
designed to aid memory and understanding, helping the client to anticipate what was going to happen
both within and across sessions and to play a more active role in therapy.
Adaptations to BeatIt
A number of adaptations was made to ensure that the behavioural activation intervention was both
accessible to clients with a learning disability and sensitive to their life circumstances. There was careful
piloting of the intervention and the views of people with learning disabilities and their families played a
crucial role in determining the adaptations.
Supporter involvement
One of the main changes to the existing intervention was to involve a significant other in the client’s life in
therapy sessions. People with learning disabilities are likely to rely on others for support in their everyday
lives, including engagement in activity. They may lack the agency or the ability to recall and follow through
with plans for activity without support. Involving a significant other in the therapy sessions helps to ensure
ecological validity (i.e. that the intervention makes sense in the context of their wider lives).
Adapting materials and exercises
Adapting materials and therapeutic activities was designed to ensure that they were accessible and
engaging. All exercises and forms were carefully developed and piloted before use. Using visual materials,
such as photographs of activities, allowed participants to make active choices and helped to scaffold the
therapeutic dialogue.
Assessing level and salience of activity
Care was required when examining a participant’s pattern of activity to avoid making assumptions about
what level of activity was satisfactory. For example, a participant attending a college course several
afternoons a week and going to a drama group on a weekly basis might have only 6 hours of regular
purposeful daytime activity per week. However, this may be regarded as a relatively substantial package
of support compared with that of other people with intellectual disabilities. Therefore, therapists were
encouraged to carefully chart a participant’s ratio of activity and inactivity. Another issue the therapists
were asked to consider was a participant’s level of control and engagement with the activities in which
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they took part. Being present at an activity does not necessarily mean that someone takes part or interacts
with others who are there.
Formulation
A formulation was presented to the participant and their supporter using a behavioural activation framework
to explain the participant’s difficulties and provide a shared ‘story’ or common frame of reference for joint
work with the participant and supporter.
Barriers
Few participants presented with depression alone and most had other emotional, interpersonal and practical
difficulties that needed to be addressed to allow people to increase their purposeful activity. Thus, another
adaptation of the intervention was to tackle other barriers to change; the manual included guidance about
how to deal with the most common barriers that were identified when the intervention was piloted.
These common barriers included (1) anxiety, (2) self-confidence and negative self-perceptions related to
having a learning disability, (3) anger management/interpersonal difficulties, (4) chronic pain, (5) needing
to learn or re-learn skills and (6) organisational barriers, such as a lack of support or inflexible support,
which prevented participants from carrying out planned activities.
The manual made clear that this was not an exhaustive list of barriers and that this aspect of the
intervention needed to be tailored to the individual concerned.
Ending therapy and final booklet
Twelve weeks of therapy were not considered to be sufficient to solve all clients’ difficulties, which it was
thought would fluctuate in relation to the ongoing challenges they faced in their lives. Therefore, steps
were taken to help maintain or build on therapeutic change. First, care was taken to avoid an abrupt end to
therapy. Second, the participant and supporter were given a final booklet at the end of therapy, detailing
the progress made, how this had been achieved and how progress could be maintained. Third, the presence
of the supporter meant that there would be continuing support when the therapist input ended.
BeatIt materials
A comprehensive set of materials was provided to facilitate therapy session activities, including pictures
and post boxes for an initial activity to gain insight into the participant’s pattern of activity, worksheets for
a life-goals task and forms to chart a hierarchy of activities to work on. There were also mood and activity
diaries for participants to complete between sessions with the help of supporters and activity sheets to be
used to plan and schedule activities to be carried out between sessions. Templates were also provided for
the formulation and final booklets to be produced for participants and supporters.
BeatIt: the therapy sessions
The manual describes 12 sessions, which can be divided into three main phases: (1) assessment and
formulation, (2) working towards change and (3) finishing therapy. There was sufficient flexibility within
the manual to allow the intervention to be tailored to the individual’s particular difficulties and life
circumstances. The therapist could also make telephone contact between sessions to prompt participants
about planned activities between sessions.
The first phase consisted of five sessions and involved socialising the client into the approach, identifying
key areas to work on in relation to increasing activity/overcoming avoidance, and developing an individual
formulation. The first three sessions involved key exercises: (1) to develop an understanding of the person’s
activities, in the past and present, and what they would like to do in the future, (2) to help identify their
main life goals and (3) to develop a hierarchy of potential activities in the areas of purposeful daytime,
domestic and social activities, along with a plan of how these could be accessed.
TRIAL DESIGN AND METHODS
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In this first phase, the therapist also introduced mood and activity diaries, which the clients were asked to
complete with the assistance of their supporter between sessions. Activity scheduling was also gradually
introduced. Self-monitoring and scheduled activities were core features of the intervention.
Information gleaned from the first three therapy sessions furnished the therapist with material to develop
an outline formulation. Session 4 was used to review what had been covered in the first three sessions
and to check whether or not ideas for the formulation resonated with the participant and supporter.
This feedback helped to finalise the illustrated formulation booklet, which was delivered in session 5.
The formulation included the agreed plan to increase the participant’s activity or engagement through
scheduled activity in three life domains: (1) domestic tasks, (2) purposeful daytime activity and (3) social/
recreational activity. The plans may have included (1) recovering lost skills and interests, (2) graded
exposure to reduce avoidant behaviours and (3) targeting inherently reinforcing activity and activity likely
to increase access to other positive reinforcers through a programme of scheduled activity.
In the second phase of therapy (sessions 6–10), the participant, therapist and supporter worked to
follow through with their plans, although these could be altered in light of new information or changing
circumstances. For cases in which progress was limited, care was taken to highlight whatever achievements
had been made, and activities and goals could be renegotiated to make them more achievable. The
advantage of having the supporters present in sessions was that the scheduled activities were negotiated
with both the supporters and participants, thereby helping to avoid making plans that the participant was
not motivated to carry through or the supporter was unwilling or unable to support.
As stated above, the challenge of the approach was to overcome the barriers to change; the main issues
faced by participants were tackled in the second phase of the therapy. These barriers included gaps in
skills or lost skills, tackling emotional or interpersonal problems such as anxiety or anger difficulties, low
self-esteem and chronic pain. Of course, the barriers were not all to do with the participants themselves
and work also had to be carried out with supporters and organisations to ensure that people received the
sensitive and flexible support that they required. For example, in some settings participants were not even
allowed to engage in domestic tasks such as cooking or making themselves a snack.
If rapid progress was made, the number of sessions in this middle phase could be reduced.
The third and final phase (sessions 11 and 12) concerned the end of therapy. The first of these sessions
involved recapping on the work that had been completed and highlighting progress made. At the final
session, a booklet was given to the participant and supporter, describing their achievements and including
a plan for maintenance and continued improvement.
Guided self-help (StepUp)
Guided self-help (StepUp) was chosen as an active control intervention because it is comparable to BeatIt
in terms of receipt of some therapist attention, the use of a structured approach and the presence of a
supporter in all therapy sessions. StepUp also offered an ethical alternative in the absence of any other
evidence-based psychological therapies for people with learning disabilities and depression and a lack
of information about the outcomes of usual care. Guided self-help is a psychoeducational approach,
providing new knowledge and skills to help participants deal with common difficulties associated with
depression to help lift their mood.
Once again, this intervention was delivered on an outreach basis, face to face at the participant’s home,
unless they asked to meet elsewhere or their living circumstances made it impossible to deliver the
intervention at home. Sessions were scheduled to last for 1 to 1.5 hours, with a break scheduled for
sessions that continued beyond 1 hour. The sessions were delivered on a weekly to fortnightly basis to
help build rapport and ensure continuity across sessions.
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StepUp adaptations
Accessibility
The self-help booklets were developed in Glasgow with the assistance of people with learning disabilities
from Enable, a third-sector organisation in Scotland. The resources were designed to be used by people
with learning disabilities alongside a supporter. Most study participants had few, if any, literacy skills.
Care was taken to ensure that the topics covered, the language used and the format, including the use of
case examples, helped to make the booklets comprehensible for individuals with learning disabilities.
Relevance
The involvement of people with learning disabilities from Enable also helped to ensure that the content of
the booklets and the examples used would be familiar and relevant to individuals with a learning disability.
As this was a manualised approach, the therapist went through all of the booklets in the same order with
each participant and supporter. The drawback was that the different booklets were perceived to be more
or less salient to different participants. Hence, when someone stated that they slept well, the booklet on
sleep was delivered in light of this and reframed as reviewing the participant’s strengths and as a way of
keeping well.
StepUp materials
This was a manualised approach, and the main accompanying materials were the four booklets concerning
(1) feeling down, (2) sleep, (3) exercise and (4) problem-solving. There were also worksheets for the therapists
to record the main points that the client and supporter had taken from the sessions, and worksheets to plan
and review a problem-solving exercise to be used with the final self-help booklet. Paperwork was provided for
the final two sessions, to draw together key points from across the different booklets and to produce a plan
for the continued use of the booklets.
StepUp: the therapy sessions
Therapists attempted to promote a spirit of collaboration with the participant and supporter, and an
agenda was agreed at the beginning of each session.
Setting the scene
The therapy started (session 1) with an initial meeting with the participant and carer to build rapport,
explain the materials and provide coaching in the use of the materials.
Going through the booklets
In the subsequent five meetings (sessions 2–6), the therapist went through the booklets with the clients
and supporters. The first three booklets were read within one session each, starting with ‘feeling down’,
which provided an explanation of depression and depressive symptoms. The next two booklets concerned
‘sleep’ and ‘exercise’, describing how they are linked to depression and how improving sleep and
increasing exercise can help to lift someone’s mood. The final booklet dealt with the more complicated
topic of problem-solving and how such skills can help in overcoming depression. Owing to the complexity
of this final topic, the problem-solving booklet was delivered over two sessions.
The booklets were designed to be made personally relevant to individuals. Characters were introduced
to illustrate particular points and participants were asked how their experiences compared with those of
the characters. The booklets also prompted discussion about whether or not the suggested changes or plans
could be helpful for the participants and supporters. However, with the exception of the problem-solving
booklet, in which the participant was asked to complete an exercise between sessions, a clear instruction was
given to therapists to avoid returning to any particular plans or ideas that were discussed in previous sessions.
It was important for therapists to avoid creating any expectation that clients and supporters were being set
specific tasks to carry out between sessions.
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Ending therapy
The two final sessions (7 and 8) helped to avoid an abrupt ending to therapy and gave time to consider
the continued use of the booklets moving forward. The aim of the penultimate session was to review
key messages from each booklet for participants, before going on to consider how the booklets could
complement each other. For example, doing more exercise could help with sleep. In the same vein, better
problem-solving abilities could help someone to manage their finances better, leaving sufficient funds to
get out on a more regular basis.
At the final session, plans were made with the patient and supporter for the continued use of
the booklets.
To clarify areas of overlap and difference between the behavioural activation and guided self-help
interventions used in the study, an overview of the two interventions is shown in Table 3.
Fidelity to the intervention
Development of the fidelity measure
The first part of the fidelity measure concerned the presence of techniques and elements that were
essential components of the described interventions. Each session for the two interventions had a different
structure and content, with a greater variation in content for BeatIt than for StepUp. A simple descriptive
rating of three core key activities specific to each session was developed for both interventions. For
example, the core items for session 3 of BeatIt were: ‘Review of first homework activities and consider
strategies for increasing motivation’, ‘Collaboratively draw up hierarchy of activities that include each
target life domain’ and ‘Use a pictorial or other prompt that successfully engages the client’, with each
TABLE 3 Overview of BeatIt and StepUp characteristics
Characteristic
Trial arm
BeatIt StepUp
Type of intervention Behavioural activation Guided self-help
Number of sessions 12 8
Supporter present during
sessions
Yes Yes
Manualised Yes Yes
Review progress made
between sessions
Yes No
Address barriers to change Yes No
Intervention-specific
materials
Mood and activity diaries to be completed
between sessions; worksheets and identifying
meaningful activities (post boxes and pictures);
worksheets for identifying life goals and
values; worksheets for planning and reviewing
activities between sessions; individualised
formulation booklet; list of common barriers
to change with suggested materials for
addressing them; final end-of-therapy booklet
Four self-help booklets about
1. understanding depression
2. sleep
3. physical activity
4. problem-solving
In addition, summary sheets to identify
key messages from each booklet and
worksheets for problem-solving booklet
homework task; and worksheets for
making plans for continued use of
booklets
Homework between sessions Homework activities planned each session
from session 3 to 11 and reviewed at
following session
One homework task set during
session 5 after reading through
problem-solving booklet
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item scored as simply present or absent. For StepUp, items for sessions 2, 3 and 4 were ‘The therapist asks
the client and supporter what they can remember from the last session and reviews and discusses the
topic’, ’The booklet for the current session is read through together with the client and supporter’ and
‘The client and supporter are asked what they think are the most important messages from the booklet
that has been read’. For BeatIt there were additional items regarding homework and the use of diaries,
which were unique aspects of this intervention.
The second part of the fidelity assessment concerned the ‘quality’ of therapy delivery. This was designed as
a quality and non-specific therapy process measure for structured and manualised therapies. The structure
of the measure was based on fidelity scales such as those described by Hepner et al.48 and reported in
Hunter et al.,49 themselves based on the Cognitive Therapy Scale50 which is a precursor of the Cognitive
Therapy Scale – Revised (CTS-R).51 The 10 items in the current measure assessed whether or not
the therapist:
1. creates an agenda and agrees what will be covered in the session
2. maintains a focus and clear structure to the session
3. avoids offering therapy outside the remit of the intervention
4. asks for feedback from the previous session
5. asks for feedback and reaction to the current session
6. conveys understanding by checking and rephrasing
7. adjusts content and style of own communication
8. communicates clearly without hesitations and with good pace
9. shows empathy
10. shows warmth and respect.
The rating of these was accompanied by an extended description of the factor addressed by the item, with
the addition of clear operationalisation as part of the manual for the measure. For example, the descriptor
for item 7, ‘adjusts content and style of own communication’ was as follows:
A core skill in working with people with learning disabilities is the ability to adjust how the therapist
communicates to ensure that the client understands the communication. This is a complex skill and
requires the therapist to be very aware of the client’s responses as clients may not communicate a lack
of understanding in an obvious manner; this item may involve therapists using shorter sentences,
breaking information into smaller chunks, using pictures and drawings.
The operationalisation aid was as follows:
There is a difficulty in judging adjustment, as many clients seem to follow the interaction well, and on
that basis it could be argued that the therapist is adjusting the interaction to meet the client’s needs.
To rate this, we should be listening for clear signs of the therapist using a different language, shorter
statements and more pauses and that this might vary at key points in the interaction when new
information or a more complex part of the process is introduced. Some therapists have difficulty doing
this and use very complex language. In cases of very high complexity, speed or very long passages of
speech by the therapist, it should be safe to assume that adjustment is not happening (all people with
learning disability will struggle with multiple complex concepts without the opportunity to adjust and
repeat). An additional complexity is that the therapist may be speaking to the carer in a different
manner than they do to the client. This will demonstrate adaptation of delivery; however, it may be
seen as excluding the client from parts of the therapy. This item will be judged on the complexity of
delivery (some delivery may be so complex that it will not be possible for any person with a learning
disability to understand even if they appear to do so) and evidence of rephrasing and adjusting
language to explain and repeat a point.
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The scale was rated on a four-point anchored scale, specific to each item. Thus, for item 7 the anchors
were as follows:
l The therapist does not adjust their communication style and communicates in a way that seems to be
too complex for the client (and carer) or overcompensates and communicates in a way that seems
condescending.
l The therapist makes some adjustment to their communication style at some points in the session, but
this is not based on how the client and carer respond and is not consistent throughout the session.
l The therapist adjusts their communication style throughout most of the session and this appears to be
well matched to the level of understanding of the client (and carer).
l The therapist adjusts their communication style throughout the session and clearly reflects the client’s
understanding in their adjustments in a way that shows accommodation to the client’s needs in each
part and activity of the session.
The fidelity measures were then piloted by Dave Dagnan and Andrew Jahoda to assess six recorded sessions
(three BeatIt and three StepUp). Each recording was separately rated by Dave Dagnan or Andrew Jahoda and
then discussed to identify challenges in the wording of the items, their descriptors and operationalisation
information. These processes enabled the further development of operationalisation information. A consensus
rating of these recordings was agreed and used to develop criteria for training raters.
When each participant was allocated to a therapist, the therapist was instructed to record two particular
sessions for fidelity purposes. These were selected to ensure that an early and a later session were
recorded and that exemplars from every session would be equally available across both arms of the study.
The recordings were returned to the research centre and uploaded. To avoid unblinding, researchers from
one centre were allocated recordings from a different centre to rate for fidelity. Training for fidelity raters
was delivered as follows:
l Each researcher rated each of the six criterion recordings. After each recording was rated, a discussion
was held with Dave Dagnan in which the reasoning behind each rating was discussed. Criteria for
satisfactory agreement was set as full agreement on the technical presence or absence of treatment
components and disagreement by no more than one point on four or fewer items in the 10-item
therapy quality scale. A minimum of four recordings were rated in the training. If a researcher achieved
criterion in less than four recordings, further recordings were rated and discussed until four recordings
had been rated. Six raters were trained, although only four contributed to the final data set, with one
rater carrying out ratings for inter-rater reliability; all achieved criterion between three and six recordings.
l To ensure consistency and prevent drift throughout the fidelity rating process, a further recording
was jointly rated by Dave Dagnan and the researcher every 20 fidelity ratings; the same criteria for
agreement was applied as in the original training.
l Inter-rater reliability data were generated by a further rater who rated 48 recordings with a balanced
number of ratings from each site in each arm of the study. This rater was trained using the same
procedure as the primary fidelity raters with the same consistency rating every 20 ratings.
Supervision
To help ensure that the therapy was delivered with fidelity to the manual, therapists received supervision
from a clinical psychologist experienced in delivering psychological therapies to people with a learning
disability on a weekly or fortnightly basis, with face-to-face supervision meetings at least once a month. In
some locations, supervision was given to small groups of therapists (two to four). A supervision agreement
was made with each of the therapists at the outset. The therapists brought therapy logs to supervision that
they had completed after meeting with clients. The therapist used the logs to record (1) what tasks had
been carried out in the session, (2) what had been carried out successfully, (3) barriers faced and (4) their
plan for the next session. There was also a space for any other notes or thoughts to be recorded and an
additional section for the BeatIt participants about any homework set for the participant to complete
between sessions. The logs provided a structure for the supervision and notes were kept to provide a
record of each supervision meeting and signed by both supervisor and therapist.
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Data management
The trial was conducted in accordance with the principles of Good Clinical Practice (GCP) to ensure quality
of data and protection of participants. These matters were carefully discussed with members of the Trial
Steering Committee; members of the Committee with learning disabilities requested to run through the
measures with the researchers in Scotland. When doing so, the Committee members offered helpful
advice about ensuring that the process of data collection was engaging and accessible for participants.
Data were collected by trained researchers and health professionals, using detailed standard operating
procedures. Any inconsistencies were investigated and resolved in a timely manner. Careful quality checks
were made before data were submitted to RCB. Once data had been submitted, further independent
quality checks were performed by RCB before database lock. After database lock, the final statistical
analyses were carried out.
Data collection and blinding
As shown in Figure 1, data were collected at three time points:
1. baseline
2. time 1 – 4 months post randomisation (post intervention)
3. time 2 – 12 months post randomisation (follow-up/maintenance).
The data were collected on an outreach basis, face to face, and this ordinarily occurred at a participant’s
home, unless another location that offered privacy was preferable. As data were also collected from
carers, arrangements were made to have separate meetings with both carers and participants when the
researcher visited. There was one additional data collection point at 8 months via telephone with the carer
alone, to chart any changes in the participant’s medication use and receipt of services.
Both treatments were of similar duration and included a support person. Moreover, both groups of
participants were told that they were joining the BeatIt trial, rather than being told that they were being
allocated to the BeatIt or StepUp intervention. These key similarities helped prevent research assistants
from becoming unblinded if participants made reference to their therapy sessions during follow-up
meetings. In addition, none of the researchers conducted qualitative interviews or was involved in the
fidelity checks for participants from whom they collected outcome data. Qualitative interviews and therapy
fidelity ratings were carried out by a researcher other than the researcher who gathered the outcome data
from the participant concerned.
Measures
Primary outcome measure
The primary outcome was the Glasgow Depression Scale for people with a Learning Disability (GDS-LD),40
a self-reported measure of depressive symptoms. The GDS-LD is a 20-item scale that asks participants to
indicate how often they have experienced particular depressive symptoms over the previous week using a
three-point scale (never/sometimes/always).
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Secondary outcome measures
Measures of depression and anxiety
Depressive symptoms (carer rating)
Carers completed the Intellectual Disabilities Depression Scale (IDDS)52 to provide an informant view of
participants’ depressive symptoms. This is a 38-item behavioural checklist designed to measure the
frequency of observable depressive behaviours within a 4-week period.
Anxiety symptoms (self-rating)
Self-reported anxiety symptoms were measured using the Glasgow Anxiety Scale for people with an
Intellectual Disability (GAS-ID).53 This scale has three sections dealing with worries, specific fears and
physiological symptoms that the respondent may have experienced over the previous week and grades
them using a three-point scale (never/sometimes/always).
Level of aggressive behaviour
The aggressive/destructive behaviour subscale of the Behavior Problems Inventory for Individuals with
Intellectual Disabilities – Short Form (BPI-S)54 was completed by carers and used to examine the frequency
with which the participants displayed different aggressive behaviours.
Quality of life
Quality of life (self-report)
The EuroQol-5 Dimensions – Youth version (EQ-5D-Y)55 was used to measure QoL outcomes. This version
was developed for young people aged ≥ 8 years. Although the language is not childish, it is more
straightforward and comprehensible.56 The five questions are accompanied by a 100-point visual analogue
scale [EuroQol Visual Analogue Scale (EQ-VAS)], on which participants are asked to rate how good or bad
their health is on that day.
Community involvement
The Index of Community Involvement (ICI)57 recorded the frequency of participation in social,
community-based and domestic and leisure activities over a 4-week period.
Domestic activity
The Index of Participation in Domestic Life (IPDL)58 was designed to record changes to participation in
13 household tasks during the previous 4 weeks.
Perceived social support
The Social Support Questionnaire – three questions (SSQ3)59 is a three-item questionnaire that examines
perceived social support (PSS). It recorded both the size of participants’ social networks and their
satisfaction with the levels of support that they received.
Adaptive behaviour
Four subscales of part 1 of the ABS-RC2,43 concerning the motivation to engage in tasks and to take
responsibility, were used as a proxy measure of activity avoidance. These subscales were (1) domestic
activity (six items), (2) self-direction (five items), (3) responsibility (three items) and (4) socialisation
(seven items).
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Carer self-efficacy and carer–patient relationship
Carer self-efficacy
The carers’ perceptions of their ability to provide support to adults with a learning disability was examined
using the Emotional Difficulties Self-Efficacy (EDSE) scale.60,61 This is a four-item questionnaire that asks carers
to rate their confidence in supporting the emotional difficulties of the person with a learning disability.
Carer–patient relationship
The Expressed Emotion: Five-Minute Speech sample (FMSS)62 was used to assess the relationships between
carers and participants by asking carers to speak about their thoughts and feelings towards the people
whom they support, uninterrupted for 5 minutes, and rating their responses.
Life events
Finally, the Bangor Life Events Schedule for Intellectual Disabilities (BLESID)63 self-report version was used to
record participants’ recent life events. This questionnaire was used to record the important life events that
had taken place in participants’ lives over the previous 12 months and the impact that these events had on
their lives. This allowed for the analysis of potential changes in the reactions to life events over time, such
as a reduction in the negative impact experienced in response to new events that occurred during the
course of the study. Because BLESID records events experienced over a period of 12 months, it was used
only at baseline and the 12-month follow-up.
Health economics
Resource use
The Client Service Receipt Inventory (CSRI)64 is a validated tool to measure total package resource use
and has been used in evaluations involving service users with psychiatric problems and service users with
learning disabilities. It records items such as contacts with community-based primary care, other health or
social services, educational services, and outpatient and inpatient attendances. Unit costs for most of these
are available.
Medication inventory
Both prescription and over-the-counter (OTC) medication use was recorded. Any changes in the use of
medication over the course of the intervention and during follow-up were noted to determine if there were
treatment differences between the two arms of the study. In combination with the CSRI, medication use
was costed.
Expectations of therapy
Participants’ expectations of the potential of therapy to be successful were assessed before starting the
intervention using two questions rated on a four-point scale. The questions were taken from the Therapy
Expectation Measure,65 developed for use with people who have learning disabilities.
Sample items from the primary outcome measure and selected secondary outcome measures can be found
in Appendix 1.
Sample size
In the first 18 months of an earlier pre–post trial of BeatIt, the mean reduction in GDS-LD39 scores at
3 months’ follow-up was 8.50 points [standard deviation (SD) 5.24 points].
The present study was powered to detect a mean between-group difference of 0.6 SD units, or 3.14 points
on the GDS-LD.
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If the BeatIt group in this study could achieve an 8.5-point improvement in GDS-LD scores at 12 months,
then this allows for the StepUp group showing 5.36-point improvement over the same time period
(i.e. 63% of the improvement in the BeatIt group).
Alternatively, this allows for a small improvement in the StepUp group, in conjunction with a large
short-term improvement in the BeatIt group, followed by some regression. For example, if the BeatIt
group show an improvement from baseline to 12 months of 6 points, then the study would be powered
to detect a difference if the mean improvement in the StepUp group was 2.86 points.
To have 90% power to detect this difference, the study required 60 participants in each arm to provide
outcome data at 12 months post randomisation. The primary analysis was to be an analysis of covariance,
adjusting for baseline GDS-LD score, which would have the power to detect smaller intervention effects,
depending on the level of correlation in scores over time.
There were no data to inform the effect of clustering of outcomes for participants with learning disabilities
seen by each therapist. The assumption was made that each therapist would work with an average of nine
participants (i.e. several part-time therapists at each site) and an intraclass correlation of 0.025 was assumed,
resulting in the sample size being increased by 20% to 72 per group, or 144 in total. A recruitment target of
166 participants allowed for a loss to follow-up of ≤ 13.3%. A meta-analysis of research with the general
population66 found a post-intervention effect size on self-reported depression symptoms of behavioural
activation therapy versus supportive therapy of 0.75. These designs were similar to our own attention control
design. However, they did not report data regarding long-term follow-up in comparison with supportive
therapy. The effects relative to brief psychotherapy were 0.56 post intervention and 0.50 after an average
follow-up of 4 months, suggesting that the effects of behavioural activation therapy might persist for some
time. Our follow-up at 12 months post randomisation was approximately 9 months post intervention, so we
would be able to detect differences between groups only if they persisted over a longer time frame than
usually studied. Therefore, we believed that an effect size for sample size estimation purposes of 0.60 was
realistic given the results of this meta-analysis for behavioural activation versus supportive therapy, and this
would also be considered to be of ‘moderate’ size and thus meaningful from a clinical perspective for an
individual therapeutic intervention.
Statistical analyses
The statistical analyses were specified in a statistical analysis plan (SAP) (see Appendix 2), which was
approved before database lock.
The primary analysis compared GDS-LD scores at 12 months post randomisation between intervention
groups, adjusting for baseline GDS-LD scores, study centre and use of antidepressants at baseline within
a mixed-effects linear regression model, including therapist as a random effect. Similar methods were
applied to the primary outcome measure at the immediate post-intervention assessment (4 months post
randomisation) and to secondary outcome measures at each assessment point. These models were used to
estimate between-group differences at each follow-up time point, and to estimate mean changes from
baseline within each intervention group. Repeated measures analyses, adjusting for stratification factors,
were also applied to each outcome measure. These models were used to confirm the results of analyses
looking at each follow-up time point separately, as well as estimating mean changes in outcomes between
4 and 12 months. In general, analyses were carried out using the available data. However, analyses of the
primary outcome were repeated using multiple imputation, to assess whether or not the results were
sensitive to missing data. To impute missing values at each time point, prediction models were based on
age, antidepressant use and any previous or subsequent measurements of the primary outcome; prediction
models did not include randomised group. Models for the primary outcome were extended to explore the
effects of baseline characteristics, including the stratification factors, chronicity of depressive symptoms,
life events and history of previous psychological intervention. The moderating effects of these factors were
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explored by using appropriately constructed interaction terms within linear regression models. These
moderation analyses were exploratory only and designed to inform future translation of the intervention
into routine clinical practice. Selected analyses were repeated using a per-protocol population of
participants who attended at least eight BeatIt therapy sessions or at least six StepUp sessions.
Additional exploratory analyses were outlined in the SAP as potential avenues for future investigation.
These analyses have not yet been carried out and are not included in this report.
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Chapter 3 Participants
This chapter describes the characteristics and circumstances of participants recruited to the trial.This includes:
l the flow of participants into the trial, including referral sources
l demographic characteristics and circumstances of participants across the two therapy arms
l characteristics of carers across the two therapy arms
l the services people were receiving in the 4 months before baseline across the two therapy arms.
Flow of participants into the trial
Figure 2 reports the flow of participants into the trial. In total, 934 information packs were sent out, from
which 233 reply slips were received (four of these slips indicated that the potential participant was not
interested in taking part). In total, 186 people gave their consent to take part in the study, and at that
point their eligibility was assessed. Of these 186 people, 19 people were excluded, most as a result of
not meeting depression criteria (eight people) or the IQ being above the threshold for inclusion in the
trial (six people). An additional three people withdrew before randomisation, and three people were
randomised but no therapist was available.
This resulted in 161 people being randomised into the trial. Six people were lost to follow-up and
14 people withdrew during the trial, resulting in a total of 141 participants who completed the trial.
Sixty-nine of these 141 participants were recruited in Scotland, 38 in England and 34 in Wales.
Table 4 shows that two-thirds of the participants were referred by community nurses, psychologists and
psychiatrists who worked in community teams for people with learning disabilities.
Participants at baseline
Seventy-seven participants were randomised to receive StepUp and 84 participants were randomised
to receive BeatIt. The imbalance of seven participants was a result of using a stratified randomisation
scheme. Participants were randomised in six strata defined by recruitment site (Scotland, England, Wales)
and whether or not participants were taking antidepressants at baseline (yes/no). Within these strata,
participants were randomised in blocks of length four (two to each arm) and six (three to each arm), with
block lengths occurring at random. Therefore, within each stratum, the imbalance between treatment
groups could be at most three in either direction (if the study stopped midway through a block of six
allocations, and that block had consisted of three allocations to one group by three allocations to the
other group). Across the six strata, at the end of the trial, the balance of randomisations were as follows:
l Scotland, taking antidepressants: 29 to BeatIt and 27 to StepUp; difference = +2
l Scotland, not taking antidepressants: 10 to BeatIt and eight to StepUp; difference = +2
l England, taking antidepressants: 12 to BeatIt and 13 to StepUp; difference = –1
l England, not taking antidepressants: 12 to BeatIt and nine to StepUp; difference = +3
l Wales, taking antidepressants: 12 to BeatIt and 11 to StepUp; difference = +1
l Wales, not taking antidepressants: nine to BeatIt, and nine to StepUp; difference = 0.
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Allocated to BeatIt
(n = 84)
Intention-to-treat
population at 4 months
(n = 74)
Intention-to-treat
population at 12 months
(n = 68)
Withdrew
(n = 8)
Lost to follow-up
(n = 2)
Withdrew
(n = 4)
Lost to follow-up
(n = 2)
Information packs given out
(n = 934)
(a)
Reply slips returned
(n = 233)
Consented and eligibility
assessed
(n = 186) Excluded
(n = 25)
Randomised
(n = 161)
• Scotland, n = 85
• England, n = 56
• Wales (and SSSFT), n = 45
• Suicidal, n = 2
• Did not meet clinical depression criteria, n = 8a
• IQ too high, n = 6
• Unable to give informed consent, n = 1
• Taking part in another study, n = 1
• Unable to engage, n = 1
• Withdrew before randomisation, n = 3
• No therapist available, n = 3
• Scotland, n = 74
• England, n = 46
• Wales (and SSSFT), n = 41
141 (87.6%) participants completed the study
• 68 (81.0%) in the BeatIt arm
• 73 (94.8%) in the StepUp arm
• Scotland, n = 39
• England, n = 24
• Wales (and SSSFT), n = 21
Allocated to StepUp
(n = 77)
Intention-to-treat
population at 4 months
(n = 75)
Intention-to-treat
population at 12 months
(n = 73)
Withdrew
(n = 2)
Lost to follow-up
(n = 2)
• Scotland, n = 35
• England, n = 22
• Wales (and SSSFT), n = 20
FIGURE 2 Participant flow diagram. Data were removed from analysis. (a) Intention-to-treat population; and
(b) per-protocol population. SSSFT, South Staffordshire and Shropshire Healthcare NHS Foundation Trust.
a, Includes one participant initially allocated to StepUp in error. (continued )
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• Scotland, n = 32
• England, n = 18
• Wales (and SSSFT), n = 11
Allocated to BeatIt
(n = 84)
Lost to follow-up
(n = 1)
Withdrew
(n = 2)
Did not receive at least
eight treatment sessions
(n = 23)
118 (73.3%) completed study per protocol
• 58 (69.0%) completed study in BeatIt arm per protocol
• 60 (77.9%) completed study in StepUp arm per protocol
(b)
Completed BeatIt per protocol
(n = 61)
Per-protocol population at 4 months
(n = 60)
Per-protocol population at 12 months
(n = 58)
• Scotland, n = 31
• England, n = 16
• Wales (and SSSFT), n = 16
Allocated to StepUp
(n = 77)
Withdrew
(n = 1)
Lost to follow-up
(n = 2)
Did not receive at least
six treatment sessions
(n = 14)
Completed StepUp per protocol
(n = 63)
Per-protocol population at 4 months
(n = 62)
Per-protocol population at 12 months
(n = 60)
FIGURE 2 Participant flow diagram. Data were removed from analysis. (a) Intention-to-treat population; and (b) per-protocol population. SSSFT, South Staffordshire and
Shropshire Healthcare NHS Foundation Trust. a, Includes one participant initially allocated to StepUp in error.
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Table 5 describes demographic and health characteristics of the 161 participants who began the trial at
baseline, broken down across the two therapy arms. Overall, a slight majority of participants were female,
with a mean age of 40 years. Most participants were white and single. The mean Full Scale IQ was 58.34
for StepUp participants and 55.44 for BeatIt participants.
TABLE 4 Referral sources for participants in the trial: referrers’ profession
Profession
Site (n)
Total (n)Scotland England Wales
Nurse 30 23 30 83
Psychologist 27 0 1 28
Psychiatrist 11 0 4 15
Social worker 4 0 4 8
Dietitian 2 0 0 2
Self-referral 0 6 0 6
IAPT therapist 0 9 0 9
Clinical studies officer 0 5 0 5
Support worker 0 3 0 3
Reviewing officer 0 0 2 2
Unknown 0 0 0 0
Total 74 46 41 161
TABLE 5 Baseline demographic and health characteristics of participants
Variable
Trial arm
StepUp (N= 77) BeatIt (N= 84)
Gender, n (%)
Male 38 (49.4) 38 (45.2)
Female 39 (50.6) 46 (54.8)
Age (years)
Mean (SD) 40.1 (12.0) 40.3 (11.7)
IQ, mean (SD)
Verbal 63.14 (10.15) 58.87 (8.67)
Performance 58.45 (8.11) 57.84 (9.18)
Full Scale 58.34 (8.38) 55.44 (8.02)
Ethnicity, n (%)
White 75 (97.4) 81 (96.4)
Other 1 (1.3) 2 (2.4)
Unknown 1 (1.3) 1 (1.2)
Marital status, n (%)
Married/live-in partner 7 (9.1) 5 (6.0)
Separated/divorced/widowed 1 (1.3) 6 (7.1)
Single 67 (87.0) 73 (86.9)
Unknown 2 (2.6) 0 (0.0)
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A majority of participants (58.4% of StepUp participants and 65.5% of BeatIt participants) had some
degree of visual impairment, with smaller proportions (10.4% of StepUp participants; 23.8% of BeatIt
participants) having some degree of hearing impairment. Approximately one-quarter of participants
(26.0% of StepUp participants; 22.6% of BeatIt participants) had mobility problems.
Table 6 describes selected circumstances of the 161 participants who began the trial at baseline, broken
down by therapy arm. In terms of deciles of neighbourhood deprivation (where 1 is the most deprived and
10 is the least deprived) based on participants’ postcodes, participants on average were living in slightly
more deprived postcodes than the median. In terms of negative life events, participants in both therapy
arms had experienced on average more than one negatively experienced life event in the 12 months before
baseline (mean 1.36 events for StepUp participants; mean 1.48 events for BeatIt participants).
Service receipt in the 4 months prior to baseline
Over two-thirds of participants (68.8% of StepUp participants; 70.2% of BeatIt participants) were receiving
support from services at least daily. According to the PSS scale, participants were receiving social support
from an average of fewer than two family members (1.32 for StepUp participants; 1.98 for BeatIt
participants) and social support from an average of approximately three non-family members (3.30 for
StepUp participants; 2.92 for BeatIt participants).
Approximately one-fifth of participants had previously received therapy for depression (18.2% of
StepUp participants; 20.2% of BeatIt participants). Approximately two-thirds of participants were being
prescribed antidepressant medication (66.2% of StepUp participants; 63.1% of BeatIt participants). In
terms of mood-stabilising medication, 19.5% of StepUp participants and 13.1% of BeatIt participants were
prescribed this medication. It was also established that 11.7% of StepUp participants and 4.8% of BeatIt
participants were taking antiepileptic medication.
Table 7 describes the services used by participants in the 4 months prior to baseline, broken down by
therapy type. This was collected using the Client Service Receipt Inventory (CSRI) and gives some indication
of the context of participants’ lives as they entered the trial.
TABLE 5 Baseline demographic and health characteristics of participants (continued )
Variable
Trial arm
StepUp (N= 77) BeatIt (N= 84)
Vision, n (%)
Visual impairment 45 (58.4) 55 (65.5)
No visual impairment 32 (41.6) 29 (34.5)
Hearing, n (%)
Hearing impairment 8 (10.4) 20 (23.8)
No hearing impairment 69 (89.6) 64 (76.2)
Mobility problems, n (%)
Mobility problems 20 (26.0) 19 (22.6)
No mobility problems 57 (74.0) 65 (77.4)
Antiepileptic medication, n (%) 9 (11.7) 4 (4.8)
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TABLE 6 Baseline selected circumstances of participants
Variable
Trial arm
StepUp (N= 77) BeatIt (N= 84)
Deprivation decile, mean (SD) 3.8 (2.1) 4.5 (2.6)
BLESID (life events): number of life events experienced negatively, mean (SD) 1.36 (1.60) 1.48 (1.59)
Degree of service support, n (%)
Less than daily support 24 (31.2) 25 (29.8)
Daily support 53 (68.8) 59 (70.2)
PSS: number of family members, mean (SD) 1.32 (1.5) 1.98 (2.3)
PSS: number of non-family members, mean (SD) 3.30 (2.6) 2.92 (2.3)
Previous therapy for depression, n (%)
Yes 14 (18.2) 17 (20.2)
No 63 (81.8) 67 (79.8)
Use of antidepressants, n (%)
Yes 51 (66.2) 53 (63.1)
No 26 (33.8) 31 (36.9)
Use of mood stabilisers, n (%)
Yes 15 (19.5) 11 (13.1)
No 62 (80.5) 73 (86.9)
Antiepileptic medication, n (%)
Yes 9 (11.7) 4 (4.8)
No 68 (88.3) 80 (95.2)
TABLE 7 Mean resource use for participants using resources 4 months prior to baseline
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Daytime activities
Day centre
Weeks attended 14.9 (3.93) 10 (13.7) 15.3 (2.69) 13 (19.1) –0.41 (1.45) –3.49 to 2.68
Hours per week 18.4 (8.14) 10 (13.7) 20.8 (11.61) 13 (19.1) –2.46 (4.12) –11.0 to 6.12
Voluntary work
Weeks attended 12.7 (6.25) 18 (24.7) 13.6 (4.87) 13 (19.1) –0.89 (2.0) –4.98 to 3.20
Hours per week 4.69 (5.99) 18 (24.7) 5.31 (4.12) 13 (19.1) –0.61 (1.82) –4.33 to 3.10
Adult education
Weeks attended 15.4 (1.81) 7 (9.6) 8.71 (5.62) 7 (10.3) 6.71 (2.23) 1.47 to 12.0
Hours per week 4.93 (2.32) 7 (9.6) 8.57 (10.9) 7 (10.3) –3.64 (4.22) –13.8 to 6.48
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In cases in which < 5% of participants at baseline had received a particular service in the 4 months before
baseline (eight participants or fewer), full data are excluded from Table 7. Specific services used by eight or
fewer participants in total in the 4 months before baseline were sheltered work (used by three people in
total); drop-in centre (four people); learning disabilities centre (zero people); psychiatric intensive care ward
(zero people); acute psychiatric ward (one person); psychiatric rehabilitation ward (one person); general
medical ward (seven people); other hospital specialties (two people); day hospital (two people); psychiatric
outpatient visits (five people); community mental health team member (one person); healthcare assistant
(three people); speech therapist (one person); art/drama/music therapist (one person); alternative therapist
(two people); social work assistant (two people); and audiologist (five people).
Table 7 shows 25 indicators of service use, used by nine or more participants in the trial in the 4 months
prior to baseline. For specific types of daytime activity, the number of weeks a service was used in the
4 months prior to baseline, the mean number of hours per week the service was used, and the number of
TABLE 7 Mean resource use for participants using resources 4 months prior to baseline (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Social club
Weeks attended 13.1 (5.67) 23 (31.5) 13.4 (5.56) 22 (32.4) –0.32 (1.67) –3.70 to 3.06
Hours per week 3.28 (2.01) 23 (31.5) 3.32 (1.96) 22 (32.4) –0.04 –1.23 to 1.16
Hospital services: number of contacts
Other hospital outpatient visit 5.31 (11.2) 13 (17.8) 2.94 (3.55) 16 (23.5) 2.37 (3.23) –4.55 to 9.30
A&E visit 1.56 (1.01) 9 (12.3) 1 (0) 7 (10.3) 0.56 (0.34) –0.22 to 1.33
Community-based services: number of contacts
Community psychiatrist 1.77 (1.07) 26 (35.6) 2.43 (2.17) 28 (41.2) –0.66 (0.46) –1.59 to 0.271
Psychologist 5.41 (8.14) 17 (23.3) 5.14 (6.68) 14 (20.6) 0.27 (2.66) –5.17 to 5.71
GP 3.17 (3.40) 48 (65.8) 3.07 (2.33) 46 (67.6) 0.10 (0.60) –1.09 to 1.29
Community psychiatric nurse 5.25 (3.20) 4 (5.5) 8.20 (5.85) 5 (7.4) –2.95 (3.07) –10.3 to 4.45
Community learning disability
nurse
5.91 (4.84) 32 (43.8) 6.21 (5.76) 24 (35.3) –0.30 (1.45) –3.23 to 2.63
Other community nurse 28.8 (66.5) 12 (16.4) 3.27 (4.71) 11 (16.2) 25.6 (19.3) –16.8 to 67.9
Physiotherapist 6.29 (6.02) 7 (9.6) 4.6 (6.95) 5 (7.4) 1.69 (3.85) –7.21 to 10.6
Occupational therapist 6.10 (6.40) 10 (13.7) 5.40 (6.58) 5 (7.4) 0.70 (3.57) –7.56 to 8.96
Social worker/care manager 3.16 (4.08) 32 (43.8) 3.72 (4.12) 25 (36.8) –0.56 (1.09) –2.76 to 1.63
Home help/home care worker 80.3 (53.1) 23 (31.5) 84.3 (57.1) 24 (35.3) –4.07 (16.01) –36.5 to 28.3
Advocate/counsellor 5.30 (6.36) 10 (13.7) 4.67 (5.89) 9 (13.2) 0.63 (2.81) –5.30 to 6.57
Dentist 1.95 (1.81) 37 (50.7) 1.48 (0.77) 25 (36.8) 0.466 (0.335) –0.21 to 1.14
Optician 1.45 (0.69) 11 (15.1) 1.08 (0.29) 12 (17.6) 0.37 (0.22) –0.11 to 0.85
Chiropodist 1.80 (1.01) 15 (20.5) 2.31 (1.03) 13 (19.1) –0.51 (0.39) –1.31 to 0.291
Employment services/job
centre
5.60 (6.50) 5 (6.8) 6.57 (7.35) 7 (10.3) –0.97 (4.02) –10.0 to 8.07
A&E, accident and emergency; CI, confidence interval; SE, standard error.
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people who used the service are presented. For hospital services and community-based services, the mean
number of contacts with the service in the 4 months prior to baseline and the number of people having
contact with the service are presented.
There was a statistically significant difference between BeatIt and StepUp participants in one of these
indicators – StepUp participants had been attending adult education for more weeks than BeatIt
participants.
In terms of daytime activities, across both therapy arms, 23 participants had attended a day centre in the
4 months prior to baseline, 31 participants had engaged in voluntary work, 14 participants had attended
adult education and 45 participants had attended a social club. For those participants that had engaged in
each daytime activity, participants spent 18–21 hours per week attending a day centre (mean 18.4 hours
for StepUp participants; mean 20.8 hours for BeatIt participants), 5 hours per week engaged in voluntary
work (mean 4.7 hours for StepUp participants; mean 5.3 hours for BeatIt participants), 5–9 hours per week
attending adult education (mean 4.9 hours for StepUp participants; mean 8.6 hours for BeatIt participants),
and 3 hours per week attending a social club (mean 3.3 hours for both StepUp and BeatIt participants).
In terms of contact with hospital services, across both therapy arms, 29 participants had attended other
hospital outpatient visits in the 4 months prior to baseline, with StepUp participants having a mean of
5.3 contacts and BeatIt participants having a mean of 2.9 contacts. Sixteen participants had visited
accident and emergency (A&E) in the 4 months prior to baseline, with StepUp participants having a
mean of 1.6 contacts with A&E and BeatIt participants having 1 contact with A&E.
In terms of contacts with community-based services in the 4 months prior to baseline, most participants
(94 across both therapy arms) had had contact with a GP, with a mean of 3.2 contacts for StepUp
participants and 3.1 contacts for BeatIt participants).
Across both therapy arms 54 participants had had contact with a community psychiatrist (mean 1.8 contacts
for StepUp participants; mean 2.4 contacts for BeatIt participants), 31 participants had had contact with a
psychologist (mean 5.4 contacts for StepUp participants; mean 5.1 contacts for BeatIt participants), and nine
participants had had contact with a community psychiatric nurse (mean 5.3 contacts for StepUp participants;
mean 8.2 contacts for BeatIt participants).
In total, 56 participants had had contact with a learning disability nurse (mean 5.9 contacts for StepUp
participants; mean 6.2 contacts for BeatIt participants), 23 participants had had contact with another
community nurse (mean 28.8 contacts for StepUp participants; mean 3.3 contacts for BeatIt participants),
12 participants had had contact with a physiotherapist (mean 6.3 contacts for StepUp participants; mean
4.6 contacts for BeatIt participants) and 15 participants had had contact with an occupational therapist
(mean 6.1 contacts for StepUp participants; mean 5.4 contacts for BeatIt participants).
Across both therapy arms, 57 participants had had contact with a social worker or care manager in the
4 months prior to baseline (mean 3.2 contacts for StepUp participants; mean 3.7 contacts for BeatIt
participants), 47 participants had had contact with a home help or home care worker (mean 80.3 contacts
for StepUp participants; mean 84.3 contacts for BeatIt participants), and 19 participants had had contact
with an advocate or counsellor (mean 5.3 contacts for StepUp participants; mean 4.7 contacts for
BeatIt participants).
Overall, 62 participants had had contact with a dentist (mean 2.0 contacts for StepUp participants;
mean 1.5 contacts for BeatIt participants), 23 had had contact with an optician (mean 1.5 contacts for
StepUp participants; mean 1.1 contacts for BeatIt participants), and 28 participants had had contact with a
chiropodist (mean 1.8 contacts for StepUp participants; mean 2.3 contacts for BeatIt participants). In total,
12 participants had had contact with employment services or a job centre in the 4 months prior to baseline
(mean 5.6 contacts for StepUp participants; mean 6.6 contacts for BeatIt participants).
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Carers at baseline
Table 8 describes characteristics of the carers of the 161 participants who began the trial, broken down by
therapy arm. Carers were those who had a significant caring responsibility for the participant and knew
the participant sufficiently well to complete the informant measures in the study. A carer could also be the
supporter for the participant in the therapy, but this was not a requirement, and a participant could have
several people in their lives with significant caring roles.
Table 8 shows that approximately three-quarters of carers were female (74.0% of carers of StepUp
participants; 75.0% of carers of BeatIt participants), with an average age of 47 years. Almost all carers
were white. In terms of their relationship to the participant, over one-quarter were family members (28.6%
of carers of participants in each therapy arm), over two-fifths were workers (41.6% of carers of StepUp
participants; 41.7% of carers of BeatIt participants), and over one-quarter were ‘other’ carers (29.9% of
carers of StepUp participants; 29.8% of carers of BeatIt participants). In terms of average weekly contact
between the carer and the participant, approximately two-thirds of carers had less than daily contact with
participants (64.9% of carers of StepUp participants; 67.9% of carers of BeatIt participants); a small
proportion had daily contact with participants (11.7% of StepUp participants; 9.5% of BeatIt participants);
and almost one-quarter of carers were living with the participant (23.4% of carers of StepUp participants;
22.6% of carers of BeatIt participants).
TABLE 8 Selected baseline characteristics of carers
Variable
Trial arm
StepUp (N= 77) BeatIt (N= 84)
Gender, n (%)
Male 20 (26.0) 21 (25.0)
Female 57 (74.0) 63 (75.0)
Age (years), mean (SD) 47.0 (13.0) 46.7 (12.6)
Ethnicity, n (%)
White 77 (100.0) 82 (97.6)
Other 0 (0.0) 2 (2.4)
Relationship to participant, n (%)
Family 22 (28.6) 24 (28.6)
Worker 32 (41.6) 35 (41.7)
Other 23 (29.9) 25 (29.8)
Average weekly contact with participant, n (%)
Less than daily 50 (64.9) 57 (67.9)
Daily 9 (11.7) 8 (9.5)
Lives with participant 18 (23.4) 19 (22.6)
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Chapter 4 Fidelity
Training and supervision
The therapy was provided by 76 therapists. Sixteen (21.1%) therapists were men (BeatIt, n = 8 men;
StepUp, n = 8 men) and 60 (78.9%) were women (BeatIt, n = 35 women; StepUp, n = 25 women),
with a mean age of 40.5 years (SD 10.5 years) [BeatIt therapist mean age = 40.4 years (SD 11.4 years);
StepUp therapist mean age = 41.8 years (SD 9.7 years)]. There were no significant differences in sex
[χ2 = 0.36, degrees of freedom (df) = 1, not significant] or age (t = 0.55, df = 73, not significant) of
therapist. Fifty (65.8%) therapists were nurses (BeatIt, n = 28 nurses; StepUp, n = 22 nurses), 13 (17.1%)
were psychology assistants or trainees (BeatIt, n = 9 assistants or trainees; StepUp, n = 4 assistants or
trainees), 4 (5.3%) were occupational therapists (BeatIt, n = 1 occupational therapist; StepUp, n = 3
occupational therapists) and 6 (7.9%) were CBT therapists (BeatIt, n = 3 CBT therapists; StepUp, n = 3 CBT
therapists). There were three therapists whose profession was not recorded. There was no significant
difference in distribution of professions between the arms of the study (χ2 = 2.6, df = 3, not significant).
Forty-six (60.5%) therapists had worked with people with learning disabilities for > 5 years (BeatIt, n = 26
therapists; StepUp, n = 20 therapists), 10 (13.2%) for 1 to 5 years (BeatIt, n = 7 therapists; StepUp, n = 3
therapists) and 18 (23.7%) for < 1 year (BeatIt, n = 10 therapists; StepUp, n = 8 therapists). These data
were not available for two therapists. There was no significant difference between the arms of the
study in the distribution of the duration that therapists had been working with people who have learning
disabilities (χ2 = 0.68, df = 2, not significant). Twenty-nine (38.2%) of the therapists had no previous
therapy training (BeatIt, n = 14 therapists; StepUp, n = 15 therapists); 13 (17.1%) had attended an
accredited training course (BeatIt, n = 6 therapists; StepUp, n = 7 therapists); 10 (13.2%) had received
‘in-house’ training (BeatIt, n = 4 therapists; StepUp, n = 6 therapists), 10 (13.2%) had received training as
part of their professional training (BeatIt, n = 5 therapists; StepUp, n = 5 therapists) and 4 (4.8%) had
received training from other sources (BeatIt, n = 4 therapists; StepUp, n = 0 therapists). These data were
not available for 10 therapists. There was no significant difference between the arms of the study in the
distribution of previous therapy training (χ2 = 4.38, df = 4, not significant).
The manual stipulated that there should be one supervision meeting for every two therapy sessions.
All supervisors in the study were clinical psychologists. Therapists in the BeatIt arm received a mean of
6.4 supervision sessions (SD 0.37 sessions, range 1–13 sessions), and those in the StepUp arm had a
mean of 4.7 supervision sessions (SD 0.29 sessions, range 1–10 sessions). However, these data can be
misleading, as not all participants received the full number of sessions (as a result of drop-out etc.), and
preferred levels of supervision were actually defined in terms of the ratio of supervision meetings to
therapy sessions. Excluding participants who received no sessions, the mean ratio of supervision meetings
to therapy sessions delivered was 1.9 (SD 1.36). The expected ratio was 2.0, and a mean of < 2.0 indicates
a slightly higher than expected level of supervision. Ninety-eight (73.1%) cases met the criterion of at least
one supervision meeting for every two therapy sessions, whereas 36 (25.5%) did not. The lowest ratio of
supervision to therapy was 4.0, which occurred in one BeatIt case in which only three supervision meetings
were recorded for 12 therapy sessions.
The measurement of fidelity during the course of the intervention
There were 144 fidelity recordings available for analysis. These constituted recordings for 93 participants,
49 from StepUp and 44 from BeatIt, with 51 participants having two recordings available. There are
multiple reasons why recordings were not always completed: 21 participants refused consent for recording,
39 participants did not provide recordings because they withdrew from the study before being recorded,
12 recordings were not made because the participant or carer refused to have the recording made on the
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day and two recordings were lost in transfer or as a result of other technical difficulties with recording
equipment. The baseline scores for GDS-LD, IDDS and BPI-S Aggressive Behaviour subscale and age for the
93 participants for whom fidelity recordings were available were compared with the 68 participants for
whom they were not, and there were no statistically significant differences. There was also no association
between the availability of fidelity recording and the sex of the participants. A second researcher rated 48
recordings to determine inter-rater reliability; the intraclass correlation for agreement was 0.76 (df = 43;
p < 0.001).
Therapy quality and non-specific factors
When looking at the first available recording from each of the 93 participants who provided recordings,
the 10-item fidelity scale had a mean total score of 33.1 points (SD 4.1 points, range 18–39 points).
Table 9 shows that there was a very similar pattern of findings for both the BeatIt and StepUp arms. The
highest scoring items were those relating to empathy, warmth and not including therapy activity that was
not part of the manual; the lowest scoring items were for including the client and supporter in the process
of setting the session agenda and asking for feedback at the end of the session. The scale had an alpha
of 0.76 and a mean-adjusted item-total correlation of 0.42 (SD 0.1, range 0.31–0.58). The stability of
fidelity was 0.64, estimated through a Pearson’s correlation of first and second fidelity ratings for the
51 participants with two recordings. There was no significant difference in the fidelity scores between the
two arms (BeatIt: mean = 32.3, SD 4.1; StepUp: mean = 33.9, SD 3.9; t = 1.5, not significant).
TABLE 9 Non-specific factors
Scale items
Total group (n= 93)
Trial arm
BeatIt StepUp
Minimum,
maximum Mean
Corrected
item-total
correlation Mean SD Mean SD
1. Creates agenda, agrees what will be covered
in session
1, 4 2.74 0.35 2.75 1.04 2.73 0.79
2. The presence of a focus and clear structure to
the session
1, 4 3.44 0.58 3.32 0.77 3.55 0.65
3. Avoids offering therapy outside the remit of
the intervention
2, 4 3.73 0.31 3.64 0.69 3.82 0.49
4. Asks for feedback from previous session 1, 4 3.19 0.43 3.14 0.73 3.24 0.72
5. Asks for feedback and reaction to the current
session
1, 4 2.89 0.43 2.84 0.75 2.94 0.88
6. Conveys understanding by checking and
rephrasing
1, 4 3.13 0.52 3.09 0.80 3.16 0.85
7. Adjusts content and style of own
communication
2, 4 3.28 0.31 3.14 0.73 3.41 0.61
8. Communicates clearly without hesitations and
with good pace
1, 4 3.48 0.51 3.45 0.70 3.51 0.77
9. Shows empathy 2, 4 3.58 0.45 3.55 0.50 3.61 0.57
10. Shows warmth and respect 1, 4 3.65 0.56 3.68 0.47 3.61 0.64
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Covering key elements/activities in individual therapy sessions
For the session-specific technical ratings, each session could gain a score that ranged from 3, if all
elements were conformed to, to 0 if none of the elements was conformed to. For BeatIt, 33 sessions
obtained a score of 3, 10 sessions obtained a score of 2, one session obtained a score of 1 and no sessions
received a score of 0. In the StepUp arm, 42 sessions obtained a score of 3, seven sessions obtained a
score of 2 and no sessions received a score of 1 or 0. The differences in distribution of scores between the
groups is not significant (Fisher’s exact test p = 0.23). For the purpose of further analysis, the data were
collapsed across both arms and treated as dichotomous, with 75 sessions gaining a full score of 3 and
18 obtaining a score of < 3. The 75 sessions with a score of 3 had a mean therapy quality scale score of
33.7 (SD 3.6); the 18 sessions with a score of < 3 had a mean score of 33.1 (SD 4.7). This is a statistically
significant difference (t = 2.5, df = 91; p = 0.014), showing a significant relationship between two
measures of fidelity.
Delivery and consistency of support
Patients randomised to the BeatIt arm of the trial began their therapy sessions a median of 36 days
(interquartile range 28–49 days) after randomisation, compared with 27 days (interquartile range 21–42 days)
for those randomised to StepUp; this was a statistically significant difference (p = 0.003, Mann–Whitney
U-test). This difference was because the BeatIt intervention began with a session for the supporters alone,
to provide them with information about therapy and their role in sessions.
There was excellent attendance of the sessions, with participants in the BeatIt arm attending an average of
9.9 sessions (SD 3.2 sessions) and StepUp participants attending an average of 7.1 sessions (SD 2.1 sessions).
Sixty-six per cent of the BeatIt therapy sessions were delivered as scheduled and 77% of the StepUp sessions
were delivered as planned.
For BeatIt, 38 (51%) participants had the same supporter throughout their therapy, 16 (23%) had two
supporters, 10 (14%) had three supporters, 1 (1%) had four supporters and 2 (3%) had five supporters. For
StepUp, 42 (61%) participants had one supporter throughout their therapy, 16 (23%) had two supporters,
6 (9%) had three supporters, 1 (1%) had four supporters and 2 (3%) had five supporters.
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Chapter 5 Trial results
Primary outcome
A reduction in the GDS-LD total score represents an improvement in symptoms of depression. In the
analyses reported here, a positive intervention effect indicates a greater reduction in depression symptoms
in the BeatIt group compared with the StepUp group. The GDS-LD scores post intervention (4 months after
randomisation) and at follow-up (12 months after randomisation – the primary end point) were analysed
in adjusted mixed-effects linear regression models (Table 10) that adjusted for baseline GDS-LD scores,
therapist effects (as a random effect), study centre and baseline antidepressant use.
There were no statistically significant unadjusted or adjusted group differences in the effects of the StepUp
or BeatIt interventions on GDS-LD scores at 12 months (primary end point) or 4 months (p-value column
of Table 10).
The same analysis models were also applied to the changes in GDS-LD scores between 4 and 12 months
to examine whether or not the treatments may have had different effects on GDS-LD scores from post
intervention to follow-up. There was no overall change in GDS-LD scores from 4 to 12 months [estimate
–0.42, 95% confidence interval (CI) –2.30 to 1.47; p = 0.663] and no interaction between treatment
group and data collection point (4 vs. 12 months) (estimate 0.56, 95% CI –2.15 to 3.27; p = 0.685).
All of the above reported analyses were repeated using multiple imputation for missing data. Although the
estimates for effects changed slightly, the overall pattern of findings was identical.
TABLE 10 Mean GDS-LD scores and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 16.90 (6.73) 84 (0) 16.60 (7.91)
Post intervention (4 months) 72 (5) 12.94 (7.77) 68 (16) 11.91 (7.43) 1.03 (–1.51 to 3.58) 0.424a
Follow-up (12 months) 70 (7) 12.43 (7.64) 65 (19) 12.03 (7.99) 0.40 (–2.26 to 3.06) 0.768a
Change in mean scores from baseline (95% CI); p-value
Post intervention (4 months) –4.40 (–5.89 to –2.91);
< 0.001b
–5.15 (–6.70 to –3.60);
< 0.001b
–0.75 (–2.80 to 1.31) 0.471c
Follow-up (12 months) –4.46 (–6.21 to –2.70);
< 0.001b
–4.20 (–6.0 to –2.40);
< 0.001b
0.26 (–2.18 to 2.70) 0.833c
CI, confidence interval.
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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Secondary, within-group analyses (see Table 10) showed that participants in both treatment groups
reported significant reductions in GDS-LD scores at both 4 and 12 months. The analysis of 4- to 12-month
change summarised above suggests that these changes from baseline are accounted for mainly by
reductions in GDS-LD scores from baseline to post intervention (4 months), with no change from post
intervention (4 months) to follow-up (12 months).
Secondary outcomes
Measures of depression and anxiety
Carers of participants were asked to complete the IDDS as a secondary measure of the effects of StepUp
and BeatIt on behavioural symptoms of depression (Table 11). As with the primary outcome, reductions
in IDDS scores represent improvement and, in the analyses reported here, a positive intervention effect
indicates a greater reduction in depression symptoms in the BeatIt group compared with the StepUp group.
There were no statistically significant unadjusted or adjusted group differences in the effects of StepUp
and BeatIt on IDDS scores at 12 months (primary end point) or 4 months (p-value column of Table 11).
The same analysis models were also applied to the changes in IDDS scores between 4 and 12 months to
examine whether or not the treatments may have had different effects on IDDS scores from post intervention
to follow-up. There was no overall change in IDDS scores from 4 to 12 months, and no interaction between
treatment group and data collection point (4 vs. 12 months).
Within-group analyses (see Table 11) showed that participants in both treatment groups reported
significant reductions in IDDS scores at both 4 and 12 months. The analysis of 4- to 12-month change
summarised above suggests that these changes from baseline are accounted for mainly by reductions
in IDDS scores from baseline to post intervention (4 months), with no change from post intervention
(4 months) to follow-up (12 months).
TABLE 11 Mean IDDS scores and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 73.57 (31.37) 84 (0) 83.87 (32.70)
Post intervention
(4 months)
70 (7) 59.66 (34.13) 65 (19) 60.37 (29.01) –0.71 (–11.54 to 10.11) 0.897a
Follow-up (12 months) 66 (11) 55.02 (30.06) 63 (21) 61.02 (31.82) –6.00 (–16.78 to 4.78) 0.273a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
–17.01 (–23.71 to –10.31);
< 0.001b
–21.50 (–28.51 to –14.49);
< 0.001b
–4.49 (–13.72 to 4.75) 0.336c
Follow-up (12 months) –22.01 (–29.62 to –14.40);
< 0.001b
–20.65 (–28.3 to –12.98);
< 0.001b
1.36 (–9.19 to 11.92) 0.797c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TRIAL RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
38
To examine potential effects on participants’ anxiety symptoms, they were asked to complete the
self-report GAS-ID as a secondary measure (Table 12). Reductions in GAS-ID scores represent improvement
and, in the analyses reported here, a positive intervention effect indicates a greater reduction in anxiety
symptoms in the BeatIt group compared with the StepUp group.
There were no statistically significant unadjusted or adjusted group differences in the effects of StepUp
and BeatIt on GAS-ID scores at 12 months (primary end point) or 4 months (p-value column of Table 12).
The same analysis models were also applied to the changes in GAS-ID scores between 4 and 12 months.
Again, there was no overall change in GAS-ID scores from 4 to 12 months, and no interaction between
treatment group and data collection point (4 vs. 12 months).
Within-group analyses (see Table 12) showed that participants in both treatment groups reported
significant reductions in GAS-ID scores at both 4 and 12 months. The analysis of 4- to 12-month change
summarised above suggests that these changes from baseline are accounted for mainly by reductions in
GAS-ID scores from baseline to post intervention (4 months), with no change from post intervention
(4 months) to follow-up (12 months).
Level of aggressive behaviour
Carers of participants were asked to complete the Aggressive and Destructive Behaviour subscale from
the BPI-S as a secondary measure of the effects of StepUp and BeatIt on aggressive behaviour (Table 13).
Reductions in BPI-S scores represent improvement and, in the analyses reported here, a positive intervention
effect indicates a greater reduction in depression symptoms in the BeatIt group compared with the
StepUp group.
There were no statistically significant unadjusted or adjusted group differences in the effects of StepUp
and BeatIt on BPI-S scores at 12 months (primary end point) or 4 months (p-value column of Table 13).
The same analysis models were also applied to the changes in BPI-S scores between 4 and 12 months.
There was no overall change in BPI-S scores from 4 to 12 months, and no interaction between treatment
group and data collection point (4 vs. 12 months).
TABLE 12 Mean GAS-ID scores and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 24.71 (11.00) 83 (1) 25.05 (11.15)
Post intervention
(4 months)
70 (7) 21.39 (11.70) 65 (19) 20.96 (11.18) 0.43 (–3.39 to 4.26) 0.823a
Follow-up (12 months) 70 (7) 20.07 (11.15) 65 (19) 20.77 (11.36) –0.70 (–4.53 to 3.14) 0.719a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
–3.96 (–5.86 to –2.06);
< 0.001b
–4.73 (–6.71 to –2.75);
< 0.001b
–0.77 (–3.38 to 1.84) 0.559c
Follow-up (12 months) –4.83 (–7.00 to –2.66);
< 0.001b
–4.40 (–6.61 to –2.20);
< 0.001b
0.43 (–2.59 to 3.45) 0.776c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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Within-group analyses (see Table 13) showed that participants in the BeatIt group, but not in the StepUp
group, reported significant reductions in BPI-S scores at both 4 and 12 months. The analysis of 4- to
12-month change summarised above suggests that these changes from baseline are accounted for mainly
by reductions in BPI-S scores from baseline to post intervention (4 months), with no change from post
intervention (4 months) to follow-up (12 months).
Quality-of-life measures
A range of self-reported and assisted-completion QoL measures were included as secondary outcomes.
Higher EQ-5D-Y and EQ-VAS scores equated to better QoL, as did higher scores on the total and
subdomains of the ICI and IPDL. Higher scores on the PSS scale indicated a larger social network and
increased satisfaction with the social support received. All of these QoL indicators were analysed using the
same approaches as for the primary outcome and other secondary outcomes reported in preceding sections.
For outcomes at 12 months (primary end point) and 4 months (post intervention), there were no treatment
group differences for any QoL measure except the ICI domestic and leisure subscale (Tables 14–22).
Participants in the BeatIt group had a statistically significant higher mean score on this outcome domain
at the 12-month follow-up.
The change in QoL scores across all measures between the 4- and 12-month follow-ups was associated
with no significant effects and no interaction with treatment group, with two exceptions. First, there was a
reduction overall in ICI domestic and leisure scores between 4 and 12 months (estimate –1.44, 95% CI
–2.78 to –0.09; p = 0.037), but no interaction between treatment group and data collection point
(4 vs. 12 months) (estimate 1.35, 95% CI –0.58 to 3.28; p = 0.170). Second, there was a reduction overall
in IPDL scores between 4 and 12 months (estimate –2.43, 95% CI –4.04 to –0.83; p = 0.003), but no
interaction between treatment group and data collection point (4 vs. 12 months) (estimate 1.29, 95% CI
–1.01 to 3.59; p = 0.271).
TABLE 13 Mean BPI-S Aggressive and Destructive subscale scores and differences in mean scores at the 4- and
12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 2.10 (3.61) 84 (0) 1.96 (2.74)
Post intervention
(4 months)
69 (8) 2.09 (3.84) 66 (18) 1.24 (2.19) 0.84 (–0.22 to 1.91) 0.118a
Follow-up (12 months) 67 (10) 1.82 (3.42) 64 (20) 1.09 (1.85) 0.73 (–0.22 to 1.67) 0.131a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
–0.17 (–0.82 to 0.48);
0.861b
–0.82 (–1.49 to –0.15);
0.017b
–0.65 (–1.55 to 0.25) 0.154c
Follow-up (12 months) –0.22 (–0.80 to 0.36);
0.447b
–0.89 (–1.49 to –0.30);
0.004b
–0.67 (–1.46 to 0.12) 0.093c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TRIAL RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
40
TABLE 15 Mean EQ-VAS scores and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 56.96 (29.53) 84 (0) 46.56 (28.63)
Post intervention
(4 months)
72 (5) 56.64 (29.61) 68 (16) 48.72 (28.21) –4.54 (–14.76 to 5.67) 0.381a
Follow-up (12 months) 70 (7) 57.36 (28.92) 65 (19) 49.23 (28.76) –3.32 (–13.48 to 6.85) 0.520a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
4.96 (–1.81 to 11.72);
0.149b
13.10 (6.11 to 20.09);
< 0.001b
8.15 (–1.16 to 17.45) 0.085c
Follow-up (12 months) 0.48 (–6.60 to 7.55);
0.893b
7.22 (–0.11 to 14.56);
0.053b
6.75 (–3.07 to 16.56) 0.174c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TABLE 14 Mean EQ-5D-Y scores and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 76 (1) 0.62 (0.38) 84 (0) 0.46 (0.44)
Post intervention
(4 months)
72 (5) 0.69 (0.36) 68 (16) 0.64 (0.41) 0.05 (–0.08 to 0.18) 0.411a
Follow-up (12 months) 70 (7) 0.70 (0.35) 65 (19) 0.68 (0.41) 0.02 (–0.11 to 0.15) 0.742a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.15 (0.06 to 0.24);
0.002b
0.16 (0.06 to 0.25);
0.001b
0.01 (–0.12 to 0.14) 0.878c
Follow-up (12 months) 0.12 (0.04 to 0.21);
0.005b
0.16 (0.07 to 0.25);
< 0.001b
0.04 (–0.08 to 0.15) 0.546c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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TABLE 17 Mean ICI community subscale and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 22.51 (10.51) 84 (0) 21.63 (9.02)
Post intervention
(4 months)
72 (5) 23.53 (10.42) 68 (16) 23.99 (10.90) –0.46 (–4.02 to 3.11) 0.800a
Follow-up (12 months) 69 (8) 22.04 (9.61) 66 (18) 22.20 (9.77) –0.15 (–3.45 to 3.15) 0.927a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
1.23 (–0.40 to 2.85);
0.137b
2.86 (1.18 to 4.55);
0.001b
1.64 (–0.59 to 3.87) 0.148c
Follow-up (12 months) –0.69 (–2.42 to 1.04);
0.427b
0.12 (–1.65 to 1.89);
0.892b
0.81 (–1.55 to 3.18) 0.495c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TABLE 16 Mean ICI total score and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 51.26 (17.35) 84 (0) 49.81 (15.94)
Post intervention
(4 months)
72 (5) 51.47 (17.44) 68 (16) 53.71 (16.80) –2.23 (–7.96 to 3.49) 0.442a
Follow-up (12 months) 69 (8) 48.52 (16.95) 66 (18) 51.45 (15.34) –2.93 (–8.44 to 2.58) 0.294a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
1.53 (–1.06 to 4.12);
0.243b
4.76 (2.07 to 7.45);
< 0.001b
3.23 (–0.33 to 6.78) 0.074c
Follow-up (12 months) –2.11 (–4.89 to 0.67);
0.135b
1.00 (–1.84 to 3.85);
0.483b
3.11 (–0.68 to 6.90) 0.106c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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TABLE 19 Mean ICI social subscale and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 12.55 (8.05) 84 (0) 12.63 (7.78)
Post intervention
(4 months)
72 (5) 11.78 (8.21) 68 (16) 13.38 (6.64) –1.60 (–4.11 to 0.90) 0.207a
Follow-up (12 months) 69 (8) 11.52 (7.46) 66 (18) 12.42 (7.72) –1.38 (–4.02 to 1.26) 0.303a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
–0.28 (–1.56 to 0.99);
0.660b
1.16 (–0.16 to 2.48);
0.085b
1.44 (–0.32 to 3.19) 0.107c
Follow-up (12 months) –0.22 (–1.53 to 1.08);
0.732b
0.37 (–0.97 to 1.70);
0.586b
0.59 (–1.19 to 2.37) 0.511c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TABLE 18 Mean ICI domestic and leisure subscale and differences in mean scores at the 4- and 12-month
follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 16.21 (5.66) 84 (0) 15.55 (5.32)
Post intervention
(4 months)
72 (5) 16.17 (5.28) 68 (16) 16.34 (5.62) –0.17 (–1.99 to 1.65) 0.853a
Follow-up (12 months) 69 (8) 14.81 (5.72) 66 (18) 16.21 (5.55) –1.40 (–3.32 to 0.52) 0.151a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.62 (–0.38 to 1.61);
0.220b
0.86 (–0.17 to 1.89);
0.101b
0.24 (–1.12 to 1.60) 0.722c
Follow-up (12 months) –1.16 (–2.31 to –0.01);
0.049b
0.46 (–0.72 to 1.63);
0.441b
1.62 (0.04 to 3.19) 0.045c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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TABLE 21 Mean PSS total network size and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 4.62 (2.6) 83 (1) 4.89 (3.2)
Post intervention
(4 months)
72 (5) 4.92 (2.99) 68 (16) 5.31 (2.95) –0.39 (–1.39 to 0.60) 0.436a
Follow-up (12 months) 69 (8) 4.71 (2.74) 65 (19) 4.92 (2.91) –0.21 (–1.18 to 0.75) 0.663a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.353 (–0.203 to 0.910);
0.210b
0.440 (–0.136 to 1.016);
0.132b
0.087 (–0.682 to 0.856) 0.823c
Follow-up (12 months) 0.150 (–0.447 to 0.747);
0.616b
0.186 (–0.431 to 0.803);
0.550b
0.035 (–0.786 to 0.857);
0.98
0.932c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TABLE 20 Mean IPDL scores and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 18.19 (9.03) 84 (0) 19.07 (8.46)
Post intervention
(4 months)
72 (5) 18.46 (8.45) 68 (16) 18.34 (9.24) 0.12 (–2.84 to 3.08) 0.936a
Follow-up (12 months) 69 (8) 15.86 (7.97) 66(18) 16.47 (8.01) –0.61 (–3.34 to 2.11) 0.656a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.82 (–0.38 to 2.03);
0.176b
0.31 (–0.94 to 1.57);
0.620b
–0.51 (–2.16 to 1.14) 0.539c
Follow-up (12 months) –1.58 (–2.94 to –0.22);
0.024b
–0.83 (–2.22 to 0.56);
0.238b
0.75 (–1.11 to 2.61) 0.424c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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In terms of changes from baseline scores in each treatment group separately, the EQ-5D-Y scores were
more positive than at baseline at both 4 and 12 months in both treatment groups. The lack of evidence
for change between 4 and 12 months suggests that this change occurred during the therapies and not
afterwards. The EQ-VAS scores improved in the BeatIt group at 4 months but not in the StepUp group.
At 12 months, neither treatment group had EQ-VAS scores that were different from those at baseline.
For two measures (ICI total score and ICI community subscale), the BeatIt group but not the StepUp group
had higher scores at 4 months than at baseline, but neither group differed from baseline by 12-month
follow-up. For two other measures (ICI domestic and leisure, and the IPDL), neither treatment group’s
scores differed from baseline at 4 months but for both measures the StepUp group had scores lower at
12 months than at baseline, whereas the BeatIt group scores at 12-month follow-up were not different
from baseline. For the final three measures (ICI social, PSS network size, PSS satisfaction), neither the BeatIt
nor the StepUp group had scores different from baseline at either 4 or 12 months.
Adaptive behaviour
The ABS-RC2 subscales on socialisation, self-direction and responsibility were used to measure change in
participants’ adaptive skills/functioning. Higher scores on each of these scores indicate higher levels of
skills/functioning.
For the socialisation score (Table 23), there was a treatment group difference at 4 months, but not by the
time of the 12-month follow-up. For the self-direction (Table 24) and responsibility scores (Table 25), there
were no treatment group differences at either 12 months’ follow-up (primary end point) or at 4 months.
Participants in the BeatIt group had higher socialisation scores at 4 months than participants in the
StepUp group.
Focusing on changes between 4 and 12 months, there were no significant interactions between treatment
group and outcome point. For both socialisation (estimate 1.29, 95% CI 0.41 to 2.17; p = 0.004) and
self-direction scores (estimate 1.15, 95% CI 0.01 to 2.30; p = 0.049), but not for responsibility scores, there
was a main effect of time, with higher scores at 12-month follow-up than at 4 months post intervention.
TABLE 22 Mean PSS satisfaction and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 2.62 (0.55) 83 (1) 2.48 (0.53)
Post intervention
(4 months)
72 (5) 2.65 (0.53) 68 (16) 2.59 (0.49) 0.07 (–0.11 to 0.24) 0.448a
Follow-up (12 months) 69 (8) 2.66 (0.44) 65 (19) 2.62 (0.50) 0.04 (–0.12 to 0.20) 0.627a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.08 (–0.03 to 0.18);
0.168b
0.05 (–0.06 to 0.16);
0.369b
–0.02 (–0.17 to 0.12) 0.741c
Follow-up (12 months) 0.11 (–0.002 to 0.22);
0.054b
0.11 (–0.004 to 0.22);
0.059b
0.001 (–0.15 to 0.15)
0.98
0.987c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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TABLE 23 Mean ABS-RC2 socialisation subscale and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 20.75 (3.12) 84 (0) 20.92 (3.55)
Post intervention
(4 months)
71 (6) 20.20 (3.57) 67 (17) 21.37 (3.19) –1.18 (–2.32 to –0.03) 0.044a
Follow-up (12 months) 68 (9) 21.47 (2.52) 66 (18) 21.59 (3.17) –0.12 (–1.10 to 0.86) 0.808a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
–0.29 (–0.96 to 0.37);
0.379b
0.82 (0.13 to 1.51);
0.021b
1.11 (0.20 to 2.02) 0.017c
Follow-up (12 months) 0.76 (0.12 to 1.39);
0.020b
0.89 (0.25 to 1.54);
0.007b
0.14 (–0.72 to 1.00) 0.750c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
TABLE 24 Mean ABS-RC2 self-direction subscale and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 14.60 (5.49) 84 (0) 15.38 (5.41)
Post intervention
(4 months)
71 (6) 15.54 (4.83) 67 (17) 16.87 (4.68) –1.33 (–2.93 to 0.27) 0.103a
Follow-up (12 months) 68 (9) 16.59 (4.28) 66 (18) 16.94 (4.50) –0.35 (–1.85 to 1.15) 0.644a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.80 (–0.03 to 1.62);
0.059b
1.78 (0.92 to 2.64);
< 0.001b
0.98 (–0.15 to 2.12);
0.089
0.089c
Follow-up (12 months) 1.92 (0.99 to 2.84);
< 0.001b
2.04 (1.10 to 2.99);
< 0.001b
0.13 (–1.13 to 1.39) 0.838c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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Within the BeatIt group, socialisation and self-direction scores showed a statistically significant increase
from baseline to 4- and 12-month data collection points, but responsibility scores did not differ from
baseline at either point (see Tables 23–25). Within the StepUp group, socialisation and self-direction scores
were significantly higher than baseline at the 12-month follow-up only, whereas responsibility scores were
higher at both 4- and 12-month follow-ups (see Tables 23–25). Considering these findings, in contrast to
several of the other secondary outcomes, there is some evidence that participants’ adaptive skills increased
during the course of study participation.
Self-efficacy and carer–patient relationship
Carers of participants completed the EDSE scale to report on their confidence in supporting participants
with their emotional difficulties, including depression. Higher scores indicate higher levels of self-efficacy in
this domain.
There were no statistically significant unadjusted or adjusted group differences in the effects of the StepUp
or BeatIt interventions on EDSE scores at 12 months (primary end point) or 4 months (see p-value column
of Table 26).
The same analysis models were also applied to the changes in EDSE scores between 4 and 12 months to
examine whether or not the treatments may have had different effects on EDSE scores from post intervention
to follow-up. There was no overall change in EDSE scores from 4 to 12 months, and no interaction between
treatment group and data collection point (4 vs. 12 months).
Within-group analyses (Table 26) showed that supporters in both treatment groups reported significant
increases in EDSE scores at both 4 and 12 months. The analysis of 4- to 12-month change summarised
above suggests that these changes from baseline are accounted for mainly by increases in EDSE scores
from baseline to post intervention (4 months), with no change from post intervention (4 months) to
follow-up (12 months).
TABLE 25 Mean ABS-RC2 responsibility subscale and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 7.62 (2.10) 84 (0) 8.27 (1.77)
Post intervention
(4 months)
71 (6) 7.72 (2.02) 67 (17) 8.28 (1.84) –0.23 (–0.85 to 0.39) 0.466a
Follow-up (12 months) 68 (9) 8.40 (1.51) 67 (17) 8.20 (1.76) 0.20 (–0.36 to 0.76) 0.481a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
0.32 (0.008 to 0.63);
0.045b
0.16 (–0.17 to 0.48);
0.336b
–0.16 (–0.59 to 0.27);
0.4
0.452c
Follow-up (12 months) 0.68 (0.33 to 1.03);
< 0.001b
0.24 (–0.11 to 0.60);
0.176b
–0.44 (–0.92 to 0.05) 0.076c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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Carers also provided a FMSS focusing on their relationship with the participant. The presence of evidence
for a high or low level of criticism (a dichotomous code) in the relationship from the speech sample was
coded following standard criteria.62 These data could not be analysed using mixed-effect logistic regression
models. The models failed to fit owing to very small numbers with the high criticism code. Overall, speech
sample data were available for 139 supporters at baseline (missing, n = 22) and 97% of supporters were
coded low for criticism in the relationship with the participant at baseline. Missing data were more
problematic at 4 months (missing, n = 63) and at 12-month follow-up (missing, n = 80). Overall, 94% of
supporters whose data were available were given the same criticism code at 4- and 12-month follow-ups
(i.e. the vast majority evidenced no change).
Life events
At the 12-month follow-up, BLESID was used as an outcome, because it asks participants to report life
events experienced over the previous 12 months. The score used for analysis was the product of the
frequency scores for each life event experienced that had a negative impact on the participant. Each life
event is rated as not experienced over the 12-month period (score 0), experienced once only (score 1),
or experienced more than once (score 2). Each life event experienced is also rated on whether it had
a positive impact, no impact, or a negative impact on the person. Thus, a reduced score over time
represents, overall, a less negative impact of life events on the participant.
The same approach to statistical data analysis was used as for all continuous outcomes, except that data
were available at baseline and at 12-month follow-up only (Table 27). There was no treatment group
difference for life event scores at 12-month follow-up after controlling for baseline life event scores and
other factors. Within-group analysis showed reductions in life event scores from baseline to 12-month
follow-up in both the StepUp and BeatIt groups.
TABLE 26 Mean EDSE scale total score and differences in mean scores at the 4- and 12-month follow-ups
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 76 (1) 21.04 (4.68) 84 (0) 20.73 (4.98)
Post intervention
(4 months)
70 (7) 22.01 (4.80) 66 (18) 22.45 (4.06) –0.44 (–1.95 to 1.07) 0.566a
Follow-up (12 months) 67 (10) 22.67 (3.83) 64 (20) 21.98 (4.34) 0.69 (–0.73 to 2.10) 0.338a
Change in mean scores from baseline (95% CI); p-value
Post intervention
(4 months)
1.16 (0.21 to 2.10);
0.017b
2.01 (1.03 to 2.99);
< 0.001b
0.86 (–0.44 to 2.16) 0.192c
Follow-up (12 months) 1.76 (0.87 to 2.64);
< 0.001b
1.37 (0.46 to 2.28);
0.004b
–0.39 (–1.60 to 0.83) 0.527c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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Exploratory moderator analyses
For the primary outcome measure, measured using the GDS-LD, exploratory moderator analyses were
conducted on a number of variables at baseline for outcomes at 4 months and 12 months. These analyses
investigated whether or not there were main effects at 4 months and 12 months related to the baseline
variable, and whether there were interaction effects at 4 months and 12 months between the baseline
variable and the therapy arm.
Table 28 presents the exploratory moderator analyses for the following baseline variables: participant age,
gender, Full Scale IQ, expectations of change and ABS-RC2 domains (personal self-sufficiency, community
self-sufficiency, personal social responsibility, self-direction, responsibility and socialisation), study site,
neighbourhood deprivation, relationship of carer to participant, level of service support for participant,
BLESID impact of negative life events in the 12 months before baseline, whether or not the participant had
received any previous psychological therapy for depression, prescribed usage of antidepressants and
prescribed usage of mood-stabilising medication.
Out of 18 potential predictor variables of change in GDS-LD score from baseline to 4 months, there were
two statistically significant main effects. For participants with higher ABS-RC2 socialisation scores at
baseline, there were bigger reductions in GDS-LD scores at 4 months. There was also a main effect of
study site: for participants in Wales there were bigger reductions in GDS-LD scores at 4 months compared
with participants in Scotland. There were no interaction effects of baseline variables by therapy type for
change in GDS-LD scores at 4 months.
Out of 18 potential predictor variables of change in GDS-LD scores from baseline to 12 months, there
were two statistically significant main effects. For participants with lower ABS-RC2 personal self-sufficiency
scores at baseline, there were bigger reductions in GDS-LD scores at 12 months. For participants with
higher expectations of change at baseline, there were bigger reductions in GDS-LD scores at 12 months.
There was also one interaction effect of study site: in Scotland there were bigger decreases in GDS-LD
scores from baseline to 12 months for participants in the BeatIt group, whereas in Wales there were bigger
decreases in GDS-LD scores from baseline to 12 months for participants in the StepUp group.
TABLE 27 Mean BLESID negative product score and differences in mean scores at the 12-month follow-up
Time point
Trial arm Statistics
StepUp BeatIt
Intervention
effects (95% CI) p-valuen (n missing) Mean (SD) n (n missing) Mean (SD)
Baseline 77 (0) 1.79 (2.03) 84 (0) 2.04 (2.35)
Follow-up (12 months) 69 (8) 1.29 (1.72) 66 (18) 1.56 (1.86) –0.27 (–0.88 to 0.34) 0.380a
Change in mean scores from baseline (95% CI) p-value
Follow-up (12 months) –0.670 (–1.130 to –0.270);
0.002b
–0.45 (–0.89 to –0.01);
0.044b
0.25 (–0.34 to 0.83) 0.406c
a Unadjusted.
b Within-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
c Between-group estimates derived from a mixed-effects linear regression model adjusted for therapist effects, baseline
GDS-LD, antidepressant use and study centre.
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TABLE 28 Exploratory moderator analyses for the GDS-LD at the 4- and 12-month follow-ups
Predictor variable
Change in GDS-LD score at
4 months 12 months
Predictor effect, estimate
(95% CI); p-value
Interaction,
p-value
Predictor effect, estimate
(95% CI); p-value
Interaction,
p-value
Age –0.05 (–0.14 to 0.04); 0.243 0.445 –0.05 (–0.15 to 0.05); 0.299 0.119
Gender (male vs. female) –0.84 (–2.87 to 1.19); 0.412 0.933 1.54 (–0.71 to 3.80); 0.176 0.343
Full Scale IQ 0.07 (–0.06 to 0.20); 0.260 0.204 0.12 (–0.03 to 0.26); 0.115 0.795
Expectations of change –0.2 (–0.87 to 0.47); 0.555 0.443 –0.97 (–1.71 to –0.24); 0.010 0.088
ABS-RC2 subscales
Personal self-sufficiency 0.06 (–0.12 to 0.23); 0.516 0.535 0.21 (0.02 to 0.40); 0.032 0.346
Community
self-sufficiency
–0.04 (–0.17 to 0.08); 0.497 0.646 0.01 (–0.13 to 0.15); 0.869 0.782
Personal social
responsibility
–0.15 (–0.31 to 0.02); 0.080 0.492 –0.06 (–0.25 to 0.12) 0.491 0.882
Self-direction –0.15 (–0.34 to 0.04); 0.109 0.188 –0.06 (–0.27 to 0.15); 0.586 0.738
Responsibility –0.48 (–0.99 to 0.03); 0.065 0.838 –0.31 (–0.88 to 0.25); 0.276 0.863
Socialisation –0.33 (–0.63 to –0.03); 0.034 0.417 –0.09 (–0.42 to 0.25); 0.608 0.982
Neighbourhood
deprivation
–0.27 (–0.69 to 0.15); 0.202 0.970 –0.09 (–0.56 to 0.39); 0.715 0.816
Study site Overall 0.048 0.312 Overall 0.837 0.008
England vs. Scotland 2.61 (–0.25 to 5.48); 0.073 –0.354 (–3.682 to 2.974); 0.832
England vs. Wales 3.33 (0.67 to 5.99); 0.015 –0.894 (–4.022 to 2.234); 0.570
Site-specific intervention effect estimates (BeatIt vs. StepUp)
England 1.16 (–2.96 to 5.29); 0.575
Scotland –3.14 (–6.21 to –0.08); 0.045
Wales 5.79 (1.02 to 10.57); 0.018
Relationship of carer to
participant
Overall 0.763 0.984 Overall 0.257 0.351
Family vs. other 0.36 (–2.32 to 3.04); 0.791 1.11 (–1.88 to 4.11); 0.461
Worker vs. other –0.55 (–2.99 to 1.89); 0.655 –1.24 (–3.92 to 1.45); 0.361
Level of support (less than
daily vs. daily)
1.69 (–0.46 to 3.84); 0.122 0.181 –1.33 (–3.77 to 1.11); 0.281 0.450
BLESID life events negative
impact
–0.34 (–1.05 to 0.37); 0.344 0.385 –0.13 (–0.92 to 0.66); 0.748 0.773
Previous therapies for
depression
–1.50 (–4.01 to 1.02); 0.240 0.691 0.72 (–2.08 to 3.52); 0.610 0.610
Use of antidepressants –0.76 (–2.93 to 1.40); 0.485 0.051 –0.91 (–3.32 to 1.51); 0.457 0.817
Use of mood stabilisers –1.03 (–3.76 to 1.70); 0.453 0.222 1.85 (–1.14 to 4.84); 0.220 0.825
Note
Predictor effects taken from mixed-effects linear regression model adjusted for predictor variable, baseline GDS-LD score,
intervention, antidepressant use, study centre and random effect of therapist. Interaction p-values taken from same model
with predictor-by-intervention interaction term(s) added. For any interaction with p< 0.05, intervention effect estimates are
reported for specified levels of the predictor variable.
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Per-protocol analyses
Per-protocol analyses were also conducted; however, there were no differences in the pattern of results
from those reported in this chapter. Given that there were virtually no treatment group differences found
that could be examined in terms of the effects of a per-protocol approach, these analyses are not
described further here.
Adverse events
Following randomisation, there were 19 adverse events reported by 15 participants allocated to StepUp
and 21 adverse events reported by 18 participants allocated to BeatIt (Table 29).
All 24 serious adverse events reported during the trial were hospitalisations.
Five participants in the StepUp group were admitted to a mental health ward, of whom three presented
with suicidal ideation. Four participants in the BeatIt group were admitted to a mental health ward, of
whom two presented with suicidal ideation.
There was one reported episode of attempted suicide by overdose during the trial. The participant had
been randomised into the study but had not yet started therapy sessions. The participant was subsequently
withdrawn based on previously undisclosed suicide attempts.
TABLE 29 Summary of post-randomisation adverse events throughout the study period to the 12-month follow-up
Adverse event categories
Trial arm
StepUp (N= 77) BeatIt (N= 84)
Participants with any adverse event, n (%) 15 (19.5) 18 (21.4)
Total number of adverse events, n 19 21
Mild, n 4 2
Moderate, n 8 9
Severe, n 7 10
Number of serious adverse events, n 12 12
Hospitalisation, n 12 12
Death, n 0 0
Other, n 0 0
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Chapter 6 Economic evaluation
Introduction
This chapter outlines the health economics analysis of BeatIt. The objective of the analysis was to evaluate
whether or not BeatIt is cost-effective compared with a guided self-help intervention (StepUp), as
determined by an incremental cost per quality-adjusted life-year (QALY).
Methods
Overview
The cost-effectiveness analysis was carried out from a NHS and social services perspective, in line with the NICE
guidelines;67 it was also anticipated that social care might be an important resource use in this population.
The target population was adults with mild to moderate learning disabilities and clinical depression who had a
supporter or family member available to attend treatment sessions with them and provide a minimum of
2 hours of support per week. The outcome used in the cost-effectiveness analyses was the QALY.
The intention-to-treat population was used for the economic analysis. Comparative results are presented as
an incremental cost-effectiveness ratio (ICER), which is calculated by dividing the difference in mean costs
by the difference in mean QALYs. The NICE threshold of £20,000–£30,000 was used when judging
whether or not the intervention was cost-effective.67
Health-care resource use
Resource use for hospital and community costs were collected using a CSRI.64 The CSRI was adapted,
based on a similar previous study for a population with learning disabilities,68 in conjunction with the
research team. The CSRI was completed at baseline and 4 and 12 months post randomisation with the
participant and supporter to record resource use over the previous 4 months. An additional CSRI was
completed at 8 months by the supporter alone (for the previous 4 months). Resource use included daytime
activities (measured in hours), hospital-based services (measured in units received) and community-based
services (measured in hours). The timing of the data collection is illustrated in Table 30.
The therapist and supervisor time was collected using therapist and supervisor time sheets. These were
completed by the supervisors and therapists during the trial and included time spent on supervision and on
preparation and delivery of treatment sessions, in addition to time spent travelling and mileage travelled.
Medication, both prescribed and OTC, use was collected using a medication inventory, which was
completed at baseline and at 4-, 8- and 12-month follow-up visits.
All resource use is reported for the 12-month follow-up (primary end point).
TABLE 30 Timing of data collection
Type of data Source
Time point within trial
Baseline 4 months 8 months 12 months
QoL EQ-5D-Y ✓ ✓ ✓
Resource use CSRI ✓ ✓ ✓ ✓
Therapist time sheets ✓
Medication inventory ✓ ✓ ✓ ✓
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Costs: valuing resources
Costs for prescribed medication were taken from the British National Formulary.69 Other resource costs
were obtained from the Personal Social Services Research Unit (PSSRU),70 NHS Reference Costs 2014 to
201571 and the literature.68 Intervention material costs were obtained from expert opinion (Dr Kim Appleton,
University of Glasgow, 2016, personal communication). Resources were valued at 2015 costs in Great British
Pounds (GBP), and any costs that needed to be raised were adjusted using the Hospital and Community
Health Services index.70 Unit costs and their sources are presented in Table 31.
Costs are grouped into daytime activities, hospital-based services, community-based services, medication
and intervention costs. Medication costs include prescribed and OTC medication. Intervention costs include
the cost of therapists and supervisors along with therapist training and the costs of materials for therapists
and participants. Therapist and supervisor costs consist of direct contact, travelling and administrative/
preparation costs, and include on-costs. The cost per participant for therapist training was calculated
using within-trial information; during the trial a total of 45 therapists were trained in the StepUp arm and
51 in the BeatIt arm. An average of 3.5 therapists in the StepUp arm and 3.4 in the BeatIt arm were
trained in each training session. Of the 76 therapists who were assigned participants, each therapist in the
StepUp arm saw an average of 2.3 participants, and each therapist in the BeatIt arm saw an average of
2.0 participants.
TABLE 31 Unit costs and sources
Resource (sector) Unit cost (£) Source
Daytime activities
Day centre (NHS) 38.41/hour PSSRU70
Day centre (LA) 24.44/hour PSSRU70
Day centre (voluntary) 24.44/hour PSSRU70
Day centre (private) 19.42/hour PSSRU70
Sheltered work 8.51/hour PSSRU70
Voluntary work (LA) 24.44/hour PSSRU70
Voluntary work (voluntary) 24.44/hour PSSRU70
Voluntary work (private) 19.42/hour PSSRU70
Adult education 21.70/hour PSSRU70
Drop in centre 11.53/hour PSSRU70
Social club 11.53/hour PSSRU70
Learning disabilities centre 24.44/hour PSSRU70
Hospital based
Psychiatric intensive care ward 638/inpatient day PSSRU70
Acute psychiatric ward 322/inpatient day PSSRU70
Psychiatric rehabilitation ward 296/inpatient day PSSRU70
General medical ward 260/inpatient day PSSRU70
Other specialties 276/inpatient day PSSRU70
Day hospital 157/attendance PSSRU70
Psychiatric outpatient visit 172/appointment PSSRU70
Other hospital outpatient visit 166/appointment PSSRU70
A&E visit 124/attendance PSSRU70
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TABLE 31 Unit costs and sources (continued )
Resource (sector) Unit cost (£) Source
Community based
Community psychiatrist 357.92/hour PSSRU70
Psychologist 88.39/hour PSSRU70
GP (clinic/surgery) 39.28/hour PSSRU70
GP (day centre) 57.83/hour PSSRU70
GP (home) 130.95/hour PSSRU70
Community psychiatric nurse 99.30/hour PSSRU70
Learning disability nurse 99.30/hour PSSRU70
Other community nurse 79.66/hour PSSRU70
Community mental health team member 99.30/hour PSSRU70
Health care assistant 25.10/hour PSSRU70
Therapist: speech, physiotherapist, occupational, art/drama/music, alternative
Clinic/surgery 45.83/hour PSSRU70
Day centre 37.10/hour PSSRU70
Home visit 48.01/hour PSSRU70
Social worker/care manager 94.94/hour PSSRU70
Social work assistant 36.01/hour PSSRU70
Home help/home care worker 19.00/hour PSSRU70
Advocate/counsellor 48.01/hour PSSRU70
Dentist 337.19/hour PSSRU70
Optician 45.18/hour PSSRU70
Audiologist 45.18/hour PSSRU70
Chiropodist 24.01/hour PSSRU70
Employment services/job centre 68.18/hour PSSRU70
Medication
Prescribed/OTC medication Various BNF69
Materials for delivery of intervention
BeatIt 59.13/participant Expert opinion
StepUp 41.25/participant Expert opinion
Therapist/supervisor
Supervisor time 50/hour PSSRU70
Therapist time 24/hour PSSRU70
Mileage 0.56/mile PSSRU70
Cost of therapist training per participant StepUp 279 Expert opinion
Cost of therapist training per participant BeatIt 462 Expert opinion
Carers
Carers time, average hourly wage rate 13.49/hour ONS72
BNF, British National Formulary; LA, local authority; ONS, Office for National Statistics; PSSRU, Personal Social Services
Research Unit.
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Outcome measures
Health-related QoL data were generated using the EQ-5D-Y,55 a simplified version of the EuroQol-5
Dimensions, three-level version (EQ-5D-3L). EQ-5D-Y questionnaires are aimed at young people aged
≥ 8 years and are adapted directly from the EQ-5D-3L using simplified wording. The language is accessible
and straightforward but not childlike, a good match for patients with learning disabilities.56 The EQ-5D-Y is
a generic, preference-based QoL measure designed for children and adolescents, comprising five questions
and a visual analogue scale. The questions cover five dimensions: (1) mobility, (2) ‘looking after myself’,
(3) usual activities, (4) pain/discomfort and (5) ‘feeling worried, sad or unhappy’. There are three possible
responses for each dimension (i.e. ‘no pain’, ‘some pain’ and ‘a lot of pain’) giving a total of 243 possible
health states. Participants were asked to complete the questionnaire at baseline and 4 and 12 months
post randomisation.
At present there is no child-friendly preference-based scoring algorithm value set available for the EQ-5D-Y,
and EuroQol are not advising a value set to use. As a result, an adult value set was used to value the
responses.73 Participant-reported health-related QoL obtained from EQ-5D-Y questionnaires was valued in
terms of utilities on a scale of –0.59 to 1 (in which 1 represents full health). Utilities were converted into
QALYs using standard area-under-the-curve methods. QALYs are a measure combining both quality and
length of life; patient-specific QALYs were estimated using utility measurements at each follow-up point and
weighting each time interval by the patient’s utility during that period. Discrete changes in utility values
between follow-up points were assumed to be linear.
Analysis
Resource use for each resource item in each group is presented using descriptive statistics.
The cost per participant was estimated by applying the unit cost of a resource to the number of uses.
These costs were summed and divided by the number of participants in each arm to give the mean cost
per participant in each arm. Differences in these mean costs were calculated and are presented along with
a 95% CI to illustrate uncertainty in the mean costs.
The mean QALY per participant for each intervention was estimated by summing all participants’ QALYs
and dividing by the number of participants in that intervention arm. The difference in means was
calculated along with 95% CIs.
The analysis was carried out using Stata® 14.0 (StataCorp, College Station, TX, USA).
Missing data
Two analyses were carried out: (1) a complete-case analysis of participants who had complete data and
(2) a separate analysis in which missing data were replaced using multiple imputation techniques to explore
the effect of missing data on results. The multiple imputation technique used was multiple imputation using
chained equations. Multiple imputation assumes that data are missing at random; missing data may depend
on observed data.
Costs were replaced at a disaggregated level (intervention and non-intervention in order to explore whether
or not there were cost savings associated with the non-intervention costs), and EQ-5D-Y QoL data were
replaced at utility score level at baseline and 4- and 12-month follow-ups. The regression analysis used to
impute costs comprised age, treatment arm, baseline costs and therapist. For QALYs the analysis included
age, treatment arm, baseline GDS-LD score and therapist. These variables were associated with missing data
and were strong predictors of costs and QALYs.
During the trial, 20 participants did not complete treatment (2 as a result of adverse events, 6 lost to
follow-up, 1 supporter unwilling to continue in the study and 11 participants unwilling to continue in
the study). These participants were excluded from the analyses on the grounds that it would not be
meaningful to include them in a multiple imputation model.
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Assumptions
The following assumption was made: the duration of medication was truncated at 365 days, as the
follow-up period was 365 days.
Uncertainty
To explore the robustness of the results and address the uncertainty of the point estimates, sensitivity
analyses were carried out:
1. Resource use was collected at each visit for the previous 17-week period (4 months); however,
41 participants had their resource-use data collected over a 16-week period at each visit, and a further
15 had a mix of 16 and 17 weeks between visits. The effect this had on results was explored in a
sensitivity analysis in which all the resource-use data collection periods were converted to 17 weeks for
a 4-month period.
2. The sensitivity to within-trial training costs was explored in two ways. First, by including a more ideal
scenario of nine therapists trained per training session with each therapist seeing nine participants,
and second, by using a scenario in which no training costs were included.
To assess the impact of uncertainty and to strengthen the validity of the results, a non-parametric
bootstrapping technique was employed with 1000 samples, with results presented on a cost-effectiveness
plane and cost-effectiveness acceptability curve.
To account for any difference at baseline in costs and QALYs, results were adjusted using a generalised
linear model (GLM).
Results
Missing data
Table 32 presents the proportion of missing data in the QoL and resource-use questionnaires. The percentage
of missing data was < 5% in all areas. In addition to this, one participant in the BeatIt arm had missing
therapist data.
Resources
Total resource use by participants for complete cases, at 12-month follow-up, is presented in Table 33
(for more detail see Appendix 3, Table 51).
The results from Table 33 indicate that there is no significant difference between the two arms for any of
the resource groupings. It can be seen that 90.4% of participants in the StepUp arm and 95.6% in the
BeatIt arm used medication, and the mean number of medications reported was 5.52 in both arms. In total,
69.9% of participants in the StepUp arm and 57.4% in the BeatIt arm reported participating in daytime
TABLE 32 Proportion of missing data
Time point
% (n) of participants
EQ-5D-Y Daytime activities and hospital-based services Community-based services
Baseline 0.71 (1) 0 (0) 0 (0)
4 months 4.26 (6) 4.26 (6) 4.26 (6)
8 months 3.55 (5) 3.55 (5)
12 months 4.26 (6) 4.26 (6) 4.26 (6)
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activities, with a mean number of 54.8 and 65.6 weeks of daytime activities in StepUp and BeatIt,
respectively. The mean hours per week spent participating in daytime activities was 8.07 in the StepUp arm
and 8.46 in the BeatIt arm. The mean number of contacts with hospital services was 6.90 and 7.03 in the
StepUp and BeatIt arms, respectively, with 54.8% in the StepUp arm and 47.1% in the BeatIt arm using
hospital services. Community-based services were used by 93.2% of StepUp participants and 86.8% of
BeatIt participants; the mean number of community-based contacts during the 12-month trial period was
134.8 in the StepUp arm and 135.8 in the BeatIt arm. The mean duration (minutes) of these contacts were
67.4 minutes in the StepUp arm and 61.5 in the BeatIt arm.
Costs
Total mean costs are presented in Table 34 below.
TABLE 33 Use of resources for 12 months’ follow-up
Resource type
Trial arm
Mean difference (95% CI)
StepUp BeatIt
Mean (SD)
Used by
n (%) Mean (SD)
Used by
n (%)
Number of medications 5.52 (3.69) 66 (90.4) 5.52 (4.29) 65 (95.6) 0.008 (0.700) –1.39 to 1.38
Daytime activities
Weeks attended 54.8 (32.8) 51 (69.9) 65.6 (34.4) 39 (57.4) –10.7 (7.18) –25.0 to 3.54
Mean hours per week 8.07 (7.71) 51 (69.9) 8.46 (7.59) 39 (57.4) –0.388 (1.63) –3.62 to 2.85
Hospital-based services
(number of contacts)
6.90 (12.6) 40 (54.8) 7.03 (9.88) 32 (47.1) –0.131 (2.65) –5.41 to 5.15
Community-based services
Contacts 134.8 (236.9) 68 (93.2) 135.8 (181.2) 59 (86.8) –1.03 (37.17) –74.6 to 72.5
Mean duration of
contact (minutes)
67.4 (55.8) 68 (93.2) 61.5 (46.1) 59 (86.8) 5.87 –12.0 to 23.8
TABLE 34 Total mean costs (£) for complete cases only
Resource type
Trial arm
Mean difference (95% CI)
StepUp [used by
n= 68 (93.2%)]
BeatIt [used by
n= 58 (85.3%)]
Mean (SD) Mean (SD) Mean (SE) 95% CI
Medication 807 (1409) 862 (1718) –55 (283) –616 to 506
Daytime activities 8096 (11,301) 8496 (11,766) –400 (2065) –4490 to 3689
Hospital-based services 1011 (3419) 859 (2182) 152 (504) –846 to 1151
Community-based services 15,822 (36,193) 15,512 (32,685) 670 (6139) –11,480 to 12,821
Intervention 1050 (310) 1788 (506) –738 (76) –890 to –586
Total costs 26,786 (38,232) 27,158 (35,751) –371 (6598) –13,432 to 12,689
SE, standard error.
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Total costs favour StepUp by a difference of £371 [standard error (SE) £6598], but this difference is not
significant. However, the difference in the mean costs of the interventions was highly significantly less
expensive, in favour of StepUp, with mean StepUp intervention costs of £738 (SD £76) less than mean
BeatIt costs. Conversely, there was no significant difference between the arms in any of the resource
groups, suggesting that the extra cost of BeatIt does not translate into cost savings in any of the resource
groups. This hypothesis can be further explored by aggregating non-intervention costs to see if there is any
evidence of cost savings associated with either treatment. The results from this exploratory analysis are
presented in Table 35.
It can be seen from Table 35 that although there is no significant difference between arms for
non-intervention costs, the results favour the StepUp arm.
A simple societal perspective was also assessed: the time burden associated with carers for accompanying
participants to therapy sessions. Carers’ time was valued using the Office for National Statistics 2015
average hourly wage rate.72 The results reflect that the BeatIt intervention requires more carers’ time than
the StepUp intervention. Carers’ costs added £104 to the costs of the StepUp arm and £184 to the costs
of the BeatIt arm.
Outcomes
Results of the EQ-5D-Y at each level, dimension and visit are presented in Table 36. For the mobility
dimension, the proportion of participants who experienced ‘no problems walking about’ increased
from 70.0% to 80.7%, and the proportion reporting ‘a lot of problems walking about’ decreased from
16.4% at baseline to 8.9% at the 12-month visit. For the self-care (‘looking after myself’) dimension, the
proportion of participants reporting ‘no problems washing or dressing myself’ increased from 69.3% at
baseline to 76.3% at the 12-month follow-up period, and the proportion reporting ‘a lot’ of problems
decreased from 13.6% at baseline to 8.9% at follow-up. Although for the usual activities (hobbies, sports,
etc.) dimension, the proportion of participants reporting ‘no problems’ decreased from 80.0% to 76.3%
over the 12-month follow-up period, the proportion reporting ‘a lot’ of problems doing usual activities
increased from 7.86% to 10.4%. The pain or discomfort domain returned to the previous trends seen in
the mobility and ‘looking after myself’ dimensions: the proportion of participants reporting no pain or
discomfort increased from 62.8% to 77.8% over the trial period, and those experiencing ‘a lot of pain or
discomfort’ decreased from 11.4% to 7.4%. The final dimension of ‘feeling worried, sad or unhappy’ is
arguably the most important one in this trial, with the proportion of participants reporting that they were
‘not worried, sad or unhappy’ increasing from 42.1% to 55.6%, and the proportion reporting that they
felt ‘very worried, sad or unhappy’ decreasing from 20.7% to 13.3%.
The EQ-5D-Y results for utilities at baseline and 4 and 12 months post randomisation and QALYs for the
12-month trial period are presented in Table 37.
TABLE 35 Intervention and non-intervention costs (£)
Costs
Trial arm
Mean difference (95% CI)
StepUp [used by
n= 68 (93.2%)]
BeatIt [used by
n= 58 (85.3%)]
Mean (SD) Mean (SD) Mean (SE) 95% CI
Intervention 1050 (310) 1788 (506) –738 (76) –890 to –586
Non-intervention 25,736 (38,228) 25,370 (35,703) 367 (6593) –12,684 to 13,418
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
59
TABLE 36 The EQ-5D-Y results by dimension
EQ-5D-Y dimension
n (%)
Baseline 4 months 12 months
Mobility
Level 1 (no problems) 98 (70.0) 103 (76.3) 109 (80.7)
Level 2 (some problems) 19 (13.6) 17 (13.6) 14 (10.4)
Level 3 (a lot of problems) 23 (16.4) 15 (11.1) 12 (8.9)
Looking after myself
Level 1 (no problems) 97 (69.3) 99 (73.3) 103 (76.3)
Level 2 (some problems) 24 (17.1) 25 (18.5) 20 (14.8)
Level 3 (a lot of problems) 19 (13.6) 11 (8.2) 12 (8.9)
Usual activities
Level 1 (no problems) 112 (80.0) 101 (74.8) 103 (76.3)
Level 2 (some problems) 17 (12.1) 24 (17.8) 18 (13.3)
Level 3 (a lot of problems) 11 (7.86) 10 (7.4) 14 (10.4)
Pain or discomfort
Level 1 (no pain) 88 (62.8) 92 (68.2) 105 (77.8)
Level 2 (some pain) 36 (25.7) 29 (21.5) 20 (14.8)
Level 3 (a lot of pain) 16 (11.4) 14 (10.4) 10 (7.4)
Feeling worried, sad or unhappy
Level 1 (not worried, sad or unhappy) 59 (42.1) 79 (58.5) 75 (55.6)
Level 2 (a bit worried, sad or unhappy) 52 (37.1) 44 (32.6) 42 (31.1)
Level 3 (very worried, sad or unhappy) 29 (20.7) 12 (8.9) 18 (13.3)
TABLE 37 EQ-5D-Y utilities and QALYs
Time point
Trial arm
DifferenceStepUp BeatIt
Mean (SD) n (%) Mean (SD) n (%) Mean (SE) 95% CI
Baseline 0.638 (0.374) 72 (98.6) 0.474 (0.438) 68 (100.0) 0.163 (0.069) 0.0270 to 0.300
4 months 0.701 (0.358) 71 (97.3) 0.637 (0.412) 64 (94.1) 0.064 (0.067) –0.069 to 0.196
12 months 0.697 (0.349) 70 (95.9) 0.675 (0.410) 65 (95.6) 0.022 (0.066) –0.109 to 0.152
QALYs 0.691 (0.287) 68 (93.2) 0.628 (0.361) 61 (89.7) 0.063 (0.058) –0.052 to 0.178
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It can be seen that there is no significant difference between arms in utilities at 4 months or 12 months;
however, at baseline there is a significant difference of 0.163 (SE 0.069), with BeatIt participants reporting
significantly lower QoL than StepUp participants. The results of the EQ-5D-Y scores are illustrated as a
profile over time in Figure 3. This clearly illustrates the difference between the groups at baseline and 4
and 12 months. The area between the two lines represents the QALYs gained over the 12-month follow-up
period between treatments. Figure 3 also presents the 95% CI (as bars) around StepUp and BeatIt EQ-5D-Y
scores at baseline and 4 and 12 months. The scores and 95% CIs for both trial arms converge towards the
12-month follow-up point.
Multiple imputation results
The unadjusted multiple imputation results are presented in Table 38.
It can be seen from the multiple imputation results in Table 38 that after imputing missing costs and QALYs,
the differences in the intervention costs, total costs and QALYs remain consistent with the complete-case
results. The difference between arms for intervention costs is £751, a significant difference; however,
although the difference in total mean costs has increased to £1201 (SE £6319), this remains a statistically
insignificant result. The mean difference in QALYs has increased slightly from the complete-case difference
of 0.063 to 0.076, but again this mean difference is statistically insignificant. Non-intervention costs now
favour StepUp; however, this difference is not significant.
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FIGURE 3 The EQ-5D-Y scores over time, by group (all available data).
TABLE 38 Multiple imputation results (unadjusted)
Results
Trial arm
Difference (SE) 95% CIStepUp (SE) BeatIt (SE)
Intervention costs (£) 1027 (36.70) 1779 (68.20) –751a (76.00) –601 to –902
Non-intervention costs (£) 24,994 (4358) 25,444 (4549) –450 (6310) –12,932 to 12,031
Total costs (£) 26,021 (4359) 27,223 (4562) –1201 (6319) –13,702 to 11,299
Total QALYs 0.693 (0.034) 0.617 (0.044) 0.076 (0.055) –0.033 to 0.185
a Subject to rounding.
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Sensitivity analysis
The results of the sensitivity analysis are presented in Table 39.
It can be observed from the sensitivity analysis results that altering unit costs do not alter the results in any
scenario from complete case or multiple imputation results; total mean cost differences in all three scenarios
favour StepUp, but this difference is not significant. This indicates that the point estimates used as unit costs
are robust.
The incremental cost-effectiveness results are presented in Table 40, and include multiple imputation
results, both unadjusted and adjusted. Costs are split between intervention and non-intervention to explore
whether or not the increased intervention costs have any effect on non-intervention costs. As a result of the
imbalance in EQ-5D-Y scores at baseline, multiple imputation results for QALYs were adjusted as planned,
using baseline EQ-5D-Y score and baseline GDS-LD score (both significant predictors of QALYs). Costs were
adjusted for baseline costs and therapist (both significant predictors of costs). The model used to adjust for
costs and QALYs was a GLM.
TABLE 39 Sensitivity analysis (£)
Sensitivity analysis
Trial arm, mean costs (£) (SE)
Difference (SE) 95% CIStepUp BeatIt
17-week/4-month period for resource-use
data collection
25,489 (4362) 26,478 (4354) –989 (6181) –13,216 to 11,238
Nine therapists trained in each training
session and nine participants per therapist
25,451 (4362) 26,428 (4354) –977 (6181) –13,204 to 11,250
No therapist training costs included 25,989 (4382) 27,172 (4396) –1183 (6225) –13,499 to 11,133
TABLE 40 Cost-effectiveness results (multiple imputation, unadjusted and adjusted)
Outcomes
Analysis, mean (SE)
Difference (SE) 95% CI
Unadjusted Adjusted
Trial arm Trial arm
StepUp BeatIt StepUp BeatIt
Intervention costs (£) 1027 (36.70) 1779 (68.20) 1019 (36.40) 1789 (65.90) –769a (75.10) –622 to –917
Non-intervention
costs (£)
24,994 (4358) 25,444 (4549) 27,181 (2491) 24,630 (2503) 2552 (1807) –1021 to 6215
Total costs (£) 26,021 (4359) 27,223 (4562) 27,962 (2347) 26,369 (2382) 1593 (1827) –2008 to 5194
Total QALYs 0.693 (0.034) 0.617 (0.044) 0.655 (0.029) 0.657 (0.031) –0.002 (0.043) –0.085 to 0.082
Incremental costs (£) –1201 (6319) 1593 (1827)
Incremental adjusted
QALYs
0.076 (0.055) –0.002 (0.043)
ICER StepUp dominates BeatIt dominates
a Subject to rounding.
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Unadjusted results show that BeatIt is more costly than StepUp and results in lower QALYs, which indicate
that BeatIt is dominated by StepUp; however, it should be noted that the difference in both mean costs and
QALYs is not significant. As expected, the intervention costs are greater for BeatIt, and this is a significant
difference. The non-intervention costs are also higher for BeatIt, but this difference is not significant. The
adjusted results indicate that the intervention costs are significantly higher for BeatIt, as in the unadjusted
results; however, the non-intervention and total costs for BeatIt are lower than those for StepUp. Adjusted
QALYs are higher in the BeatIt arm than in the StepUp arm; however, neither cost nor QALY differences are
significant. This would suggest that BeatIt is a dominant intervention compared with StepUp for adjusted
results: it is less costly with higher QALYs; however, this is the case only if non-significant non-intervention
cost differences are allowed to over-ride the significant intervention differences in cost. The uncertainty in
these results is explored further in Uncertainty.
Uncertainty
The complete-case and multiple imputation analyses both show no statistical differences between mean
costs or QALYs. To explore the robustness of these results, 1000 non-parametric bootstrapping samples
(unadjusted) were taken from the observed data and the resultant cost-effectiveness pairs are used in this
exploratory analysis.
The cost-effectiveness plane presented in Figure 4 illustrates the 1000 bootstrap samples, showing the
mean difference in costs and QALYs between the StepUp and BeatIt interventions. It can be seen that
the samples fall into all four quadrants of the cost-effectiveness plane, showing that the difference in
mean costs and QALYs can favour either intervention and that there is no evidence to show that one
intervention is more cost-effective than the other.
The likelihood of cost-effectiveness at various thresholds is illustrated in the cost-effectiveness acceptability
curve presented in Figure 5.
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FIGURE 4 Cost-effectiveness plane showing mean difference in costs and QALYs between StepUp and BeatIt.
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Figure 5 illustrates that at a willingness-to-pay (WTP) threshold of £0, there is a 41.7% likelihood of BeatIt
being cost-effective compared with StepUp, and at the current NICE WTP threshold of £30,000, there is a
41.1% chance of BeatIt being cost-effective compared with StepUp. Conversely, StepUp has a 58.9%
likelihood of being cost-effective at the £30,000 WTP threshold. The results in Figure 5 show that BeatIt is
not likely to be cost-effective compared with StepUp at any WTP threshold: at £120,000 the likelihood of
BeatIt being cost-effective compared with StepUp is 44.1%. This reflects the huge uncertainty in the results.
A further exploratory bootstrapping exercise has been carried out using only the intervention costs; we are
certain that BeatIt is more costly than StepUp to deliver, but there is no significant difference in the other
cost data collected. The results of the exploratory bootstrapping are presented on a cost-effectiveness
plane in Figure 6.
It can be seen from Figure 6 that, although we can be certain that BeatIt is costlier than StepUp to deliver,
we cannot be certain that the QALYs differ between arms, as is the same for the primary outcome of
GDS-LD score. The 95% CI for the ICER ranges from –£307,000 to £211,000, indicating that at no point
does the ICER fall below £211,000 for BeatIt compared with StepUp, which is not considered cost-effective.
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FIGURE 5 Cost-effectiveness acceptability curve for the BeatIt intervention.
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These exploratory bootstrapping results have also been presented on a cost-effectiveness acceptability
curve in Figure 7.
It can be seen from Figure 7 that at a WTP threshold of £0, there is an 0% likelihood of BeatIt being
cost-effective compared with StepUp; however, as the WTP threshold increases, the probability of BeatIt
being cost-effective compared with StepUp increases. At the current NICE WTP threshold of £30,000 there
is a 29.5% chance of BeatIt being cost-effective compared with StepUp.
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FIGURE 7 Cost-effectiveness acceptability curve, for intervention costs only.
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Chapter 7 Qualitative study
Introduction
When examining the cost-effectiveness of psychological interventions for mental health problems in people
with learning disabilities, it is important to seek to understand the experiences of people centrally involved
in the intervention alongside the quantitative data. This may illuminate facilitators of and barriers to
change and offer insights about how to implement interventions effectively. This component of the study
garnered qualitative data separately from people with learning disabilities who had received therapy,
supporters in therapy sessions and therapists (all across both types of intervention) to understand the
experiences of the therapy process from each perspective.
Previous research asking people with learning disabilities about their experiences of undergoing psychological
therapy has found that people valued specific techniques used as part of the particular intervention they were
receiving, but placed more emphasis on the non-specific aspects of their therapy such as the therapeutic
relationship, being listened to and respected by the therapist, and being able to talk about their lives.74,75
People with learning disabilities participating in a group intervention found it challenging to talk about their
individual feelings in a group context.75
Having a supporter (whether a family member or a paid carer) with the person with learning disabilities
during at least part of a psychological intervention has been suggested as an important adjustment to the
routine therapy process, to assist people undergoing the therapy with motivation and activities between
therapy sessions.76–78 Research on the impact of the presence of a member of staff as a supporter during
psychological interventions with people with learning disabilities is mixed;74,79 however, research asking
supporters directly about their experiences is lacking.
There has also been very little research concerning the experience of therapists trained to deliver
manualised psychological interventions to people with learning disabilities. Stimpson et al.80 explored the
views of lay therapists who ran anger management groups as part of a trial of a group anger management
intervention for people with learning disabilities. Although the therapists had some trepidation about
taking on the role, they were largely positive about running the groups. Obtaining the views of more
experienced professionals, trained to deliver individual psychological interventions, has the potential to
provide important insights that would help with the wider roll-out of the interventions by services.
Method
Participants
People with learning disabilities
A purposive sample of 26 people with learning disabilities was interviewed, all of whom had received either
the BeatIt or StepUp intervention. Participants were purposively sampled to reflect diversity in intervention
type (BeatIt, n = 16; StepUp, n = 10), living situation (living independently, n = 13; living in family home,
n = 5; living in group home, n = 3; living in supported accommodation, n = 5), location (England, n = 9;
Scotland, n = 7; Wales, n = 10), gender (women, n = 18; men, n = 8) and participant–supporter relationship
(family member, n = 7; non-family member, n = 19).
Participants’ ages ranged from 21 to 66 years. Participants’ WASI42 IQ scores ranged from 44 to 75.
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Supporters
A purposive sample of 21 carers was interviewed, all of whom had supported an adult with learning
disabilities through either the BeatIt or StepUp intervention. One supporter had supported two people
through therapy. Of the 21 supporters, 11 had supported someone through the BeatIt intervention and 10
had supported someone through the StepUp intervention. Nineteen supporters were women and two were
men. Fourteen supporters were paid support workers and seven were parents of the person with learning
disabilities in therapy. Four supporters were from Scotland, nine from England and eight from Wales.
Therapists
Within each location (Scotland, Wales, England) separate focus groups were conducted with BeatIt
therapists and therapists for the StepUp intervention. In total, 15 therapists (England, n = 7; Scotland, n = 5;
Wales, n = 3) trained to deliver BeatIt took part across three focus groups, and 11 therapists (England,
n = 2; Scotland, n = 6; Wales, n = 3) trained to deliver the StepUp intervention took part across three
focus groups.
Materials
People with learning disabilities
A semistructured interview schedule was developed to explore people’s experiences of receiving either
the BeatIt or StepUp intervention, as outlined in the protocol.41 An initial interview schedule, based on the
aims outlined in the protocol, was piloted in three interviews and then revised by the project team to focus
more on exploring participants’ experiences of various aspects of the therapy process. The final interview
schedule was divided into four topics, with opening questions that could be followed up with open-ended
questions or prompts: (1) participants’ expectations of therapy, (2) participants’ views of the therapy
sessions, (3) working relationships with the therapist and supporter and (4) perceived changes and
maintenance of change. The aim was to establish a dialogue with participants, using the schedule to
ensure that key topics were covered while having the flexibility to follow up other salient issues they raised.
Supporters
The same process as described above was used to develop a semistructured interview schedule for
supporters. This interview schedule also comprised four general topics that could be followed up with
questions or prompts: (1) supporters’ expectations of therapy, (2) supporters’ views of the therapy sessions,
(3) working relationships with the therapist and person with learning disabilities and (4) perceived changes
and maintenance of change post therapy.
Therapists
Semistructured focus group topic guides (with similar topics but some tailoring to the specific intervention
being discussed) were developed. Topics covered included the following: (1) therapists’ initial expectations
and understanding of the therapy, including views of the therapist training, (2) therapists’ views of the
therapy process, (3) therapists’ views of helpful and unhelpful aspects of the therapy and how they might
be improved and (4) therapists’ views of whether or not the therapy had any impact on the person’s life.
Procedure
People with learning disabilities and supporters
All participants (people with learning disabilities and supporters) had agreed to be interviewed as part of
their consent when first agreeing to take part in the wider study. Those selected to be interviewed, using a
purposive sampling grid, were contacted again by researchers to check that they were still willing to take
part in the qualitative component of the study. For participants with learning disabilities who did not want
their supporter to be interviewed, the supporters were not approached.
All interviews with people with learning disabilities and supporters took place within 8 weeks of
participants completing therapy, to increase the probability that participants and supporters would clearly
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recall their experiences of therapy. Interviews were conducted by a team of four researchers, each in a
different location to where they were collecting quantitative data for the wider study, to ensure that they
were not unblinded to the therapy type assigned to participants within their location. Participants with
learning disabilities and supporters were interviewed at a location of their choosing, either the home of the
person with learning disabilities or a day centre they attended. All interviews with participants who had
learning disabilities and supporters were carried out in person by one of the researchers.
Interviews were audio-recorded using digital recording equipment and transcribed verbatim. Interviews
were 20- to 80-minutes long. Two people with learning disabilities and two supporters opted for the
interviewer to take written notes of the interview rather than have the interview audio-recorded and
transcribed. At the start of the interviews, the researchers made it clear to the participants with learning
disabilities and supporters that their views were of great interest and would be kept confidential, and they
could therefore speak openly about their experiences.
Therapists
A focus group with therapists took place after all therapeutic activity in that location (Scotland, England or
Wales) had been completed. All therapists who were still currently working in that location were invited to
a focus group in their area (Scotland, Wales or England) concerning the specific type of therapy that they
had been delivering. At the point of the initial invitation, therapists were sent information about the focus
groups. Before the focus group started, the information was repeated to those who attended and their
signed consent was obtained.
All focus groups were face to face, and were facilitated by one or two senior members of the research
team. Focus groups were audio-recorded using digital recording and transcribed verbatim. Focus groups
were between 35 and 113 minutes long, with a mean length of 81 minutes.
Data analysis
Framework analysis81 was selected as the analytic approach to allow for comparisons to be made across
the sample and also within individual interviews, meaning that although comprehensive analyses of key
themes arising across the entire data set were possible, individual participants’ views remained.82 In
addition, a key aim of this qualitative component of the wider trial was to increase our understanding
of how participants and supporters experienced therapy processes, to add to our interpretation of the
quantitative data. Framework analysis allowed some specification of the dimensions of interest while
retaining the potential for emergent themes to revise or add to the framework. Using framework analysis
also made it possible for each of the researchers to code their own interviews and subsequently merge
them together when applying the thematic framework. This process was made easier by the highly
structured way in which the data were synthesised using a framework analysis. Summarising the data
was particularly helpful owing to the large number of interviews in this study: 26 interviews with people
with learning disabilities and 21 interviews with supporters.
People with learning disabilities
Once the interviews were transcribed, an initial thematic framework, closely related to the interview schedule,
was developed. The framework was agreed by the team carrying out the analyses, which consisted of
three researchers who conducted the bulk of the interviews, the researcher responsible for merging coded
interviews, and two researchers with experience in conducting qualitative research. The three researchers
who conducted the interviews then coded two interview transcripts each, with a fourth researcher responsible
for merging these coded interviews into the agreed framework. At this point, the merged document was
reviewed and discussed by the whole team, including the two experienced qualitative researchers, and the
framework was modified to encompass themes and subthemes missing from the original framework. The
researchers then coded the transcripts of all their interviews and all coded responses were subsequently
merged into the revised framework by the fourth researcher using NVivo 11 (QSR International, Warrington,
UK).83 The same overall framework of themes and subthemes was used for participants receiving either the
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BeatIt or StepUp intervention, although specific aspects of subthemes could vary in accordance with the type
of intervention experienced.
Supporters
The same data analysis process as described previously was used with transcripts from the supporters’
interviews. A similar overall framework, in terms of themes, was developed, with similarities and
differences in subthemes and specific aspects of subthemes.
Therapists
Framework analysis was also used to analyse transcripts from the focus groups with therapists. An initial
framework of themes and subthemes was developed by a researcher within the team who is experienced in
conducting qualitative research, and then revised by an independent researcher, who is also experienced in
analysing qualitative data. The same overall framework of themes and subthemes was used for therapists
delivering the BeatIt intervention and for those delivering the StepUp intervention, although specific aspects
of subthemes could vary in accordance with the type of intervention delivered.
Findings
Findings from the qualitative analyses are outlined in terms of themes, subthemes and specific issues
within subthemes. As the overall thematic structure derived from framework analysis was the same for
people with learning disabilities and supporters, these findings will be presented together. The thematic
structure for therapists was different from that for people with learning disabilities and supporters;
therefore, findings from therapists will be presented separately.
Findings from people with learning disabilities and supporters
The overall framework relating to the experiences of people with learning disabilities and supporters
consisted of six themes: (1) before therapy, (2) the therapy process, (3) relationships in therapy, (4) ending
and after therapy, (5) the impact of therapy and (6) views on the therapy. Table 41 presents the themes,
subthemes and specific issues mentioned within each subtheme. Most of the specific issues were
TABLE 41 Themes and subthemes for people with learning disabilities and supporters
Theme/subtheme
Specific issues
People with learning disabilities Supporters
Theme 1: before therapy
Subtheme Participants’ problems
l feeling down, loss, loneliness, bullying
Participants’ problems
l feeling down, life events, weight gain,
lack of energy
Subtheme Participants’ expectations
l no worries, nervous/uncertain, help with mood
and life goals generally
Supporters’ expectations
l worth a try, hoping for positive impact,
unclear, nothing else available
Theme 2: the therapy process
Subtheme Important aspects of therapy process
l BeatIt: talking and being listened to, getting
ideas and making plans, building confidence,
understanding paperwork
l StepUp: reading, understanding the books and
making them relevant to me
Supporters’ role in therapy process
l advocacy, providing moral support/
encouragement, liaison between
therapy and home, learning
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TABLE 41 Themes and subthemes for people with learning disabilities and supporters (continued )
Theme/subtheme
Specific issues
People with learning disabilities Supporters
Subtheme Therapy materials
l BeatIt: diaries useful if supported, activity
materials and formulation booklets useful,
problems remembering to use materials
l StepUp: booklets useful when accessible
Therapy materials
l BeatIt: diaries useful if supported, but
can be hard to complete in daily
routine; mood ratings useful; mood
ratings too simplistic; care plan
person centred
l StepUp: booklets useful when relevant
to person and in an accessible format,
use of booklets could be inflexible
Subtheme Between sessions
l BeatIt: using diaries but support needed,
getting out more, taking control and
doing more
l StepUp: reading through booklets with
supporter, using coping strategies discussed
in sessions
Between sessions
l therapy stimulating activities between
sessions, diaries/activities between
sessions difficult to conduct
Subtheme Learning about the person receiving therapy
l the therapy helped the supporter to
better understand the person, brought
them closer
Subtheme Suitability of therapy
l therapy pitched at the right level for the
person, person enjoyed participating
Subtheme What worked well in the therapy
l honest, open conversation; therapist on
the ‘right wavelength’; materials using
pictures; therapy done in the person’s
home
l BeatIt: planning and doing activities
tailored to the person, helping to instil
a routine
l StepUp: booklets useful, task-oriented
problem-solving
Theme 3: relationships in therapy
Subtheme Relationship with therapist
l could talk openly and trust the therapist,
developed a close relationship
Supporter relationship with therapist
l felt at ease, therapist and supporter
helped each other, helpful to have
person, supporter and therapist
together
Subtheme Relationship with supporter in therapy
l helpful/put me at ease, key to achieving
change, supporter unhelpful/challenging
Supporter relationship with person in
therapy
l intervening vs. staying quiet
Subtheme Working with therapist and supporter
l therapy sessions scaffolded by supporter, joint
working, supporter unhelpful/unnecessary
continued
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TABLE 41 Themes and subthemes for people with learning disabilities and supporters (continued )
Theme/subtheme
Specific issues
People with learning disabilities Supporters
Theme 4: ending and after therapy
Subtheme Feelings about ending therapy
l too short/can I do it again, sad to end
relationship with therapist, reluctant
acceptance of end
Subtheme Maintaining change
l BeatIt: using formulation booklets, keeping
activities going, still completing diary sheets,
still working towards goals
l StepUp: using booklets and strategies, think
books helpful but not looked at them since
end of therapy
Maintaining change
l still using adapted materials with
prompting, still doing more activities
with encouragement, continuing to
make planned changes, not used
materials since end of therapy
Subtheme Barriers
l activities/changes not encouraged at
person’s home, life events/physical
illness, need for person to be
prompted, support/services for planned
activities not available
Subtheme Helpful factors
l using adapted materials, supporter
more receptive to the person asking
for help, encouraging the person to
do more
Theme 5: the impact of therapy
Subtheme Impact on the person
l more active life, improved mood, better
relationships, more positive sense of self, more
independent, bullying stopped
Impact on the person
l talking more; more confident; engaging
in more activities, happier; more
empowered/problem-solving; improved
social skills; better relationships with
family, friends and supporter
Subtheme Broader impacts
l same approach could be used with
other people, proactive mental
health practice
Theme 6: views on the therapy
Subtheme Ideas for improving the therapy
l make aspects of therapy less complicated
l StepUp: more booklets, better pictures and
presentation, more sessions, more time
within sessions
Ideas for improving the therapy
l tailor the therapy more to the person,
shorter and simpler sessions, extra
review session after end of therapy,
involve person’s family more, more
depth, more booklets
Subtheme Would recommend the therapy to others
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mentioned in relation to both the BeatIt and StepUp interventions. When specific issues relate to one or
the other type of intervention, they are clearly indicated.
Theme 1: before therapy
People with learning disabilities and supporters across both therapy arms mentioned the participant
feeling depressed or down before the therapy started. Supporters also mentioned the person experiencing
negative life events and/or bereavements, but focused more on observable issues such as the person’s
weight, a lack of energy/mobility, and/or withdrawal from other people. In addition, people with learning
disabilities mentioned experiencing bereavements and bullying or victimisation, as well as feelings of
loneliness, a lack of confidence and anger and/or anxiety:
That’s what made me so depressed at one time, because I kept being bullied at work and that’s why
I didn’t go in [to work] for a couple of days . . . Mum thought it was great joining the programme
because I was feeling down at the time.
StepUp; participant 295
People with learning disabilities across both therapy arms mentioned a range of feelings and expectations
before the therapy started, from not being worried, and feeling the therapy might help with their mood
and the achievement of life goals, through to nervousness and uncertainty. Similarly, supporters across
both therapy arms hoped that the therapy would have a positive impact on the person and thought it
was worth giving the therapy a try. This was in a context in which there was nothing else available for the
person, or other approaches had been tried without success. However, they remained unclear about what
to expect:
I’d not really heard about anything else for people with learning disabilities who had got depression,
so yeah, I thought it was a good idea and I’d give it a try.
BeatIt; Supporter of participants 218 and 219
Theme 2: the therapy process
People with learning disabilities who received the BeatIt intervention described important aspects of the
therapy as having the time and space to talk and be listened to, getting ideas about activities and making
plans, building their confidence and understanding the materials and paperwork used within the therapy.
For people with learning disabilities who received the StepUp intervention, important aspects of therapy
were the process of reading and understanding the self-help booklets and making them relevant to their
own situations:
I liked that I could explain more in the sessions to the therapist and supporter, you knew what you
were talking about . . . I felt listened to.
BeatIt; participant 200
One week we did one book about sleeping and then we went through all the books we were given.
We were given lots of books to read through . . . The other ones were to do with things like getting
up and moving, things like dancing, go to groups, socialising, getting out and about, doing different
things, getting in the community, doing things you don’t normally do.
StepUp; participant 211
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Supporters across both therapy arms described their role in the therapy process as being an advocate for the
person receiving therapy and also providing moral support and encouragement to the person. Supporters
in the BeatIt intervention described acting as a liaison between the therapy and the person’s home, and
supporters in the StepUp intervention mentioned learning more about the person and about depression:
I’m just here to support [name] because I know [name] wants to please and just wants to tell you
things that he knows will make you smile and so my job I think really is just to say ‘is that really what
you think [name]?’ I did try to let [name] be himself and say what he wanted but it’s just on the odd
occasion to be a bit supportive and remind him about different things.
BeatIt; supporter of participant 186
In terms of the materials used in the therapies, both people with learning disabilities and supporters
involved in the BeatIt intervention reported that the diaries were useful if the person was supported to
use them, although they could be hard to complete within the person’s daily routine. Some supporters
reported the mood ratings to be helpful, whereas others felt them to be too simplistic. Other activity
materials and formulation booklets were also mentioned as useful, and the plan that was developed with
the person at the end of therapy was seen as person centred. However, there were sometimes problems
with remembering to use the materials:
I remember the cards, the things that you say what you do day to day. I had the two boxes and the
cards rather than the pictures and things like that. So that was quite fun. And drawings and diaries
as well.
BeatIt; participant 290
Both people with learning disabilities and supporters involved in the StepUp intervention reported that the
booklets were useful when they were accessible and relevant to the person’s situation but that the use of
the booklets within the context of a research trial could be inflexible:
I do think she could have done with a little bit longer because, personally, the first couple of booklets
weren’t really too relevant, it just wasn’t amazingly relevant, but the last couple, you know where you
tackle the problems head on, they were better I think and we could have done with a bit longer on
them because with them coming at the end, there was only a couple of weeks to really tackle
the problems.
StepUp; supporter of participant 209
People with learning disabilities receiving the BeatIt intervention reported using the diaries between
sessions, getting out more, doing more and taking control of their lives, although they needed support to
do this. People with learning disabilities receiving the StepUp intervention reported reading through the
booklets with their supporter between sessions and using coping strategies discussed in the therapy
sessions. Supporters across both types of intervention mentioned that the therapy stimulated activities
between sessions, although supporting these activities could be difficult within people’s daily routines and
because of the amount of support available to the person:
And then I started taking meself off instead of going to the pub because Susan helped me get a pass
from my doctor so I get free travel and all that . . . Days out, going to different places and just having
a wander round and some dinner and coming back . . . That’s when I used to see them [diaries] and
write it down . . . I used to love those little booklet [diaries] things.
BeatIt; participant 182
There were additional subthemes from supporters’ interviews about the therapy process. Supporters
involved in both types of intervention reported that being involved in the therapy helped them learn more
about the person they were supporting and brought them closer. Supporters also mentioned that both
therapies were generally pitched at the right level for the person they were supporting and that the person
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enjoyed participating in the therapy. In terms of what worked well in therapy, supporters involved in both
types of intervention mentioned being able to have honest, open conversations with the person; the
therapist being on the right wavelength; and the availability of materials that were accessible to the
person. Some supporters appreciated the therapy taking place in the person’s home. Supporters of people
receiving the BeatIt intervention thought that activities worked well when they were both tailored to the
person and helped to instil a more active routine. Supporters of people receiving StepUp talked about the
booklets and thought the focus on task-oriented problem-solving was particularly helpful:
The problem-solving book is really good, I’ve actually found it beneficial for myself. Definitely the
sleeping one was good, it’s good to recognise depression as well in the initial booklet because I think
people don’t realise, so I think all of the booklets were informative in different ways, but particularly
I think it is important to recognise that you have a problem and that other people recognise that you
have a problem as well.
StepUp; supporter of participant 289
Theme 3: relationships in therapy
Across both types of intervention, people with learning disabilities generally reported positive relationships
with the therapist. They felt that they could talk openly and trust the therapist, and reported that they had
developed a close relationship with the therapist. People with learning disabilities also generally reported
that having a supporter in the therapy sessions helped to put them at ease and was very important in
terms of achieving change. People with learning disabilities also mentioned that their therapy sessions
generally involved joint working between them, the therapist and the supporter, with the supporter
providing the scaffolding for the therapy session to go well:
Everything she [therapist] did, she explained, so it wasn’t so bad. I got into it, like you know. Because
the therapist let me talk about what I wanted to talk about, you know, I felt more comfortable being
that way.
StepUp; participant 252
However, supporters were not universally seen as helpful:
When my support worker was there I didn’t really like that bit of it to tell the truth, I have to be
honest with that. ‘Cause I had to sort of watch what I was saying as maybe stuff that I want to talk
about but my support worker was there all the time, it was like she took control in a way, about how
she thinks I am. But when you know how you’re feeling, you know that’s how you’re feeling . . .
I am an adult, do you know what I mean?
BeatIt; participant 075
Supporters involved in both types of intervention also reported positive relationships with the therapist,
feeling that the therapist put them at ease, and that it was helpful to work together with the therapist and
person with learning disabilities. Supporters also mentioned having to find the right balance within therapy
sessions between intervening and staying quiet, a balance that sometimes resulted in less need for them to
intervene as the therapy progressed:
I really liked the fact that as the weeks went by I could withdraw a little bit because [in] the first
session, everything was coming through me and [name] was quite shy and would address things to
me for me to pass back to the therapist but as the weeks went by she was quite confident to talk to
the therapist.
StepUp; supporter of participant 204
Theme 4: ending and after therapy
People with learning disabilities across both types of therapy described how they felt at the end of the
therapy sessions. They said that they were sad to end the relationship with the therapist and felt that the
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therapy was too short or that they wanted to do it again, with some people expressing a reluctant
acceptance that therapy was at an end:
I was quite sad that it finished because I could have done with some more sessions of therapy to be
honest, but sadly these things have to come to an end. So you have to make the most of what you’ve
got, don’t you?
StepUp; participant 211
People with learning disabilities talked about maintaining changes they had made after therapy had
finished. Those who had received the BeatIt intervention mentioned keeping their activities going and
continuing to complete diaries and use the formulation booklets. They also talked about maintaining
work towards the goals identified in the therapy. Some people who had received the StepUp intervention
mentioned continuing to use the booklets and the coping strategies developed during therapy. Although
others said that they had not used the booklets since the therapy had finished, they knew where they
were in case they were needed:
No I don’t use the diaries any more. I’ve got my own diary in my bag. I usually write what I do and
then if mum and dad, what they do . . . but I think it’s fun to.
BeatIt; participant 097
My favourite one is the activity. If I do feel down I can drag myself out and then just go somewhere
and that . . . Yeah, go for a long walk or maybe have a bath or just go to [nearby town] or something
for a day.
StepUp; participant 209
Supporters talked in similar terms to the people with learning disabilities across both types of intervention,
talking about how they still supported people to use the materials (sometimes adapting them specifically
for the person). They also described how the person (with encouragement) maintained activities and other
progress that had been made. Some supporters reported that the person had not used the materials since
the end of therapy.
Supporters identified barriers and helpful factors they had experienced when it came to maintaining
change beyond the end of therapy. Barriers included the person facing negative life events or physical
illness, a lack of encouragement or prompts required to sustain change or a lack of support/services
needed for planned activities to happen. Helpful factors identified by supporters included feeling that they
were more receptive to the person asking them for help, encouraging the person to do more activities and
adapting the therapy materials to suit the individual person they supported:
We adapted the problem-solving worksheet, we talked about it together, it was very soon after it
[therapy] finished so we adapted it and made it a little bit simpler with less ideas and I think we had
some more prompting-type questions in there to explain, so that it wasn’t just like ‘What’s the problem?
How do you solve it? What’s the idea to solve it?’ It’s really given me the confidence to try something
different and move it on so we are still taking bits from it.
StepUp; supporter of participant 203
Theme 5: the impact of therapy
Both people with learning disabilities and supporters involved in both types of intervention reported similar
positive effects of therapy on people’s lives. Supporters mentioned participants being happier, more
confident and showing improved social skills. The supporters thought people talked more, engaged in
more activities, were more empowered and used new problem-solving skills. The supporters also observed
that the individuals they supported had better relationships with their friends, families and with the
supporter themselves.
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A small number of supporters also reported broader impacts of the therapy beyond the individual who had
received it, in terms of them using some of the approach (whichever therapy it was) with other people and
the importance of taking a more proactive approach to addressing people’s mental health:
A really big difference with her, more brighter, happier, she sings away (she never used to sing away
before) she loves her singing, wanting to help everybody now. She got more social skills, going out
more, which she’ll never say no. She’ll always go out. She’s more happier anyway, she’s more brighter.
She’s just a pleasure to have now. Everyone says she’s a ray of sunshine when she comes in here.
She gained a lot of confidence, she can express herself more now, she’s more happier.
BeatIt; supporter of participant 196
People with learning disabilities mentioned experiencing improvements in their mood, having a more
positive sense of self and being more independent. They also said that they had more active lives and
better relationships, and that bullying or victimisation had stopped:
But since I’ve been to therapy it’s totally different because I’ve started cleaning up my flat, cleaning
myself up and going shopping. I have come on [in] leaps and bounds and it’s all because of this.
I don’t think I’d have got through it otherwise. If I wouldn’t have had the therapist I wouldn’t have
got through it . . . If it wasn’t for this and a couple of other friends, I think I’d be dead by now.
BeatIt; participant 182
I wanted it so that I didn’t have to be spoken to like a child and that people understood me and not,
like, treated me differently. The therapy definitely did that.
StepUp; participant 272
Theme 6: views on the therapy
Relatively few people with learning disabilities or supporters mentioned specific ideas for improving the
therapy that they had received. People with learning disabilities mentioned wanting aspects of the therapy
to be simpler, and people who had received the StepUp intervention specifically mentioned wanting more
booklets covering a wider range of topics, the booklets to be better presented, more sessions and more
time within sessions. Supporters across both types of therapy wanted to tailor the therapy more to the
specific needs of the person, and have shorter and simpler sessions. Some supporters suggested having an
extra review session after the end of therapy, and to involve the person’s family more. Supporters involved
in StepUp mentioned the need for more in-depth therapy and wanted more booklets covering a wider
range of topics. Supporters across both therapy types also generally said that they would recommend the
therapy to others:
I do think it was helpful. Yeah I think they would recommend it yeah, they were helpful. I don’t think
it was too intense which was good, it was on a level that [name] could understand which was good,
it sometimes can be different.
BeatIt; supporter of participant 302
It should be supported, I think it should be supported and offered to people, a lot more people.
Because it does really, really help. I just can’t believe that there is nothing out there for people with
depression bar from going to the doctors and they say ‘have some tablets’. It proves that it can work
without tablets. So there should be funding for it. So let’s hope they do something about it.
StepUp; supporter of participant 295
Findings from therapists
For reasons of space, selected themes from the overall framework for therapist transcripts are reported
here: (1) positive aspects of delivering the therapy (those common to both interventions, those related to
the BeatIt intervention and those related to the StepUp intervention), (2) challenges of delivering the
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therapy (those common to both interventions, those related to the BeatIt intervention and those related to
the StepUp intervention), (3) working with supporters and (4) therapist experience and supervision.
Theme 1: positive aspects of delivering the therapy
Therapists delivering either type of intervention reported positive perceptions of aspects of the therapies
that were common across interventions, particularly the structured format and manualised nature of the
interventions and the use of accessible materials throughout both interventions. Therapists generally
reported that the structured nature of sessions facilitated rather than constrained the therapy and enabled
them to quickly establish a therapeutic relationship. Having a fixed number of sessions helped therapists to
keep on track and know when to end treatment:
My experience, obviously I’ve not done a set programme therapy before, so it was quite nice to have a
bit of structure, made me feel quite comfortable, I was like ‘yes a bit of structure finally’, I’m all over
the place with lots of my clients so this was quite nice, I knew what I’m doing.
BeatIt; therapist 2
Therapists also reported positive aspects specifically tied to the intervention that they were delivering.
For example, some therapists delivering BeatIt reported that the intervention allowed them to tailor the
sessions to the particular issues faced by the person with learning disabilities, thereby facilitating the
person’s involvement in the therapeutic process:
My first participant, he had specific ideas of what he wanted to engage with himself, and that was his
goal at the very end. We got really quite far with that. At the end he was able to meet that. He made
little steps, he found it very, very useful. He asked for more copies of Make a Plan and How Did It Go?
after all the sessions completed, he wanted in order that he could plan his time, he found that useful.
BeatIt; therapist 3
Therapists delivering the StepUp intervention reported that the consistent structure of the sessions was
helpful to the person with learning disabilities. The intervention helped people to solve problems and see
their situation differently, and the intervention provided valuable tools for the person to use after therapy
had ended:
And it’s tools for not just that period or eight sessions, it’s tools for the future; that’s what it’s there
for, not just those 8 weeks, so hopefully what I was trying to get across to mine was we might have
addressed the problem that you want to discuss, that you identified, and we worked through that in
sessions 5, 6 and . . . can’t remember. But also if anything does happen in the future when you start
feeling a bit . . . which is highly likely to happen – there’s no point in saying otherwise, that StepUp is
going to cure you now, that you’re never going to suffer from depression again, you’ve got the
tools there.
StepUp; therapist 52
Theme 2: challenges of delivering the therapy
Therapists delivering either type of intervention reported some challenges in delivering the therapy that
were common to both interventions. These challenges were often the flip side of those aspects of the
interventions they viewed positively. For example, some therapists reported that the manualised, structured
approach used in both interventions made it difficult for the therapy to be flexible enough to deal with
the particular issues that a person might bring to a therapy session. The highly structured nature of the
interventions, particularly within the context of a research trial, was reported by some therapists to
QUALITATIVE STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
78
constrain them in adapting and individualising the intervention and materials to suit the person’s needs
or circumstances:
I had trouble with one family though, the sisters were saying, ‘but she doesn’t have sleep problems,
why do you keep going on about this?’, and I’m rigid in that way, that I’m saying, ‘well I have to go
through it ‘cause it’s research based and it’s part of it, let’s just do it’. And they just didn’t want it,
they were just not interested and I still went through it, it ended up being pulled out ‘cause they were
just saying it wasn’t relevant ‘cause they were saying ‘none of this is relevant, my sister doesn’t have
depression and anxiety’.
StepUp; therapist 54
Community-based learning disability nurses who had taken on a therapist role delivering either intervention
found the focus of delivering a specific, structured intervention both frustrating (in their therapist role they
could not address other needs that the person had) and valuable (it enabled them to work with the person
with learning disabilities towards a specific goal):
So the structure was good, to have it to not only guide but restrict as well, ‘cause half the time I would
be sitting there going, ‘oh this is a problem, I’ll make a referral to this’, I’m not doing it, I’m not a nurse,
I’m a therapist and so it was nice to have a very defined role to be within and a goal that was also
quite clear.
BeatIt; therapist 1
Therapists also reported challenges more specifically tied to the intervention that they were delivering.
For example, some therapists delivering the BeatIt intervention reported that the later sessions could be
too repetitive and that the intervention might be less appropriate for people with learning disabilities who
already led active lives:
. . . but it’s that gap of where you’re repeating the session, 6–10 is repetitive for that client. So we’re
doing what we did last week and what are the problems with that? So I just felt that really that’s
dependent on your individual.
BeatIt; therapist 4
Some therapists delivering the StepUp intervention reported that it was difficult to hold back from making
suggestions or following up with the person on what had happened since the previous session:
Especially when you get to the problem-solving part I think, you know you could feel it was on the tip
of your tongue all the time to prompt them, to help them, to come up with ideas that you know is
going to make a massive difference to their lives, but you can’t and that was just very frustrating.
I don’t know if it’s just part of being a nurse and that’s what we’re made to do so that was very
difficult in the sense of not doing that.
StepUp; therapist 53
Theme 3: working with supporters
Therapists delivering either intervention reported that the level and nature of supporter engagement within
the therapy process was a crucial factor in the progress of therapy. Within therapy sessions, supporters had
an important role in encouraging and supporting the person to fully engage in the session. Supporters also
had a vital role between sessions in reminding and supporting people to carry out tasks between sessions:
The support worker was absolutely brilliant with the lady that I was working with, she was very
encouraging and in the sessions she’d support the lady, if she’d forgotten what she’d done she’d say,
‘do you remember what we did?’ and she’d sort of jog her memory, so that was really, really useful.
BeatIt; therapist 5
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Therapists reported supporters to be most effective when they knew the person well, spent time with the
person on a daily basis, reliably accompanied the person to therapy sessions and took responsibility for
supporting the person between therapy sessions. Supporter negativity and lack of commitment could
be active barriers to progress. However, therapists recognised that paid supporters in particular were
sometimes under severe time constraints:
. . . and the supporter takes ownership and sees it as their responsibility to support the person to carry
through this therapy. They end up reading up on it between the weeks and stuff as well so that’s
quite good, prompting them to do that.
StepUp; therapist 54
. . . you could tell from the offset that the support worker thought that it was not any use at all. ‘Why
are we here? Why have we got to do that?’ And I think my client picked up on that, didn’t engage,
didn’t do any of the homework that he was supposed to do and I would spend most of the hour
session trying to get him to engage rather than actually doing the work.
BeatIt; therapist 4
Some therapists reported that the therapy would have benefited from having a portion of the session
without the supporter present, so that the person with learning disabilities could talk more freely:
There was one boy who was 17 or 18 and we were doing things on relationships and his mum was
sitting there and it just wasn’t appropriate. I felt like he was embarrassed and didn’t want to speak in
front of his mum, whereas if his mum had left for kind of 20 minutes and came back and recapped
on what we had done, I might have got a bit more out of him.
BeatIt; therapist 6
Theme 4: therapist experience and supervision
Therapists mentioned the importance of gaining experience in delivering therapy, helping to make it feel
like a more natural process:
From the therapy’s point of view though, the more you did it the more, I mean if it was rolling on and
we were on our sixth client, it got easier and easier and easier, it got far more flexible, it got more
client focused, it just became quite natural as a process and enthusiasm and looking at everything else
just pops into your head as you mature in it, that’s how I felt out, I’d love to have had a third and a
fourth, ‘cause you just felt like you were getting into your stride.
BeatIt; therapist 7
Although there could be challenges in arranging regular supervision sessions, therapists delivering both
interventions valued supervision as an opportunity to focus, reflect and move on when ‘stuck’:
It was really good at helping you to look at things, if you’re faced with a specific difficulty, and it
being from a psychologist as opposed to a nurse you just get slightly different perspectives in what
we were doing. I really liked the resource, the way it was set up with your steps, what to do in the
booklets, just the amount of conversation that that generates.
StepUp; therapist 55
Content analysis of therapists’ logs
The therapy logs that were completed after each session by the therapists contained a section in which
they were asked to identify barriers that they faced when delivering the therapy. Barriers recorded on all
of the therapy logs completed by therapists were extracted and the content analysed.
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For the BeatIt intervention, the most frequently reported barriers were participants’ lack of interest in
activities (reported at least once for 61 participants), a lack of resources between sessions (reported at least
once for 35 participants), the non-completion of diaries (reported at least once for 28 participants), issues
with supporters in sessions (reported at least once for 26 participants) and a lack of continuity with carers
(reported at least once for 25 participants). For the StepUp intervention, the most frequently reported
barriers were distractibility (reported at least once for 38 participants), understanding of materials (reported
at least once for 16 participants), booklets not seeming relevant (reported at least once for 13 participants)
and lack of continuity with carers (reported at least once for 11 participants).
The BeatIt therapists also recorded the participants’ planned homework activities on the therapy logs.
All these planned homework activities were also extracted from the logs and the content was analysed.
Of these, 51% were day-time activities, 26% were domestic or daily living activities, 7% were social
activities and 16% were preparatory activities.
Summary
The accounts of people with learning disabilities undergoing therapy, their supporters and the therapists
delivering the therapies increase our understanding of how people experienced the interventions in
this study.
People with learning disabilities and their supporters clearly described the circumstances they were in
before therapy and their perceived need for an intervention, focused on the person’s depression. Both
people with learning disabilities and their supporters reported a range of feelings and perspectives about
starting therapy, from nervousness and uncertainty to an attitude that it was worth trying the intervention,
particularly in the absence of other mental health interventions.
For both interventions, people with learning disabilities, supporters and therapists generally (but not
universally) described good working relationships being quickly established, and all agreed on the importance
of these therapeutic relationships. When supporters were committed, positive, reliable and had time, their
advocacy/scaffolding role within sessions and encouragement/reminders between therapy sessions were
highly valued by people with learning disabilities and therapists.
Most people with learning disabilities, supporters and therapists generally viewed the materials in either
intervention as accessible and useful, although more adaptability and flexibility in their use were
also recommended.
In addition to these non-specific factors, people with learning disabilities, supporters and therapists clearly
described specific aspects of each intervention. People with learning disabilities receiving the BeatIt
intervention described important aspects of the therapy as having the time and space to talk and be listened
to, generating ideas about activities and making plans, building their confidence, and understanding the
materials and paperwork used within the therapy. Supporters described having a liaison function and
encouraging/reminding the person to engage in activities between sessions. Therapists discussed being able
to tailor aspects of the intervention towards the circumstances and interests of the person.
For people with learning disabilities receiving the StepUp intervention, important aspects of the therapy
were the process of using the self-help booklets and making them relevant to themselves. Supporters
thought that the intervention gave them new insights into the person they were supporting and gave
them a greater understanding of depression more generally. Therapists also discussed how the intervention
could be made personally relevant, and how they helped the person to solve problems that he/she faced
and to think differently about his/her situation. They felt that the intervention provided useful tools for the
person beyond the end of therapy.
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The highly structured, manualised and time-limited nature of both interventions was valued by supporters
and therapists. Although both these groups mentioned wanting to adapt and individualise interventions
more to suit individuals’ needs, therapists mentioned the importance of a clear structure in keeping them
focused. People with learning disabilities reported feeling sadness and disappointment when the therapy
came to an end, although some reluctantly accepted that this had to happen.
Some people with learning disabilities and supporters reported continuing changes beyond the end of
therapy, with materials (often individually adapted) continuing to be used and activities and coping
strategies being maintained in accordance with the specific intervention. Others reported that these had
not been maintained at the time of the interviews but mentioned that the materials would be used when
they needed them.
Both people with learning disabilities and supporters involved in both types of intervention reported similar
positive effects of the therapy on people’s lives. People with learning disabilities mentioned improvements
in their mood, a more positive sense of self and more independence, more active lives and better
relationships, and bullying or victimisation to have stopped. Supporters described people being happier
and more confident, talking more and showing improved social skills, engaging in more activities, being
more empowered and having better problem-solving skills. They also reported that people had better
relationships with friends, family and with themselves (the supporters).
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Chapter 8 Discussion
Primary objective
There were no statistically significant differences between the StepUp and BeatIt groups in GDS-LD scores
at the 12-month primary outcome point. Therefore, there is no evidence that BeatIt is effective when
compared with StepUp as an active control condition.
Although this was not designed as a non-inferiority study, an important consideration is that the study
resulted in the outcomes of two active interventions being compared (see Chapter 7). Similarly designed
trials conducted with the general population provide supportive evidence to add to the available armoury
of effective interventions for use in depression. For example, the Cost and Outcome of Behavioural
Activation versus Cognitive Behavioural Therapy for Depression (COBRA)27 non-inferiority trial promotes
behavioural activation as being as equally effective as CBT. People with learning disabilities and their
therapists are in a different position: there are no existing trials showing any psychological interventions to
be effective in the treatment of depression in people with learning disabilities, including no high-quality
evidence base for CBT. Ours is the first large-scale RCT conducted on psychological interventions for
depression, and, other than our own feasibility study,39 is the only RCT of any size concerning behavioural
activation with adults with learning disabilities. This is also the only trial involving an adapted, guided
self-help treatment for depression for adults with learning disabilities. On the main outcome measure,
participants in our trial had marked improvements in depressive symptoms in both conditions.
So how do we interpret these findings? We cannot conclude that either intervention is effective. However,
both BeatIt and StepUp recipients reported considerable improvements in their symptoms of depression at
4 months post randomisation (following end of treatment), and this was sustained for both groups 12 months
post randomisation. These findings could be explained by a regression of scores to the mean over time and a
range of non-specific effects of receiving therapy and being involved in a clinical trial, but improvement in
depression could suggest a successful response to both interventions, given the following factors:
l The ‘unsuccessful’ previous treatment histories of the participants. At baseline, 66% of the participants
with learning disabilities who were allocated to the StepUp intervention, and 63% who were allocated
to the BeatIt intervention, were taking antidepressants. A total of 19% of the participants allocated to
the StepUp intervention were taking mood-stabilising drugs (primarily for the management of epilepsy,
but still with a theoretically mood-stabilising effect), and 13% allocated to the BeatIt intervention were
taking mood-stabilising drugs [with 69% taking drugs of one or both of these classes (i.e. antidepressants
and mood-stabilising drugs)]. In addition, 18% of the participants allocated to the StepUp intervention
and 20% of the participants allocated to the BeatIt intervention had received prior psychological therapy
(not specifically defined). Despite these ‘interventions’, all participants were depressed at baseline. This is
suggestive of a view that these adults might have been at the severe and/or more enduring end of the
depression spectrum.
l The natural history of depression in the population with learning disabilities. It is apparent from
previously published literature that people with learning disabilities are more likely to have enduring
depression than those without learning difficulties. For example, reports from the longitudinal UK
1958 birth cohort found that at 33 years of age, adults with learning disabilities had significantly higher
depressive scores than the adults without learning disabilities,84 and 15% of the cohort with learning
disabilities, compared with only 3% of those without, had chronic depression (high depressive scores at
ages 23, 33 and 43 years).11 Similar evidence comes from the longitudinal study of the UK 1946 birth
cohort. When aged 15, 36, and 43 years, individuals with learning disabilities were found to have
significantly more depression and anxiety symptoms than those without learning disabilities,12
suggesting a more severe and enduring pattern of depressive illness.
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
83
l Six previous small pilot trials of psychological interventions for depression in people with mild/moderate
learning disabilities,33–38 reviewed by NICE,31 have reported depression data from TAU conditions. For
participants in TAU in all six studies, there was virtually no change in depression scores from baseline to
follow-up, including up to 11 months after baseline.
Although it cannot be discounted, it seems unlikely that the pattern of improvements in self-reported
depressive symptoms in both BeatIt and StepUp groups – improvements by 4 months that were sustained
at 12 months – could be just as a result of a natural history of spontaneous recovery of symptoms;
however, participation in the trial may have had an effect.
Alongside these findings from the study, there were no related serious adverse events reported, suggesting
that neither intervention carries any notable risk to participants.
Secondary objectives
Other psychological outcomes followed a similar pattern of results to the primary outcome. Again, there
was no evidence that the BeatIt intervention is effective when compared with the StepUp intervention.
For carer-reported depression in the participants, self-reported anxiety and carer-reported aggressive
behaviour, there were no treatment group differences at the 12-month follow-up (primary end point)
or at 4 months post baseline. Within-treatment group analyses showed significant reductions from baseline
in carer-reported depression and self-reported anxiety at both 4 and 12 months, associated primarily
with reductions from baseline to 4 months that were maintained to follow-up. Similar analyses for
carer-reported aggression showed a reduction from baseline to 4 months, but only for the BeatIt group.
Considering QoL outcomes together (self-reported health-related QoL, community and domestic activity
measures, PSS), there were again no treatment group differences at the 12-month follow-up (primary
outcome) or at 4 months after baseline. The one exception was increased participation in domestic and
leisure activities among the BeatIt group participants at 12-month follow-up compared with the StepUp
group participants. Although self-reported health-related QoL (measured using the EQ-5D) followed a
similar pattern of within-group changes (improvements compared with baseline in both treatment groups),
other QoL indicators demonstrated a more mixed pattern of results, with some showing no change from
baseline, some a positive change in the BeatIt group, and some a positive change in the StepUp group.
Two of the three indicators of participants’ adaptive behaviour skills showed no treatment group
differences at either the 4- or 12-month follow-ups, but BeatIt participants had higher socialisation scores
at 4 months only (i.e. not at the 12-month follow-up primary end point). Within-group analyses suggested
generally increased adaptive skills in the two treatment groups in comparison with baseline, including
added increases following therapy up to the 12-month follow-up point.
Carers’ sense of self-efficacy in supporting adults with learning disabilities and depression increased
within both treatment groups from baseline, but again there were no treatment group differences at
either 4 or 12 months. Carers’ relationships with participants were almost universally lacking evidence of
negativity on the basis of analysis of FMSSs, showing very little change, and analysis models could not be
appropriately fitted.
Exploratory analyses of predictors and potential moderators of outcome suggested that the two treatments
worked equally well across a variety of participant characteristics. Notably, IQ scores were unrelated to
outcome. One interesting finding was that the participants’ positive expectation of change at the outset
predicted a better outcome.
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Health economics
The results of the economic evaluation indicate that there was no difference in outcomes between arms as
measured by changes in mean QALYs between baseline and the 12-month follow-up, which is reflected by
the lack of difference between arms in the primary outcome of change to GDS-LD score.
Although there was no significant difference in mean total costs between arms, this masks a highly
significant difference in intervention costs. An alternative interpretation, therefore, is that the increased
intervention cost in the BeatIt arm did not result in any significant cost savings in non-intervention-
related costs.
The uncertainty around the complete-case and multiple imputation analyses results was explored using
bootstrapping techniques. The results of the bootstrapping exercise confirmed the results: there was no
evidence to suggest either intervention was cost-effective compared with the other if the focus was on
the total costs. However, if non-significant, non-intervention costs were excluded, the bootstrap analysis
confirmed that the BeatIt intervention never entered the cost-effectiveness range.
A review by Romeo and Molosankwe85 in 2010 found a paucity of economic evaluations carried out on
people with learning disabilities. They found 10 papers reporting economic studies in learning disability,
4 of which reported costs and outcomes, and the areas covered included service use, community living
and challenging behaviour. None of these studies had a cost–utility analysis, in which the outcome is
preference-based, such as a QALY. In 2011, Ekers et al.86 reported on a small pragmatic RCT (n = 47
participants) comparing behavioural activation with TAU for depression in adults with learning difficulties.
Ekers et al.86 found that behavioural activation resulted in a gain of 0.20 QALYs, producing an ICER of
£5756 per QALY, which is considered cost-effective using NICE’s current threshold of £20,000 to £30,000
per QALY.87 More recently, a report was published by Willner et al.68 in 2013 exploring how costs are
affected by challenging behaviour in people with learning disabilities. The participants were randomised to
either a CBT manualised intervention or TAU ‘waiting list’ control arm. Willner et al.68 concluded that there
were no statistically significant differences in costs between groups, and because of lack of power, the
study was not able to detect economic differences between groups. We have not found any previous
studies looking at the cost-effectiveness of depression treatments for people with learning disabilities.
The strengths of this study are that < 5% of data were missing in all questionnaires for resource use and
QoL, and cost-effectiveness results are consistent across all analyses carried out.
Limitations of the study include the imbalance in EQ-5D-Y utilities at baseline, with the BeatIt group
participants reporting significantly lower QoL than those in the StepUp group. The generic EQ-5D-Y
may not be sufficiently sensitive for this population. We found a small association between GDS-LD and
EQ-5D-Y scores, but note that the analysis suggests a high amount of unexplained variability.
It was possible to administer the EQ-5D-Y to a population with learning difficulties. However, there is no
tariff available to value the EQ-5D-Y for children and adolescents, or for those with a learning disability.
Future research could include investigating whether or not there is a need for a learning-disability tariff.
In summary, given the lack of differences between the BeatIt and StepUp groups at the primary end
point (12-month follow-up), it is not surprising that there was also no economic evidence to suggest that
BeatIt may be more cost-effective than StepUp. No differences in resource use were found at 12 months,
although the BeatIt intervention did cost more to deliver than the StepUp intervention. Overall, the vast
majority of the support costs for participants in both treatment groups were not related to the treatments
themselves: intervention costs were approximately 4%–6.5% of the total support costs.
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Qualitative study
Results of the qualitative research with participants, supporters and therapists were in concert with the
quantitative findings. In particular, both treatments were perceived as active interventions, and both
treatments were valued in terms of their structure, content and perceived impact/outcomes. The qualitative
data from supporters did offer additional insight into the impact of taking part in therapy on carer–participant
relationships. Supporters reported understanding more about the person and/or his/her depression following
either treatment, and reported more positive relationships with participants following either treatment.
Delivery of the interventions
Data from multiple sources across the study are consistent in showing that both therapies were conducted
to the criteria set out in the protocol, and that participants, supporters and therapists viewed both
interventions positively.
From fidelity ratings of therapy sessions, therapists across the BeatIt and StepUp interventions demonstrated
similar high levels of fidelity to non-specific aspects of both interventions, and also demonstrated high
fidelity to specific aspects of the intervention that they were delivering. This high level of therapist fidelity
was achieved with a large cohort of 84 therapists who generally saw very few participants as part of the
trial. From the qualitative interviews and focus groups, participants, supporters and therapists in both
interventions agreed that good therapeutic working relationships were established quickly and maintained
throughout therapy, and were an important component of the clinical effectiveness of either intervention.
In the qualitative study, both participants and supporters sometimes talked about feeling nervous and
uncertain about starting either intervention, yet they were also generally positive because there was a
perceived absence of other therapeutic options available for people with learning disabilities and mental
health problems or depression. From therapist logs, participant adherence to both interventions, in terms
of attending therapy sessions, was high and for most participants the presence of a supporter in therapy
sessions was relatively reliable and stable. Supervision was also delivered to therapists in both interventions
approximately once every two therapy sessions, as specified in the protocol.
The majority of therapists in the study (67.1%) were community learning disability nurses. Most therapists
(63.1%) were experienced in working with people with learning disabilities (having experience of ≥ 5 years)
and most therapists (60.7%) had received some previous therapy training.
In the qualitative interviews, community learning disability nurses valued the structure, clear focus and goals,
and clinical supervision – which were seen as contrasts to their usual working practices – of both interventions.
The highly structured, manualised and time-limited nature of both interventions was also valued by the
supporters in the qualitative interviews. People with learning disabilities in qualitative interviews reported
feeling sadness and disappointment when the therapy came to an end, although some reluctantly accepted
that this had to happen. For some supporters and therapists there was a tension between the utility of a highly
structured, manualised intervention and a desire to individualise the structure of the intervention to focus more
on the issues facing specific participants with whom they were working.
In terms of adaptations to the interventions to make them more accessible to people with learning disabilities,
both interventions used extensively adapted materials. Supporters and therapists generally reported that
these adapted materials were accessible and useful. Nevertheless, participants, supporters and therapists
all suggested specific changes to the materials in each intervention – some of the main changes being
put forward were about making the materials more accessible and flexible to suit individual participants’
circumstances and preferences. Some supporters from both interventions reported that they had continued
to use therapy materials, which they had personalised for the individual they were supporting.
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A further adaptation to both interventions was to involve a supporter in therapy sessions. In the qualitative
study, participants, supporters and therapists generally (although not universally) agreed that when
supporters were committed, positive, reliable and had time, their advocacy/scaffolding role within sessions
and encouragement/reminders between therapy sessions were highly valued and an important component
of the clinical effectiveness of either intervention. Obtaining reliable, consistent and effective supporter
involvement was problematic for a minority, as reported in therapist logs.
In terms of specific therapy factors, the participants in the BeatIt group valued having the time and space to
talk and be listened to, generating ideas about activities and making plans, and building their confidence.
Supporters described having a liaison function, and encouraging/reminding the person to engage in
activities between sessions. Therapists discussed being able to tailor aspects of the intervention towards
the circumstances and interests of the person. In therapist logs, barriers specific to the BeatIt intervention
included a lack of resources to support participants to engage in activities and the non-completion of diaries
between therapy sessions.
For the StepUp intervention, participants described using the self-help booklets and making them relevant.
Supporters thought that the intervention gave them new insights into the person they were supporting and
a greater understanding of depression. Therapists discussed how the intervention helped the person solve
problems and think differently about their situation, and felt that the intervention provided useful tools for
the person beyond the end of therapy. In therapist logs, barriers specific to the StepUp intervention included
participants getting distracted, participants’ understanding of the materials and some of the booklets not
being relevant for the individual participant.
Although participants and supporters described some aspects specific to each intervention, across both
interventions participants and supporters reported similar positive impacts of either therapy on people’s
lives, including improvements in their mood, a more positive sense of self, more independence, more
active lives and better relationships with others.
Summary of findings
Primary and secondary outcomes, economic data and qualitative results all clearly demonstrate that there
was no evidence for the BeatIt intervention being more effective than the StepUp intervention.
Based on these results, we cannot conclude that either intervention is effective. However, patients in both
arms of the trial showed improvements in outcomes during the intervention phase that were maintained
at 12 months; this may indicate that both the BeatIt and StepUp interventions are beneficial. There is a
need for the clinical effectiveness of these (or similar) interventions to be compared with TAU in future
RCT evaluations.
Conduct of the trial
Important insights and data were also obtained concerning the delivery of the trial. The ratio of trial
information packs sent out to initial responses received was 4–5 : 1. Working through intermediaries to
recruit participants was one of the challenges of conducting the trial. The main source of participants was
from community learning disability teams, with smaller numbers of participants recruited from mainstream
IAPT services and care providers. One drawback was that some professionals in IAPT services appeared to
lack knowledge of people with learning disabilities and mistakenly referred people with specific learning
difficulties such as dyslexia to the trial. Differences in the main referral sources between England, Wales
and Scotland is likely to have reflected the different service patterns and practices. This highlights that a
multipoint recruitment strategy, responsive to different service contexts, is vital in a multicentre trial.
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We successfully recruited and randomised 161 participants into the trial and informed consent was
obtained with the use of carefully developed accessible materials. There was good adherence and retention:
86% of participants in the BeatIt arm completed therapy (a minimum of 8 sessions), 82% of participants
in the StepUp arm completed therapy (a minimum of 6 sessions) and 141 (87.6%) participants were
followed up for 12 months. Community nurses and other professionals working in specialist community
learning disability teams and IAPT services were trained as therapists to deliver the interventions. However,
competing work demands meant that therapists had limited time available to deliver therapy as part of the
trial and they were generally able to work with only one or two participants at any one point in time. This
could pose a problem if therapists lacked capacity to take on new participants, as a therapist for each arm
of the trial needed to be available at a location before a participant could be randomised to that location.
Consequently, to ensure that there were sufficient numbers of therapists to allow new participants to be
randomised in a timely fashion, a far higher number of therapists needed to be trained than originally
anticipated: 95 in total. In the end, 76 of the trained therapists were assigned participants to work with.
Importantly, it proved feasible to deliver the training to this large number of therapists. Supervisors were also
recruited from local services and trained to supervise the delivery of the interventions.
The two manuals developed for the interventions provided comprehensive guidance and support materials
for the therapists and it proved possible to deliver the therapies, at scale, with good fidelity to the manuals.
Audio-recordings of therapy sessions were rated for fidelity. Although the inter-rater agreement for the
fidelity ratings was good, it proved challenging to obtain audio-recordings, because of a reluctance on the
part of some participants and therapists to consent to the audio-recording of sessions.
Overall, the successful delivery of the BeatIt trial contradicts a widely held contention that it is not possible
to recruit to a large-scale RCT of an individual psychological therapy for people who have a learning
disability.88–90 The lessons learned may have important implications for the conduct of future trials of
psychological therapies involving people with learning disabilities.
Limitations
The major limitation of the trial was the absence of a TAU condition, which would have been required to
establish the clinical effectiveness of the BeatIt intervention. This was the original design suggested by the
research team but was rejected by the funder, who asked for an attention control group to be recruited
instead. The decision was made to use guided self-help (StepUp) as the attention control arm because it
was seen as a less person-centred and more rigid approach with a different set of active ingredients, that
is, psychoeducation rather than activity based. It was also chosen because it was an ethical option, as
guided self-help is a NICE-recommended91 intervention for general adult mental health and we had a
package available, with carefully adapted materials for people with learning disabilities. The StepUp
intervention was also designed to involve a supporter in therapy sessions, thereby incorporating a key
element of attention for which we wanted to control. The research team and funder-approved protocol
failed to anticipate the ability of the therapists to personalise the materials or the agency shown by the
participants and their supporters to follow through on ideas and plans made in therapy sessions.
Although, in retrospect, comparing TAU with the BeatIt intervention would have been a preferable design
in terms of examining the clinical effectiveness of the BeatIt intervention, there remains the question of
whether or not this would have made recruitment to the trial more challenging. Participants randomised
to the trial knew that they would be receiving one of two interventions, making participation in the trial a
more attractive proposition. Moreover, working through intermediaries meant that the researchers were
not only having to recruit the participants themselves but were also having to make the case to carers or
professionals working with the individual with learning disabilities that the study was worthwhile. Carers
and professionals might have been less likely to engage with the recruitment process knowing that the
person they supported or worked with may not have received an intervention.
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There were a greater number of withdrawals from the BeatIt arm (n = 12) of the study than the StepUp
arm (n = 2). This may have reflected the greater number of BeatIt sessions and the more active nature
of the intervention, in which the aim was to support the participants and supporters to engage in
scheduled activities between sessions. However, it is also worth noting that three of the BeatIt withdrawals
happened before the participants entered therapy and another BeatIt participant withdrew when they
were contacted for the 12-month follow-up visit, after the intervention had finished.
Lessons for trials with people who have learning disabilities
Our feasibility study helped to inform careful advanced planning of recruitment to our study, with a further
opportunity to refine the strategy during the internal pilot. Consequently, when implementing our RCT, we
achieved our target recruitment within the planned time frame. This was despite the fact that recruitment of
people with learning disabilities to participate in trials is notoriously difficult. For example, a Health Technology
Assessment (HTA) programme-funded study92 on antipsychotic medication for adults with learning disabilities
had substantial recruitment problems: only 72% of the total number of intended participants were recruited,
despite an increase in the recruitment time from 2 to 4 years and extending recruitment outside the UK.
In addition, a HTA programme-funded study93 on antipsychotic drug withdrawal in adults with learning
disabilities closed at the internal pilot stage because of recruitment problems. Even in general population
trials, recruitment is often a challenge. A study94 of 114 UK trials funded by the Medical Research Council
and the HTA programme found that only 31% of trials recruited successfully, whereas 45% recruited < 80%
of the intended number of participants, and more than half required an extension. A Cochrane review
synthesised the evidence around strategies to improve recruitment to RCTs,95 and concluded that triallists
should include evaluations of their recruitment strategies in their trials, and funders should support this
because the number of interventions that have been rigorously evaluated in the context of a real trial is low.
The challenges of recruitment in learning disability studies include a smaller population base and need
for multiple sites, the randomisation process itself, the need to recruit through third-party intermediaries
and via multiple sources to engage with enough people for the message to be passed on to potential
participants, concerns by paid carers of the legalities of supporting consent to participate and the need
for information to be accessible for the potential participants.92,96–98 We have demonstrated that these
potential obstacles can be successfully navigated and overcome across three countries of the UK, now
significantly divergent in terms of the provision of health and social care services. This requires careful
planning and ensuring that adequate human resources are available to devote to the time-consuming
recruitment process, which is expensive but essential when conducting trials within this population. Finding
and training sufficient numbers of therapists to allow participants to be randomised in a timely fashion to
either arm of the trial also emerged as a significant consideration. Established links with existing services
proved vital in obtaining the numbers of therapists required. An advantage of this strategy was that the
trial demonstrated the delivery of the interventions by relevant professionals in routine clinical practice.
Clinical implications and future directions
There have been no previous large trials of psychological interventions for adults with learning disabilities.
Hence, the lack of difference between the BeatIt and StepUp interventions means it is too early to say if
both interventions are equally effective, or not effective.
Recruitment to our study was mostly from practitioners in community learning disability teams; the
participants were already receiving considerable input from team members, including community nurses,
psychologists and psychiatrists, and a higher proportion of participants in this study were receiving
antidepressants than in previous population-based studies of adults with learning disabilities.99 Despite this,
the qualitative interviews on supporters’ expectations before the study identified that supporters perceived
that there was nothing else available specifically to help with the depression being experienced by the
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person whom they supported. Participants were depressed at entry to the study, and there was an
overall group-level clinical improvement associated with both the BeatIt and StepUp interventions.
The interventions were also relatively low cost, in the context of the wider ongoing support that the
participants were receiving.
It proved difficult to recruit via IAPT services in England (there is no direct equivalent in Scotland or Wales),
and of the potential 14 participants who were referred, only 9 were suitable to be randomised. There
appeared to be a poor understanding of learning disability by IAPT services and this is consistent with
other research findings.100 Perhaps this is in part explained by the lack of any psychological interventions
for treatment of depression specifically recommended for use with adults with learning disabilities.
However, it does indicate a training need within IAPT, and the need to support research and development
initiatives to make IAPT services more accessible to people with learning disabilities.101
Difficulties with assessment also arose in the study. For example, it was challenging to measure meaningful
change in activity for people with learning disabilities, given that small and statistically insignificant increases
may have considerable personal salience. Furthermore, it is also worth noting that the mean baseline
GDS-LD40 score (16.7 points) for the study participants, although in the published clinically significant range,
was lower than the mean scores reported by the 19 participants involved in the original development of
the measure (23.4 points). This suggests that it might be important for further work to be carried out on
concerning the clinical cut-off scores for the GDS-LD.
The next step in the research agenda will be to better understand whether or not the BeatIt and StepUp
interventions could be effective with adults who have learning disabilities, exploring ethical trial designs to
do so. Given the very similar outcomes found for both the BeatIt and StepUp interventions in the present
study, it may be possible to examine the clinical effectiveness of both interventions in one trial, compared
with TAU. The participants randomised to the intervention arm could be offered a choice of either the
BeatIt or StepUp intervention, allowing a comparison of both interventions with TAU. This would be an
ethical and cost-effective design.
It is also important to note that this study was conducted with people with mild/moderate learning disabilities.
Adults with severe/profound learning disabilities also experience depression. The communicative and cognitive
demands of CBT-based interventions place such interventions out of the reach of adults with severe/profound
learning disabilities. These adults are also more at risk of adverse effects of pharmacotherapy, which can be
both disabling and potentially serious, because of limited or no verbal communication skills to describe their
symptoms of adverse effects, hence late and more severe presentations of such effects. NICE31 made a
specific recommendation that research should be undertaken with people with severe learning disabilities to
determine the clinical and cost-effectiveness of psychosocial interventions to treat mental health problems
such as depression. We strongly endorse this, and consider further modification of the BeatIt intervention to
be ideally suited for, and a high priority to trial with, adults with severe/profound learning disabilities.
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
90
Acknowledgements
We would like to thank all the participants and their supporters, who gave so generously of their timeto take part in the trial. The therapists and supervisors are also owed a debt of gratitude by the
research team, along with the unstinting efforts of the local principal investigators at each of the local
sites: Dr Helen Lynn, Dr Ian Smith, Dr Ken MacMahon and Dr Gail Thomas. Thanks are also owed to past
members of the research team who made an invaluable contribution: Marcela Gavigan, Emilly Scott,
Felicity Larson and Kevanne Sanger.
The guidance and encouragement of members of the Trial Steering Committee and Data Monitoring
Committee have been greatly appreciated and essential to the completion of this trial.
Contributions of authors
Professor Andrew Jahoda was the chief investigator, contributed to the design of the study and was
part of the writing team.
Professor Richard Hastings was a co-applicant, contributed to the design of the study and was part of
the writing team.
Professor Chris Hatton was a co-applicant, contributed to the design of the study and was part of the
writing team.
Professor Sally-Ann Cooper was a co-applicant, contributed to the design of the study and was part of
the writing team.
Ms Nicola McMeekin was the health economist working on the study and part of the writing team.
Professor Dave Dagnan was a co-applicant, contributed to the design of the study and was part of the
writing team.
Dr Kim Appleton was the trial manager and part of the writing team.
Ms Katie Scott was a researcher on the project and contributed to the report.
Ms Lauren Fulton was a researcher on the project and part of the writing team.
Professor Robert Jones was a co-applicant, contributed to the design of the project and reviewed
the report.
Dr Alex McConnachie was a co-applicant and the senior trial statistician and reviewed and contributed to
the report.
Ms Rachel Zhang is a statistician who worked on the trial and contributed to this report.
Ms Rosie Knight was a researcher on the trial and contributed to the report.
Ms Dawn Knowles was a researcher on the trial and contributed to the report.
Professor Christopher Williams was a co-applicant who contributed to the design of the study and to
this report.
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
91
Professor Andy Briggs was a co-applicant who designed the health economic component of the study
and reviewed the report.
Professor Craig Melville was a co-applicant, contributed to the design of the study and was part of the
writing team.
Publications
Jahoda A, Melville C, Cooper SA, Hastings R, Briggs A, Dagnan D, et al. BEAT-IT: comparing a behavioural
activation treatment for depression in adults with intellectual disabilities with an attention control: study
protocol for a randomised controlled trial. Trials 2015;16:595.
Jahoda A, Hastings R, Hatton C, Cooper SA, Dagnan D, Zhang R, et al. Comparison of behavioural
activation with guided self-help for treatment of depression in adults with intellectual disabilities:
a randomised controlled trial. Lancet Psychiatry 2017;4:909–19
Data-sharing statement
All data requests should be submitted to the corresponding author for consideration. Access to anonymised
data may be granted following review.
Patient data
This work uses data provided by patients and collected by the NHS as part of their care and support. Using
patient data is vital to improve health and care for everyone. There is huge potential to make better use of
information from people’s patient records, to understand more about disease, develop new treatments,
monitor safety, and plan NHS services. Patient data should be kept safe and secure, to protect everyone’s
privacy, and it’s important that there are safeguards to make sure that it is stored and used responsibly.
Everyone should be able to find out about how patient data are used. #datasaveslives You can find out
more about the background to this citation here: https://understandingpatientdata.org.uk/data-citation.
ACKNOWLEDGEMENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
92
References
1. Information Services Division Scotland. Prescribing Statistics – Medicines Used in Mental Health.
Edinburgh: NHS Scotland; 2013.
2. Prescribing & Medicines Team Health and Social Care Information Centre. Prescription Cost Analysis
England 2015: Prescription Items Dispensed in the Community in England and Listed Alphabetically
Within Chemical Entity by Therapeutic Class. Leeds: NHS Digital; 2016. URL: http://content.digital.
nhs.uk/catalogue/PUB20200/pres-cost-anal-eng-2015-rep.pdf (accessed 28 February 2017).
3. Information Services Division Scotland. Mental Health (Psychiatric) Hospital Activity Statistics.
Edinburgh: NHS Scotland; 2012.
4. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, et al. Grand challenges in global mental
health. Nature 2011;475:27–30. https://doi.org/10.1038/475027a
5. Bittles AH, Petterson BA, Sullivan SG, Hussain R, Glasson EJ, Montgomery PD. The influence
of intellectual disability on life expectancy. J Gerontol A Biol Sci Med Sci 2002;57:M470–2.
https://doi.org/10.1093/gerona/57.7.M470
6. Morris J. The National Down Syndrome Cytogenetic Register 2007/8 Annual Report. London:
Barts and The London School of Medicine and Dentistry; 2009.
7. Cooper SA, Smiley E, Morrison J, Williamson A, Allan L. Mental ill-health in adults with intellectual
disabilities: prevalence and associated factors. Br J Psychiatry 2007;190:27–35. https://doi.org/
10.1192/bjp.bp.106.022483
8. Cooper SA, Smiley E, Morrison J, Williamson A, Allan L. An epidemiological investigation of
affective disorders with a population-based cohort of 1023 adults with intellectual disabilities.
Psychol Med 2007;37:873–82. https://doi.org/10.1017/S0033291707009968
9. Buckles J, Luckasson R, Keefe E. A systematic review of the prevalence of psychiatric disorders in
adults with intellectual disability, 2003–2010. J Mental Health Res Intellect Disabil 2013;6:181–207.
https://doi.org/10.1080/19315864.2011.651682
10. Reid KA, Smiley E, Cooper SA. Prevalence and associations of anxiety disorders in adults
with intellectual disabilities. J Intellect Disabil Res 2011;55:172–81. https://doi.org/10.1111/
j.1365-2788.2010.01360.x
11. Collishaw S, Maughan B, Pickles A. Affective problems in adults with mild learning disability:
the roles of social disadvantage and ill health. Br J Psychiatry 2004;185:350–1. https://doi.org/
10.1192/bjp.185.4.350
12. Richards M, Maughan B, Hardy R, Hall I, Strydom A, Wadsworth M. Long-term affective disorder
in people with mild learning disability. Br J Psychiatry 2001;179:523–7. https://doi.org/10.1192/
bjp.179.6.523
13. Honeycutt AA, Grisse SD, Dunlap LJ, Chen H, al Homis G, Schendel D. Economic Costs of Learning
Disabilities, Cerebral Palsy, Hearing Loss, and Vision Impairment. In Altman BM, Barnartt SN,
Henderson G, Larson SK, editors. Using Survey Data to Study Disability: Results from the National
Health Interview Survey on Disability. London: Elsevier Science; 2003. pp. 207–28. https://doi.org/
10.1016/S1479-3547(03)03011-2
14. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive
therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry
2005;62:409–16. https://doi.org/10.1001/archpsyc.62.4.409
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
93
15. Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, et al. Baseline depression
severity as moderator of depression outcomes between cognitive behavioral therapy vs
pharmacotherapy: an individual patient data meta-analysis. JAMA Psychiatry 2015;72:1102–9.
https://doi.org/10.1001/jamapsychiatry.2015.1516
16. National Institute for Health and Care Excellence (NICE). Depression: Management of Depression
in Primary And Secondary Care. CG90. London: NICE; 2009.
17. Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, et al. Cognitive behavioural therapy as
an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression:
results of the CoBalT randomised controlled trial. Lancet 2013;381:375–84. https://doi.org/
10.1016/S0140-6736(12)61552-9
18. Lewinsohn PM AD, Steinmetz J, Teri L. The Coping with Depression Course: A Psychoeducational
Intervention for Unipolar Depression. Eugene, OR: Castalia Publishing Company; 1984.
19. Ridgway N, Williams C. Cognitive behavioural therapy self-help for depression: an overview.
J Ment Health 2011;20:593–603. https://doi.org/10.3109/09638237.2011.613956
20. Cavanagh K, Seccombe N, Lidbetter N. The implementation of computerized cognitive
behavioural therapies in a service user-led, third sector self help clinic. Behav Cogn Psychother
2011;39:427–42. https://doi.org/10.1017/S1352465810000858
21. Cuijpers P, Donker T, van Straten A, Li J, Andersson G. Is guided self-help as effective as face-to-face
psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of
comparative outcome studies. Psychol Med 2010;40:1943–57. https://doi.org/10.1017/
S0033291710000772
22. Gellatly J, Bower P, Hennessy S, Richards D, Gilbody S, Lovell K. What makes self-help interventions
effective in the management of depressive symptoms? Meta-analysis and meta-regression. Psychol
Med 2007;37:1217–28. https://doi.org/10.1017/S0033291707000062
23. Skinner BF. Beyond Freedom and Dignity. New York, NY: Alfred A. Knopf, Inc.; 1971.
24. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al. Randomized
trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute
treatment of adults with major depression. J Consult Clin Psychol 2006;74:658–70. https://doi.org/
10.1037/0022-006X.74.4.658
25. Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A. Behavioural activation v. antidepressant
medication for treating depression in Iran: randomised trial. Br J Psychiatry 2013;202:204–11.
https://doi.org/10.1192/bjp.bp.112.113696
26. Ekers D, Richards D, McMillan D, Bland JM, Gilbody S. Behavioural activation delivered by the
non-specialist: phase II randomised controlled trial. Br J Psychiatry 2011;198:66–72. https://doi.org/
10.1192/bjp.bp.110.079111
27. Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, et al. Cost and Outcome of
Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised,
controlled, non-inferiority trial. Lancet 2016;388:871–80. https://doi.org/10.1016/S0140-6736(16)
31140-0
28. Dobson KS, Hollon SD, Dimidjian S, Schmaling KB, Kohlenberg RJ, Gallop RJ, et al. Randomized trial
of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of
relapse and recurrence in major depression. J Consult Clin Psychol 2008;76:468–77. https://doi.org/
10.1037/0022-006X.76.3.468
29. Lejuez CW, Hopko DR, Hopko SD. The Brief Behavioural Activation Treatment For Depression:
A Comprehensive Patient Guide. Boston, MA: Pearson Custom Publishing; 2003.
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
94
30. Martell CR, Addis ME, Jacobson NS. Depression in Context: Strategies for Guided Action.
New York, NY: W. W. Norton and Company; 2001.
31. National Institute for Health and Care Excellence (NICE). Mental Health Problems in People with
Learning Disabilities: Prevention, Assessment and Management. NG54. London: NICE; 2016.
32. Lindsay WR, Jahoda A, Willner P. Adapting Psychological Therapies For People With Intellectual
Disabilities I: Assessment And Cognitive Deficit Considerations. In Taylor J, Lindsay W, Hastings R,
Hatton C, editors. Psychological Therapies for Adults with Intellectual Disabilities. Chichester:
Wiley-Blackwell; 2013. pp. 69–83. https://doi.org/10.1002/9781118329252.ch5
33. McCabe MP, McGillivray JA, Newton DC. Effectiveness of treatment programmes for depression
among adults with mild/moderate intellectual disability. J Intellect Disabil Res 2006;50:239–47.
https://doi.org/10.1111/j.1365-2788.2005.00772.x
34. McGillivray JA, McCabe MP, Kershaw MM. Depression in people with intellectual disability:
an evaluation of a staff-administered treatment program. Res Dev Disabil 2008;29:524–36.
https://doi.org/10.1016/j.ridd.2007.09.005
35. Hassiotis A, Serfaty M, Azam K, Strydom A, Blizard R, Romeo R, et al. Manualised individual
cognitive behavioural therapy for mood disorders in people with mild to moderate intellectual
disability: a feasibility randomised controlled trial. J Affect Disord 2013;151:186–95. https://doi.org/
10.1016/j.jad.2013.05.076
36. Hartley SL, Esbensen AJ, Shalev R, Vincent LB, Mihaila I, Bussanich P. Cognitive behavioral therapy
for depressed adults with mild intellectual disability: a pilot study. J Ment Health Res Intellect
Disabil 2015;8:72–97. https://doi.org/10.1080/19315864.2015.1033573
37. Lindsay WR, Tinsley S, Beail N, Hastings RP, Jahoda A, Taylor JL, Hatton C. A preliminary
controlled trial of a trans-diagnostic programme for cognitive behaviour therapy with adults with
intellectual disability. J Intellect Disabil Res 2015;59:360–9. https://doi.org/10.1111/jir.12145
38. McGillivray JA, Kershaw MM. The impact of staff initiated referral and intervention protocols on
symptoms of depression in people with mild intellectual disability. Res Dev Disabil 2013;34:730–8.
https://doi.org/10.1016/j.ridd.2012.11.005
39. Jahoda A, Melville CA, Pert C, Cooper SA, Lynn H, Williams C, Davidson C. A feasibility study of
behavioural activation for depressive symptoms in adults with intellectual disabilities. J Intellect
Disabil Res 2015;59:1010–21. https://doi.org/10.1111/jir.12175
40. Cuthill FM, Espie CA, Cooper SA. Development and psychometric properties of the Glasgow
Depression Scale for people with a Learning Disability. Individual and carer supplement versions.
Br J Psychiatry 2003;182:347–53. https://doi.org/10.1192/bjp.182.4.347
41. Jahoda A, Melville C, Cooper SA, Hastings R, Briggs A, Dagnan D, et al. BEAT-IT: comparing a
behavioural activation treatment for depression in adults with intellectual disabilities with an
attention control: study protocol for a randomised controlled trial. Trials 2015;16:595. https://doi.org/
10.1186/s13063-015-1103-5
42. Wechsler D, Hsiao-pin C. WASI®-II: Wechsler Abbreviated Scale Of Intelligence. New York, NY:
Pearson; 2011.
43. Nihira K, Lambert NM, Leland H. Adaptive Behavior Scale: Residential and Community. Examiner’s
Manual. Austin, TX: Pro-ed; 1993.
44. Cooper SA, Melville CA, Einfeld SL. Psychiatric diagnosis, intellectual disabilities and Diagnostic Criteria
for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD).
J Intellect Disabil Res 2003;47(Suppl. 1):3–15. https://doi.org/10.1046/j.1365-2788.47.s1.2.x
45. Great Britain. Mental Capacity Act 2005. London: The Stationery Office; 2005.
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
95
46. Scottish Executive. Adults with Incapacity (Scotland) Act 2000. Edinburgh: Scottish
Government; 2000.
47. Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral
activation treatment for depression: revised treatment manual. Behav Modif 2011;35:111–61.
https://doi.org/10.1177/0145445510390929
48. Hepner KA SS, Paddock SM, Hunter SB, Osilla KC, Watkins KE. A Fidelity Coding Guide for a
Group Cognitive Behavioral Therapy for Depression. Santa Monica, CA: RAND Corporation; 2011.
49. Hunter SB, Watkins KE, Hepner KA, Paddock SM, Ewing BA, Osilla KC, Perry S. Treating
depression and substance use: a randomized controlled trial. J Subst Abuse Treat 2012;43:137–51.
https://doi.org/10.1016/j.jsat.2011.12.004
50. Vallis TM, Shaw BF, Dobson KS. The Cognitive Therapy Scale: psychometric properties. J Consult
Clin Psychol 1986;54:381–5. https://doi.org/10.1037/0022-006X.54.3.381
51. Blackburn IM, James IA, Milne DL, Baker C, Standart S, Garland A, et al. The Revised Cognitive
Therapy Scale (CTS-R): psychometric properties. Behav Cogn Psychother 2001;29:431–46.
https://doi.org/10.1017/S1352465801004040
52. Evans KM, Cotton MM, Einfeld SL, Florio T. Assessment of depression in adults with severe or
profound intellectual disability. J Intellect Dev Disabil 1999;24:147–60. https://doi.org/10.1080/
13668259900033941
53. Mindham J, Espie CA. Glasgow Anxiety Scale for people with an Intellectual Disability (GAS-ID):
development and psychometric properties of a new measure for use with people with mild
intellectual disability. J Intellect Disabil Res 2003;47:22–30. https://doi.org/10.1046/j.1365-2788.
2003.00457.x
54. Rojahn J, Rowe EW, Sharber AC, Hastings R, Matson JL, Didden R, et al. The Behavior Problems
Inventory – Short Form for individuals with intellectual disabilities: part II: reliability and validity.
J Intellect Disabil Res 2012;56:546–65. https://doi.org/10.1111/j.1365-2788.2011.01506.x
55. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y:
a child-friendly version of the EQ-5D. Qual Life Res 2010;19:875–86. https://doi.org/10.1007/
s11136-010-9648-y
56. Mencap. Am I Making Myself Clear? Mencap’s Guidelines for Accessible Writing. London;
Mencap; 2002.
57. Raynes N, Sumpton R, Pettipher C. The Index of Community Involvement. Manchester:
Manchester University Department of Social Policy and Social Work; 1989.
58. Raynes N, Sumpton R, Pettipher C. Index of Participation in Domestic Life. Manchester: University
Department of Social Policy and Social Work; 1989.
59. Sarason IG, Sarason BR, Shearin EN, Pierce GR. A brief measure of social support: practical
and theoretical implications. J Soc Pers Relat 1987;4:497–510. https://doi.org/10.1177/
0265407587044007
60. Hastings RP, Brown T. Behavior problems of children with autism, parental self-efficacy, and
mental health. Am J Ment Retard 2002;107:222–32. https://doi.org/10.1352/0895-8017(2002)
107<0222:BPOCWA>2.0.CO;2
61. Hastings RP, Brown T. Behavioural knowledge, causal beliefs and self-efficacy as predictors of
special educators’ emotional reactions to challenging behaviours. J Intellect Disabil Res
2002;46:144–50. https://doi.org/10.1046/j.1365-2788.2002.00378.x
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
96
62. Magaña AB, Goldstein JM, Karno M, Miklowitz DJ, Jenkins J, Falloon IR. A brief method for
assessing expressed emotion in relatives of psychiatric patients. Psychiatry Res 1986;17:203–12.
https://doi.org/10.1016/0165-1781(86)90049-1
63. Hulbert-Williams L, Hastings RP, Crowe R, Pemberton J. Self-reported life events, social support
and psychological problems in adults with intellectual disabilities. J Applied Res Intellect Disabil
2011;24:427–36. https://doi.org/10.1111/j.1468-3148.2011.00624.x
64. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client Socio-
Demographic and Service Receipt Inventory – European Version: development of an instrument
for international research. EPSILON Study 5. European Psychiatric Services: inputs linked to
outcome domains and needs. Br J Psychiatry Suppl 2000;39:s28–33. https://doi.org/10.1192/
bjp.177.39.s28
65. Kilbane AL, Jahoda A. Therapy expectations: preliminary exploration and measurement in adults
with intellectual disabilities. J Applied Res Intellect Disabil 2011;24:528–42. https://doi.org/
10.1111/j.1468-3148.2011.00630.x
66. Ekers D, Richards D, Gilbody S. A meta-analysis of randomized trials of behavioural treatment of
depression. Psychol Med 2008;38:611–23. https://doi.org/10.1017/S0033291707001614
67. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology
Appraisal: 2013. London: NICE; 2013. URL: www.nice.org.uk/article/pmg9/chapter/foreword
(accessed 29 October 2015).
68. Willner P, Rose J, Jahoda A, Stenfert Kroese B, Felce D, MacMahon P, et al. A cluster randomised
controlled trial of a manualised cognitive behavioural anger management intervention delivered
by supervised lay therapists to people with intellectual disabilities. Health Technol Assess
2013;17(21). https://doi.org/10.3310/hta17210
69. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and
Pharmaceutical Press; 2016. URL: www.medicinescomplete.com (accessed 21 January 2016).
70. Curtis L, Burns A. Unit Costs of Health and Social Care 2015. Canterbury: PSSRU, University of
Kent; 2015. URL: www.pssru.ac.uk/project-pages/unit-costs/2015/ (accessed 15 August 2016).
71. Department of Health and Social Care. NHS Reference Costs 2014 to 2015. London: Department
of Health and Social Care; 2016.
72. Office of National Statistics (ONS). Average Usual and Paid Hours be Gender and Average Hourly
Pay by Ethnicity and Disability. Newport: ONS; 2017.
73. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108.
https://doi.org/10.1097/00005650-199711000-00002
74. Pert C, Jahoda A, Stenfert Kroese B, Trower P, Dagnan D, Selkirk M. Cognitive behavioural
therapy from the perspective of clients with mild intellectual disabilities: a qualitative investigation
of process issues. J Intellect Disabil Res 2013;57:359–69. https://doi.org/10.1111/j.1365-2788.
2012.01546.x
75. Westerhof GJ, Beernink J, Sools A. Who am I? A life story intervention for persons with intellectual
disability and psychiatric problems. Intellect Dev Disabil 2016;54:173–86. https://doi.org/10.1352/
1934-9556-54.3.173
76. Jahoda A. Cognitive Behavioural Therapy. In Beail N, editor. Psychological Therapies and People
who have Intellectual Disabilities. Leicester: The British Psychological Society; 2016. pp. 38–45.
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
97
77. Lindsay WR, Jahoda AJ, Willner P. Adapting Psychological Therapies for People with Intellectual
Disabilities II. In Taylor J, Lindsay W, Hastings R, Hatton C, editors. Psychological Therapies for
Adults with Intellectual Disabilities. Chichester: Wiley-Blackwell. pp. 85–100. https://doi.org/
10.1002/9781118329252.ch6
78. Willner P. Readiness for cognitive therapy in people with intellectual disabilities. J Applied Res
Intellect Disabil 2006;19:5–16. https://doi.org/10.1111/j.1468-3148.2005.00280.x
79. Rose J, Loftus M, Flint B, Carey L. Factors associated with the efficacy of a group intervention for
anger in people with intellectual disabilities. Br J Clin Psychol 2005;44:305–17. https://doi.org/
10.1348/014466505X29972
80. Stimpson A, Kroese BS, MacMahon P, Rose N, Townson J, Felce D, et al. The experiences of staff
taking on the role of lay therapist in a group-based cognitive behavioural therapy anger management
intervention for people with intellectual disabilities. J Appl Res Intellect Disabil 2013;26:63–70.
https://doi.org/10.1111/jar.12006
81. Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. In Bryman A, Burgess RG.
Analyzing Qualitative Data. London: Routledge; 1994. pp. 173–94. https://doi.org/10.4324/
9780203413081_chapter_9
82. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the
analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol
2013;13:117. https://doi.org/10.1186/1471-2288-13-117
83. QSR NVIVO. In Jupp V, editor. The SAGE Dictionary of Social Research Methods. London: SAGE
Publications; 2006. https://doi.org/10.4135/9780857020116
84. Maughan B, Collishaw S, Pickles A. Mild mental retardation: psychosocial functioning in
adulthood. Psychol Med 1999;29:351–66. https://doi.org/10.1017/S0033291798008058
85. Romeo R, Molosankwe I. Economic evidence in intellectual disabilities: a review. Curr Opin
Psychiatry 2010;23:427–31. https://doi.org/10.1097/YCO.0b013e32833ad946
86. Ekers D, Godfrey C, Gilbody S, Parrott S, Richards DA, Hammond D, Hayes A. Cost utility of
behavioural activation delivered by the non-specialist. Br J Psychiatry 2011;199:510–11.
https://doi.org/10.1192/bjp.bp.110.090266
87. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology
Appraisal: 2008. London: NICE; 2008.
88. Becker H, Roberts G, Morrison J, Silver J. Recruiting people with disabilities as research participants:
challenges and strategies to address them. Ment Retard 2004;42:471–5. https://doi.org/10.1352/
0047-6765(2004)42<471:RPWDAR>2.0.CO;2
89. Iacono T. Ethical challenges and complexities of including people with intellectual disability
as participants in research. J Intellect Dev Disabil 2006;31:173–9. https://doi.org/10.1080/
13668250600876392
90. Evenhuis H, van Splunder J, Vink M, Weerdenburg C, van Zanten B, Stilma J. Obstacles in
large-scale epidemiological assessment of sensory impairments in a Dutch population with
intellectual disabilities. J Intellect Disabil Res 2004;48:708–18. https://doi.org/10.1111/
j.1365-2788.2003.00562.x
91. National Institute for Health and Clinical Excellence (NICE). Depression: The Treatment and
Management of Depression in Adults (Update). London: NICE; 2009. URL: www.nice.org.uk/
guidance/CG90 (accessed 20 May 2014).
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
98
92. Oliver-Africano P, Dickens S, Ahmed Z, Bouras N, Cooray S, Deb S, et al. Overcoming the barriers
experienced in conducting a medication trial in adults with aggressive challenging behaviour and
intellectual disabilities. J Intellect Disabil Res 2010;54:17–25. https://doi.org/10.1111/j.1365-2788.
2009.01195.x
93. Kerr M. Anti-psychotic Drug Reduction in Primary Care for Adults with Learning Disabilities.
ISRCTN registry. URL: http://dx.doi.org/10.1186/ISRCTN38126962 (accessed 28 October 2016).
94. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What
influences recruitment to randomised controlled trials? A review of trials funded by two UK
funding agencies. Trials 2006;7:9. https://doi.org/10.1186/1745-6215-7-9
95. Treweek S, Pitkethly M, Cook J, Kjeldstrøm M, Taskila T, Johansen M, et al. Strategies to improve
recruitment to randomised controlled trials. Cochrane Database Syst Rev 2010;4:MR000013.
https://doi.org/10.1002/14651858.MR000013.pub5
96. Lennox N, Taylor M, Rey-Conde T, Bain C, Purdie DM, Boyle F. Beating the barriers: recruitment of
people with intellectual disability to participate in research. J Intellect Disabil Res 2005;49:296–305.
https://doi.org/10.1111/j.1365-2788.2005.00618.x
97. Nicholson L, Colyer M, Cooper SA. Recruitment to intellectual disability research: a qualitative
study. J Intellect Disabil Res 2013;57:647–56. https://doi.org/10.1111/j.1365-2788.2012.01573.x
98. Cooper SA, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, et al. Toward onset
prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study
protocol for a randomized controlled trial. Trials 2014;15:202. https://doi.org/10.1186/
1745-6215-15-202
99. Bowring DL, Totsika V, Hastings RP, Toogood S, McMahon M. Prevalence of psychotropic
medication use and association with challenging behaviour in adults with an intellectual disability.
A total population study. J Intellect Disabil Res 2017;61:604–17. https://doi.org/10.1111/jir.12359
100. Chinn D, Abraham E. Using ‘candidacy’ as a framework for understanding access to mainstream
psychological treatment for people with intellectual disabilities and common mental health problems
within the English Improving Access to Psychological Therapies service. J Intellect Disabil Res
2016;60:571–82. https://doi.org/10.1111/jir.12274
101. Dagnan D, Burke CK, Davies J, Chinn D. Improving Access to Psychological Therapies: Learning
Disabilities Positive Practice Guide. London: Foundation for People with Learning Disabilities; 2015.
102. Jahoda A, Melville C, Hastings R, Cooper SA, Briggs A, Dagnan D, et al. BEAT-IT: A Randomised
Controlled Trial Comparing a Behavioural Activation Treatment for Depression in Adults with
Learning Diabilities with an Attention Control. Protocol version 2.0. URL: www.journalslibrary.nihr.
ac.uk/programmes/hta/1010434/#/ (accessed 25 September 2018).
DOI: 10.3310/hta22530 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 53
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Jahoda et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
99

Appendix 1 Questionnaires
Glasgow Depression Scale for people with a Learning Disability
The GDS-LD is a series of 20 self-rating questions asking a participant about their experiences in the
previous week.
For each question, there are three possible answers: (1) never/no, (2) sometimes and (3) always/a lot, each
being scored 0, 1 or 2, resulting in a range of possible scores from 0 to 40.
Glasgow Anxiety Scale for people with an Intellectual Disability
The GAS-ID is a series of 27 questions asking a participant about their experiences in the previous week.
It is divided into three categories: (1) worries (10 questions), (2) specific fears (9 questions) and
(3) physiological symptoms (8 questions). For each question there are three possible answers: (1) never/no,
(2) sometimes and (3) always/a lot, each being scored 0, 1 or 2, resulting in a range of possible scores from
0 to 54.
The Index of Community Involvement
The ICI is a list of 48 activities divided into three categories: (1) domestic and leisure (8 activities),
(2) social (11 activities) and (3) community (19 activities). Participants are asked which activities they took
part in over the previous month and how often they took part in those activities.
Each item is scored from 0 (never did activity) to 5 (daily) based on frequency of participation. There is a
range of possible scores from 0 to 240.
TABLE 42 Sample from the GDS-LD questionnaire
In the last week . . . Never/no Sometimes Always/a lot
1 Have you felt sad? 0 1 2
Have you felt upset?
Have you wished you could die?
Have you felt you do not want to go on living?
TABLE 43 Sample from the GAS-ID questionnaire
Worries Never/no Sometimes Always/a lot
1 Do you worry a lot? 0 1 2
(. . . feel worked up/wound up/uptight/up to high doh)
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Emotional Difficulties Self-Efficacy scale
Supporters are asked four questions about their responses to emotional difficulties, experienced by the
participants whom they support, over the previous month. Each item is scored from 1 (not at all confident)
to 7 (very confident). There is a range of possible scores from 4 to 28.
Behavior Problems Inventory for Individuals with Intellectual
Disabilities – Short Form
The BPI-S has a list of 10 aggressive behaviours. Supporters were asked how often in the previous month
they observed the participants whom they support display each behaviour. Each item is scored from 0
(never) to 5 (more than once per hour). There is a range of possible scores from 0 to 50.
Intellectual Disabilities Depression Scale
The IDDS consists of questions on 38 behaviours. The supporters were asked how often the participants
whom they support experienced each of the behaviours, over the previous 4 weeks. Each item is scored
from 0 (never) to 6 (always). There is a range of possible scores from 0 to 228.
TABLE 44 Sample from the ICI questionnaire
Activity in the past month
No Yes
Never
Once in
the month
2–3 times in
the month Once a week
2–6 times
a week Daily
Domestic/leisure
1. Doing crafts (knitting)
TABLE 45 Sample from the EDSE scale questionnaire
How confident are you in dealing with the emotional difficulties of the person you support?
1 2 3 4 5 6 7
Not at all confident Very confident
TABLE 46 Sample from the BPI-S
Aggressive behaviours
are offensive actions or
deliberate overt attacks
directed towards other
individuals or objects Never
About once
per month
About once
per week
About once
per day
About once
per hour
More than
once per hour
1 Hitting others
TABLE 47 Sample from the IDDS questionnaire
Symptoms of depression Never Almost never Seldom Half the time Usually Almost always Always
15 Difficulty falling asleep
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Adaptive Behavior Scale at screening visit
The Adaptive Behavior Scale (ABS) questionnaire is adapted from the ABS-RC2. It is directed to the
supporter at the screening visit as a series of 39 questions from six categories: (1) personal self-sufficiency,
(2) community self-sufficiency, (3) social responsibility, (4) self-direction, (5) responsibility and (6) socialisation.
Supporters were asked to rate the participants whom they support on each of the items.
Adaptive Behavior Scale at the 4- and 12-month visits
At the 4- and 12-month visits, the supporters were asked to rate those whom they support in three of the
six categories measured at screening:
1. Self-direction (five items), with a range of possible total scores from 0 to 23.
2. Responsibility (three items), with a range of possible scores from 0 to 10.
3. Socialisation (seven items), with a range of possible total scores from 0 to 26.
Bangor Life Events Schedule for Intellectual Disabilities
The BLESID consists of 24 significant life events from five categories. It is used to determine the life events
that participants have experienced over the previous 12 months, the frequency of these events and the
impact the events have had on the participants’ lives.
Each event receives a score of 0 (did not happen), 1 (happened once), or 2 (more than once) for frequency.
If an event occurred, it then receives a score of –1 (bad), 0 (in the middle) or 1 (good) for impact.
TABLE 48 Sample from the socialisation section of the screening ABS questionnaire
Item 67 Co-operation (circle highest level) Total
Offers assistance to others 2
Is willing to help if asked 1
Never helps others 0
Item 68 Consideration for others (circle all answers) Yes No Total
Shows interest in the affairs of others 1 2
Takes care of others’ belongings 1 2
Directs or manages the affairs of others when needed 1 2
Shows consideration for others’ feelings 1 2
TABLE 49 Sample from the BLESID questionnaire
Life events
Do not
know
Frequency Impact
When?
Did not
happen
Happened
once
More than
once ‘Bad’
‘In the
middle’ ‘Good’
Health
Illness or injury requiring
hospitalisation
Do not
know
0 1 2 – 0 +
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Social Support Questionnaire – three questions
This was previously referred to as PSS.
The participant was asked to name people who they can count on to help them in each of the three ways
described. They were then asked how happy they are with the support they receive.
Their satisfaction with the help they receive is given a score of 3 (very happy), 2 (quite happy) or
1 (not happy).
TABLE 50 Sample of the SSQ3
Who can you really count on to be there for you when you need help?
No one 1) 4) 7)
2) 5) 8)
3) 6) 9)
How happy are you with their help?
Very happy 3 Quite happy 2 Not happy 1
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Appendix 2 Statistical analysis plan
A randomised controlled trial comparing a behavioural activation
treatment for depression in adults with learning disabilities with an
attention control (BeatIt) statistical analysis plan
Study title: A randomised controlled trial comparing a behavioural activation treatment for depression in adults
with learning disabilities with an attention control
Short title: BeatIt
IDs: REC number: 12/WS/0297; ISRCTN09753005
Funded by: HTA Clinical Evaluation and Trials: 10 104 34
Protocol version: V3.0 Date 5 March 2015
SAP version: V1.0 Date 23 November 2016
Signature Date
Prepared by Rachel Zhang
Trainee Biostatistician, Robertson Centre for Biostatistics, University of Glasgow
Approved by Dr Alex McConnachie
Assistant Director of Biostatistics, Robertson Centre for Biostatistics, University of Glasgow
Professor Andrew Jahoda
Professor of Learning Disabilities Psychology, Institute of Health and Wellbeing, University of Glasgow
HTA, Health Technology Assessment; ID, identification; REC, Research Ethics Committee; SAP, statistical analysis plan.
Introduction
Study background
Adults with learning disabilities are as likely to have depression as adults who do not have learning
disabilities. However, not much is known about what treatments help adults with learning disabilities
and depression.
Psychological therapies, such as CBT, are recommended as the best treatment for most people with
depression. However, psychological therapies require good verbal communication. Studies have shown
that adults with learning disabilities do not have the communication skills to participate in most available
psychological therapies. Therefore, adults with learning disabilities and depression experience inequitable
access to treatments for depression.
Behavioural activation is a psychological therapy that has been shown to be as effective as CBT.
Behavioural activation is less dependent on verbal communication. The BeatIt study is designed to test
whether or not a behavioural activation treatment developed for adults with learning disabilities and
depression is effective.
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Study objectives
Primary objective:
l To measure the clinical effectiveness of BeatIt in reducing self-reported depressive symptoms for adults
with learning disabilities and depression, compared with an attention control intervention.
Secondary objectives:
l Comparison between groups of carer-reported depressive symptoms and aggressiveness, self-reported
anxiety symptoms, activity levels and QoL.
l Comparison between groups of carers’ sense of efficacy and relationship with participants.
l Comparison between groups of cost-effectiveness.
l Comparison between groups of process issues.
Study design
Multicentre, single-blind randomised controlled trial.
Sample size and power
Section 12.2 of the study protocol102 states:
In the open trial of BEAT-IT, the mean (standard deviation, SD) reduction in GDS-LD scores at 3 month
post-intervention follow-up was 8.50 (5.24). We have powered the study to detect a mean change
of 3.14, or 0.6 SD units between study groups. This makes the conservative assumption that the
4 month post-randomisation change over that in the control group in the proposed design will be
60% of that observed from pre-test to follow-up in the intervention group during the open trial. To
detect this effect size difference, the study requires 60 patients in each arm to provide outcome data
at 12 months post randomisation (see below for a more detailed justification). The primary analysis will
be an analysis of covariance adjusting for the baseline GDS score, which will have power to detect
smaller intervention effects, depending on the level of correlation in scores over time.
There are no data to inform the effect of clustering of outcomes for patients seen by each therapist.
Assuming each therapist works with an average of 9 participants (i.e. several part-time therapists at
each site), and assuming an intraclass correlation of 0.025, the sample size must be increased by 20%
to 72 per group, or 144 in total. Recruitment of 166 participants will allow for up to 13.3% loss to
follow-up. The study would then be the largest behavioural activation evaluation to date (based on the
studies included in recent reviews of the non-disability literature), despite targeting a difficult to reach
population often excluded from research.
Jahoda et al.102 Contains information licensed under the Non-Commercial Government Licence v2.0.
See www.nationalarchives.gov.uk/doc/non-commercial-government-licence/version/2/
Study population
Inclusion criteria
l Mild/moderate learning disabilities.
l Aged ≥ 18 years.
l Clinically significant unipolar depression.
l Able to give informed consent to participate.
l Has a level of expressive and receptive communication skills in English (reading skills not required) to
allow participation in treatment.
l Has a family member or paid carer, who has supported them for ideally a minimum of 6 months, with
whom to complete the screening and baseline visits OR is able to obtain information for the 4 months
previous to randomisation. The carer, or another named individual, should be available for weekly/
fortnightly treatment sessions with the practitioner, and should currently provide ≥ 2 hours of support
per week to the participant.
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Exclusion criteria
l Suicidal.
l A measured IQ of > 75.
l Factors that prevent the participant from interacting with the carer and therapist or retaining information
from the therapy (e.g. late-stage dementia, significant agitation, withdrawal arising from psychosis).
l Does not consent to her/his GP being contacted about her/his participation in the study.
Statistical analysis plan
Statistical analysis plan objectives
The objective of this SAP is to describe the statistical analyses to be carried out for the final analysis of the
BeatIt trial.
General principles
All data will first be summarised and analysed by intention to treat, that is, on the basis of randomised
treatment group, regardless of treatment actually received. Per-protocol analysis will be repeated in those
who have attended at least eight BeatIt treatment sessions or six attention control sessions.
Study data will be summarised as a whole and by treatment group at each study assessment point. Changes
over baseline will be reported for outcome measures. Continuous variables will be summarised by the
number of observations, number of missing values, mean, SD, median, quartiles and range. Categorical
variables will be summarised by the number of observations, number of missing values, and the number and
percentage of individuals in each category.
Current protocol
The current study protocol at the time of writing is version 3.0, dated 5 March 2015. Future amendments
to the protocol will be reviewed for their impact on this SAP, which will be updated only if necessary.
Deviations to those specified in the protocol
There are no planned deviations from the protocol. In case of non-convergence for the mixed-effect
models as a result of higher-than-anticipated therapist numbers, the therapist random effect will be
removed from the models and general linear models will be used instead.
Software
Analyses will be conducted using SAS® software (SAS Institute Inc., Cary, NC, USA. SAS and all other SAS
Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the
USA and other countries. ® indicates USA registration.) for Microsoft Windows® v9.2 (Microsoft Corporation,
Redmond, WA, USA) and/or R (The R Foundation for Statistical Computing, Vienna, Austria) for Windows
v3.0.0 or higher.
Analyses
Study populations
The total number of participants screened will be summarised by region. The number of participants
randomised to each treatment group will be presented. Attendance of those randomised to treatment
sessions will be summarised by treatment group.
The number and percentage of those randomised who completed the trial or were prematurely withdrawn
will be reported by treatment group, with reasons for withdrawal summarised. Other planned analyses will
be provided for all randomised subjects.
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Baseline characteristics
Summaries will be provided for the following baseline characteristics, by treatment group:
l Patient –
¢ demographic characteristics (age in years at randomisation, sex, ethnicity, marital status, Scottish
Index of Multiple Deprivation (SIMD) decile, support with living)
¢ expectations of therapy
¢ health (epilepsy, vision, hearing, mobility problems, type and length of previous
depression therapies)
¢ GDS-LD
¢ BLESID
¢ EQ-5D-Y
¢ GAS-ID
¢ PSS scores
¢ use of antidepressants, St John’s wort, lithium, carbamazepine, sodium valproate, lamotrigine
and pindolol.
l Carer –
¢ demographic characteristics (age in years at randomisation, sex, ethnicity, education,
employment status)
¢ relationship to, and average weekly contact with, subject
¢ experience and formal training (paid carers only)
¢ IDDS
¢ The BPI-S Aggressive Behaviour subscale
¢ EDSE scale
¢ Expressed emotion: FMSS
¢ activity measures [ICI, IPDL, Adaptive Behavior subscale (self-direction, responsibility, socialisation)].
Primary outcome
The primary outcome is the change in self-rated depressive symptoms, measured by the GDS-LD score at
12 months.
Primary analysis
The GDS-LD will be summarised at baseline and 12 months, overall and by study group. The change in
GDS-LD score at 12 months from baseline will also be summarised by group.
The primary analysis will be a mixed-effects regression model, including randomised group, study centre,
antidepressant use and baseline GDS-LD score as fixed effects, and therapist as a random effect. This will
be carried out for the change in GDS-LD scores from baseline to 12 months. The mean value (change from
baseline) at 12 months for each treatment group and difference in mean change between the groups,
95% CI and p-value will be estimated from this model.
Secondary analysis
The GDS-LD scores at 4 months will be analysed in a similar manner as the 12-month GDS-LD scores.
In addition, a repeated-measures analysis will be carried out, using a mixed-effects regression model,
including randomised group, time point, study centre and antidepressant use as fixed effects, and
participant and therapist as random effects. The mean change from baseline and between-group difference
in mean change, with a 95% CI and p-value, will be estimated from this model. The model will be extended
to include a treatment-by-time interaction, to estimate the mean changes from baseline and between-group
differences at each time point.
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Sensitivity analyses
Any missing data for the primary outcome at 4 and 12 months will be imputed using multiple imputations
when possible to further test the sensitivity of the results. Data are assumed to be missing at random. To
impute missing values at each time point, prediction models will be derived based on age, antidepressant
use and any previous or subsequent measurements of GDS-LD.
Secondary outcomes
Secondary outcomes will be analysed by the same method as the primary outcome; non-normally distributed
outcomes will be transformed prior to analysis, or analysed by appropriate mixed-effects regression models.
The type of model used for each outcome will be reported in the final statistical outputs.
The secondary outcomes are the change from baseline for:
l Patient –
¢ BLESID score
¢ EQ-5D-Y
¢ total GAS-ID score
¢ PSS scores.
l Carer –
¢ IDDS
¢ The BPI-S Aggressive Behaviour subscale
¢ total EDSE scale score
¢ Expressed emotion: FMSS
¢ activity measures:
¢ subscales and total ICI frequency
¢ IPDL
¢ subscale of the Adaptive Behavior Scale.
Safety outcomes
The numbers of serious adverse events will be reported as a whole and by treatment group. For those
events that have resolved, the event duration will also be summarised.
The numbers and percentages of participants experiencing at least one serious adverse event will be
reported as a whole and by treatment group for all events, and for events classified by the Medical
Dictionary for Regulatory Activities (MedDRA) System Organ Class and Preferred Term.
Exploratory analyses
Mixed-effect models for the primary outcome will be extended to explore the effects of the following
baseline characteristics on 4- and 12-month outcomes:
l age
l sex
l study centre
l use of antidepressants, St John’s wort, lithium, carbamazepine, sodium valproate, lamotrigine
and pindolol
l negative product total BLESID measured life events
l history of previous failed psychological intervention (yes vs. no for different therapies)
l SIMD
l relationship to carer (family vs. others)
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l level of support (daily vs. other)
l locus of control.
The moderating effects of these factors will be explored using interaction terms.
Per-protocol analyses
The analyses described in Baseline characteristics, Primary outcome and Secondary outcomes will be
repeated in a per-protocol analysis. The analysis population included will be those who have attended at
least eight BeatIt treatment sessions or six attention control sessions.
Additional analyses
The analyses in the previous sections constitute the main SAP analyses, and will be programmed and
validated prior to database lock and release of the randomisation codes to the study statisticians. The
following analyses will be carried out after database lock.
Potential mediation effects will be explored through extensions to the primary analysis regression model.
Changes in outcome measures to 4 months post randomisation will be explored as mediators of effects to
follow-up at 12 months post randomisation. Attendance at therapy sessions and therapist-rated session
data will be explored as potential mediators of short- and long-term intervention effect differences.
In addition, sensitivity analyses for the secondary outcomes will be analysed by the same method as the
primary outcome outlined in Sensitivity analyses.
Depending on the results of the main analyses, complier-average causal effect (CACE) analysis may be
explored to account for missed therapy sessions.
The scope of these analyses will be agreed with the study team after review of the main SAP analysis
results and documented prior to carrying out any additional analyses.
Document history
This is v1.0 of the SAP for the final analysis of the BeatIt study, dated 23 November 2016, and is the initial
creation of this document.
Tables
Dummy tables will be produced during the development of the statistical analysis programs for review and
feedback. Approval of the content of the final statistical outputs will be a requirement for database lock.
Figures
Dummy figures will be produced during the development of the statistical analysis programs for review
and feedback. Approval of the content of the final statistical outputs will be a requirement for
database lock.
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Listings
No formal data listings will be produced as part of the final statistical outputs. Raw and derived datasets
will be made available to the study team after the final statistical outputs have been produced.
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Appendix 3 Health economics tables
TABLE 51 Mean resource use for participants using resources for 12 months within the trial
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Daytime activities
Day centre
Weeks attended 46.5 (4.74) 13 (17.8) 40.4 (13.5) 17 (25) 6.19 (3.53) –1.17 to 13.5
Mean hours per week 19.3 (8.22) 13 (17.8) 17.3 (9.95) 17 (25) 1.95 (3.32) –4.85 to 8.75
Sheltered work
Weeks attended 21.7 (7.23) 3 (4.1) 37.5 (4.95) 2 (2.9) –15.8 (5.45) –33.5 to 1.79
Mean hours per week 11.75 (10.6) 3 (4.1) 17.25 (5.30) 2 (2.9) –5.5 (7.19) –28.6 to 17.6
Voluntary work
Weeks attended 26.6 (17.0) 27 (37.0) 32.0 (16.8) 14 (20.6) –5.37 (5.55) –16.8 to 6.03
Mean hours per week 7.44 (8.01) 27 (37.0) 7.01 (8.79) 14 (20.6) 0.433 (2.81) –5.36 to 6.23
Adult education
Weeks attended 25.7 (16.0) 13 (17.8) 21.8 (18.3) 8 (11.8) 3.94 (7.83) –12.9 to 20.8
Mean hours per week 6.91 (7.23) 13 (17.8) 7.31 (7.05) 8 (11.8) –0.402 (3.20) –7.21 to 6.40
Drop-in centre
Weeks attended 11.8 (11.2) 6 (8.2) 19.6 (16.9) 5 (7.4) –7.77 (8.81) –28.8 to 13.2
Mean hours per week 1.92 (1.11) 6 (8.2) 3.4 (2.51) 5 (7.4) –1.48 (1.21) –4.54 to 1.58
Social club
Weeks attended 34.8 (15.5) 26 (35.6) 35.7 (14.1) 27 (39.7) –0.895 (4.08) –9.09 to 7.30
Mean hours per week 3.30 (2.11) 26 (35.6) 3.60 (1.94) 27 (39.7) –0.304 (0.558) –1.42 to 0.817
Learning disabilities centre
Weeks attended 48 (0) 2 (2.7) 24 (9.90) 2 (2.9) 24 (7) –64.9 to 112.9
Mean hours per week 15.75 (19.4) 2 (2.7) 7 (7.07) 2 (2.9) 8.75 (14.6) –107.1 to 124.6
Hospital services – number of contacts
Psychiatric intensive care
ward
9.5 (10.6) 2 (2.7) 0 (N/A) 0 (N/A) 9.5 (N/A) N/A
Acute psychiatric ward 57 (N/A) 1 (1.4) 20.5 (20.5) 2 (2.9) 36.5 (N/A) N/A
Psychiatric rehabilitation
ward
20 (N/A) 1 (1.4) 28 (N/A) 1 (1.5) –8 (N/A) N/A
General medical ward 5.17 (3.19) 6 (8.2) 10.3 (11.8) 3 (4.4) –5.17 (6.96) –33.2 to 22.9
Other specialties 2 (1.41) 2 (2.7) 0 (0) 0 (0) 2 (N/A) N/A
Day hospital 1 (0) 2 (2.7) 1.2 (0.447) 5 (7.4) –0.2 (0.2) –0.755 to 0.355
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TABLE 51 Mean resource use for participants using resources for 12 months within the trial (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Psychiatric outpatient visit 1.6 (0.894) 5 (6.8) 1.6 (0.894) 5 (7.4) 0 (0) –1.30 to 1.30
Other hospital outpatient
visit
4.22 (4.15) 27 (37.0) 4.0 (4.08) 25 (36.8) 0.222 (1.14) –2.07 to 2.52
A&E visit 1.75 (1.71) 12 (16.4) 1.38 (0.518) 8 (11.8) 0.375 (0.527) –0.757 to 1.51
Community based
Community psychiatrist
Contacts 3.29 (2.42) 31 (42.5) 3.9 (3.18) 30 (44.1) –0.610 (0.725) –2.06 to 0.844
Mean duration of
contact (minutes)
36.16 (16.73) 31 (42.5) 36.78 (17.82) 30 (44.1) –0.622 (4.43) –9.48 to 8.24
Psychologist
Contacts 8.31 (12.1) 13 (17.8) 12.2 (14.7) 9 (13.2) –3.91 (5.94) –16.6 to 8.75
Mean duration of
contact (minutes)
54.6 (13.1) 13 (17.8) 45.0 (18.4) 9 (13.2) 9.62 (7.13) –5.72 to 24.9
GP
Contacts 6.83 (7.95) 64 (87.7) 6.89 (6.47) 55 (80.9) –0.063 (1.32) –2.68 to 2.56
Mean duration of
contact (minutes)
11.7 (0) 64 (87.7) 11.7 (0) 55 (80.9) 0 (N/A) N/A
Community psychiatric nurse
Contacts 4 (3.83) 4 (5.5) 16.3 (14.0) 3 (4.4) –12.3 (8.31) –44.8 to 20.2
Mean duration of
contact (minutes)
58.75 (43.7) 4 (5.5) 45 (15) 3 (4.4) 13.75 (23.5) –52.3 to 79.8
Learning disability nurse
Contacts 15.9 (15.2) 36 (49.3) 14.1 (16.4) 28 (41.2) 1.75 (4.0) –6.25 to 9.76
Mean duration of
contact (minutes)
54.4 (19.5) 36 (49.3) 54.1 (19.0) 28 (41.2) 0.349 (4.84) –9.34 to 10.0
Other community nurse
Contacts 46.6 (158.0) 21 (28.8) 8.05 (12.1) 22 (32.4) 38.6 (34.6) –33.5 to 110.6
Mean duration of
contact (minutes)
24.6 (15.2) 21 (28.8) 24.9 (19.8) 22 (32.4) –0.361 (5.36) –11.2 to 10.5
Community mental health team member
Contacts 6.5 (4.95) 2 (2.7) 0 (N/A) 0 (N/A) 6.5 (N/A) N/A
Mean duration of
contact (minutes)
60 (0) 2 (2.7) 0 (N/A) 0 (N/A) 60 (N/A) N/A
Health-care assistant
Contacts 64 (82.0) 2 (2.7) 8 (7.87) 5 (7.4) 56 (58.1) –670 to 781
Mean duration of
contact (minutes)
750 (976) 2 (2.) 72 (26.8) 5 (7.4) 678 (690) –8078 to 9434
Speech therapist
Contacts 0 (0) 0 (0) 2.5 (0.707) 2 (2.9) –2.5 (N/A) N/A
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
114
TABLE 51 Mean resource use for participants using resources for 12 months within the trial (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Mean duration of
contact (minutes)
0 (0) 0 (0) 45 (21.2) 2 (2.9) –45 (N/A) N/A
Physiotherapist
Contacts 7.20 (9.04) 10 (13.7) 6.63 (7.21) 8 (11.8) 0.575 (3.83) –7.54 to 8.69
Mean duration of
contact (minutes)
47.8 (11.9) 10 (13.7) 39.7 (11.7) 8 (11.8) 8.15 (5.59) –3.74 to 20.0
Occupational therapist
Contacts 12.9 (15.6) 9 (12.3) 3 (2.83) 4 (5.9) 9.90 (5.37) –2.25 to 22.0
Mean duration of
contact (minutes)
51.7 (15.2) 9 (12.3) 55.0 (33.2) 4 (5.9) –3.33 (17.3) –53.8 to 47.2
Art/drama/music therapist
Contacts 26.0 (12.7) 2 (2.7) 4.50 (2.12) 2 (2.9) 21.5 (9.12) –81.0 to 124
Mean duration of
contact (minutes)
30.0 (0) 2 (2.7) 85.0 (0) 2 (2.9) –55.0 (35.0) –500 to 390
Alternative therapist
Contacts 3 (N/A) 1 (1.4) 5 (4.24) 2 (2.9) –2.0 (N/A) N/A
Mean duration of
contact (minutes)
30.0 (N/A) 1 (1.4) 45.0 (21.2) 2 (2.9) –15.0 (N/A) N/A
Social worker/care manager
Contacts 5.21 (6.63) 39 (53.4) 4.63 (5.66) 35 (51.5) 0.577 (1.43) –2.27 to 3.43
Mean duration of
contact (minutes)
54.0 (24.0) 39 (53.4) 59.3 (22.3) 35 (51.5) –5.31 (5.38) –16.0 to 5.40
Social work assistant
Contacts 0 (0) 0 (0) 1.76 (10.1) 3 (4.4) –1.76 (N/A) N/A
Mean duration of
contact (minutes)
0 (0) 0 (0) 133 (15.3) 3 (4.4) –133 (N/A) N/A
Home help/home care worker
Contacts 205 (192) 29 (39.7) 285 (185) 21 (30.9) –79.5 (53.8) –188 to 28.9
Mean duration of
contact (minutes)
357 (439) 29 (39.7) 338 (393) 21 (30.9) 19.3 (118) –219 to 258
Advocate/counsellor
Contacts 6.92 (10.6) 13 (17.8) 6.44 (5.66) 9 (13.2) 0.479 (3.49) –6.82 to 7.78
Mean duration of
contact (minutes)
58.5 (19.2) 13 (17.8) 55.4 (13.2) 9 (13.2) 3.09 (6.90) –11.3 to 17.5
Dentist
Contacts 2.73 (1.98) 49 (67.1) 2.55 (1.95) 40 (58.8) 0.184 (0.418) –0.646 to 1.02
Mean duration of
contact (minutes)
21.8 (11.7) 49 (67.1) 20.2 (8.36) 40 (58.8) 1.61 (2.13) –2.63 to 5.85
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TABLE 51 Mean resource use for participants using resources for 12 months within the trial (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Optician
Contacts 1.92 (1.22) 25 (34.2) 1.83 (1.15) 23 (33.8) 0.094 (0.343) –0.597 to 0.784
Mean duration of
contact (minutes)
26.5 (12.8) 25 (34.2) 24.5 (14.1) 23 (33.8) 2.00 (3.89) –5.84 to 9.85
Audiologist
Contacts 2.5 (0.707) 2 (2.7) 1.5 (0.577) 4 (5.9) 1.0 (0.577) –1.93 to 3.93
Mean duration of
contact (minutes)
40.0 (0) 2 (2.7) 28.1 (9.44) 4 (5.9) 11.9 (4.72) –3.14 to 26.9
Chiropodist
Contacts 3.88 (2.26) 25 (34.2) 3.96 (2.53) 24 (35.3) –0.078 (0.686) –1.46 to 1.30
Mean duration of
contact (minutes)
24.0 (10.1) 25 (34.2) 19.9 (6.02) 24 (35.3) 4.11 (2.36) –0.663 to 8.87
Employment services/job centre
Contacts 6.60 (9.86) 5 (6.8) 14.9 (19.2) 7 (10.3) –8.26 (8.48) –27.3 to 10.8
Mean duration of
contact (minutes)
53.3 (14.0) 5 (6.8) 54.3 (37.2) 7 (10.3) –0.952 (15.4) –36.4 to 34.5
Medication (mean of participants using medication)
Prescribed medication
Number of medications 4.95 (3.41) 66 (90.4) 5.06 (4.01) 64 (94.1) –0.108 (0.653) –1.40 to 1.19
Duration (days) 316.3 (69.6) 66 (90.4) 285.7 (93.6) 64 (94.1) 30.7 (14.5) 1.95 to 59.4
‘Use when necessary’ –
number of medications
1.53 (0.697) 19 (26.0) 1.42 (0.692) 19 (27.9) 0.105 (0.225) –0.352 to 0.562
OTC – number of
medications
2.67 (2.08) 3 (4.1) 1.33 (0.516) 6 (8.8) 1.33 (1.22) –3.63 to 6.30
Therapist and supervisor timesheets (hours)
Therapist session time 7.67 (3.08) 73 (100) 13.6 (5.87) 68 (100) –5.93 (0.797) –7.51 to –4.35
Therapist time travelling
(to session)
126.2 (102.7) 71 (97.3) 214.0 (161.0) 67 (98.5) –87.8 (23.1) –133.7 to –42.0
Therapist time travelling
(to supervisor)
24.02 (34.3) 65 (89.0) 35.4 (52.7) 63 (92.6) –11.33 (7.89) –26.98 to 4.31
Therapist administration
time
5.88 (3.46) 73 (100) 13.56 (8.39) 68 (100) –7.68 (1.10) –9.86 to –5.51
Supervisor (preparation,
supervision and travel)
2.54 (2.32) 73 (100) 3.94 (2.83) 68 (100) –1.40 (0.438) –2.27 to –0.53
N/A, not applicable.
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TABLE 52 Mean cost for participants using resources for 12 months within the trial
Resource
Trial arm
Difference (£)StepUp BeatIt
Mean cost (£) (SD)
Used by,
n (%)
Total cost
(£) Mean cost (£) (SD)
Used by,
n (%)
Total cost
(£) Mean (SE) 95% CI
Daytime activities
Day centre 21,223 (9052) 13 (17.8) 275,899 18,667 (13,607) 17 (25) 317,339 2556 (4147) –5944 to 11,056
Sheltered work 1986 (1319) 3 (4.1) 5958 5393 (966) 2 (2.9) 10,786 –3408 (1023) –6770 to –44.7
Voluntary work 5367 (7533) 27 (39) 144,909 5113 (5597) 14 (20.6) 71,582 253 (2083) –3981 to 4487
Adult education 3616 (3758) 13 (17.8) 47,008 4482 (6152) 8 (11.8) 35,856 –866 (2412) –6221 to 4489
Drop-in centre 292 (308) 6 (8.2) 1752 936 (1295) 5 (7.4) 4680 –644 (593) –2235 to 947
Social club 1463 (1301) 26 (35.6) 38,038 1578 (1141) 27 (39.7) 42,606 –116 (337) –792 to 560
Learning disabilities centre 18,477 (22,812) 2 (2.7) 36,954 4961 (5841) 2 (2.9) 9922 13,515 (16,650) –148,214 to
175,244
Total daytime cost (mean for complete
cases) (£)
500,518 (8096) 492,771 (8496)
Hospital based
Psychiatric intensive care ward 6061 (6767) 2 (2.7) 12,122 0 (0) 0 (0) 0 6061 (N/A) N/A
Acute psychiatric ward 18,354 (N/A) 1 (1.4) 18,354 6601 (6603) 2 (2.9) 13,202 11,753 (N/A) N/A
Psychiatric rehabilitation ward 5920 (N/A) 1 (1.4) 5920 8288 (N/A) 1 (1.5) 8288 –2368 (N/A) N/A
General medical ward 1343 (829) 6 (8.2) 8058 2687 (3080) 3 (4.4) 8061 1343 (1810) –8644 to 5958
Other specialties 552 (390) 2 (2.7) 1104 0 (0) 0 (0) 0 552 (N/A) N/A
Day hospital 157 (0) 2 (2.7) 314 188 (70) 5 (7.4) 940 –31 (31) –119 to 56
Psychiatric outpatient visit 275 (154) 5 (6.8) 1375 275 (154) 5 (7.4) 1375 0 (97) –224 to 224
Other hospital outpatient visit 701 (690) 27 (37.0) 18,927 664 (678) 25 (0) 16,600 37 (190) –344 to 418
A&E visit 217 (212) 12 (16.4) 2604 171 (64) 8 (11.8) 1368 47 (65) –94 to 187
Total hospital cost (mean for complete
cases) (£)
68,778 (1011) 49,834 (859)
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TABLE 52 Mean cost for participants using resources for 12 months within the trial (continued )
Resource
Trial arm
Difference (£)StepUp BeatIt
Mean cost (£) (SD)
Used by,
n (%)
Total cost
(£) Mean cost (£) (SD)
Used by,
n (%)
Total cost
(£) Mean (SE) 95% CI
Community based
Community psychiatrist 775 (839) 31 (42.5) 24,025 931 (980) 30 (44.1) 27,930 –155 (234) –623 to 313
Psychologist 757 (1217) 13 (17.8) 9841 804 (817) 9 (13.2) 7236 –48 (434) –952 to 857
GP 274 (313) 64 (87.7) 17,536 297 (293) 55 (80.9) 16,335 –24 (56) –134 to 87
Community psychiatric nurse 232 (150) 4 (5.5) 928 1324 (1475) 3 (4.4) 3972 –1092 (855) –4717 to 2532
Learning disability nurse 1561 (2019) 36 (49.3) 56,196 1468 (1853) 28 (41.2) 41,104 93 (486) –878 to 1065
Other community nurse 1129 (3329) 21 (28.8) 23,709 300 (403) 22 (32.4) 6600 829 (731) –695 to 2352
Community mental health team member 645 (492) 2 (2.7) 1290 0 (0) 0 (0) 0 645 (N/A) N/A
Health-care assistant 36,822 (51,861) 2 (2.7) 73,644 261 (269) 5 (7.4) 1305 36,561 (36,671) –429,369 to
502,490
Speech therapist 0 (0) 0 (0) 0 75.8 (28.5) 2 (2.9) 152 –75.8 (N/A) N/A
Physiotherapist 305 (438) 10 (13.7) 3050 251 (330) 8 (11.8) 2008 54.0 (181) –330 to 438
Occupational therapist 549 (742) 9 (12.3) 4941 166 (236) 4 (5.9) 664 382 (274) –224 to 989
Art/drama/music therapist 596 (292) 2 (2.7) 1192 252 (32) 2 (2.9) 504 344 (207) –2147 to 2835
Alternative therapist 72.0 (N/A) 1 (1.4) 72 144 (68) 2 (2.9) 288 –72 (N/A) N/A
Social worker/care manager 408 (600) 39 (53.4) 15,912 413 (474) 35 (51.5) 14,455 –4.85 (125) –254 to 244
Social work assistant 0 (0) 0 (0) 0 3055 (2936) 3 (4.4) 9165 –3055 (N/A) N/A
Home help/home care worker 28,184 (47,039) 29 (39.7) 817,336 34,601 (46,795) 21 (30.9) 726,621 –6417 (13,437) –33,510 to 20,675
Advocate/counsellor 302 (459) 13 (17.8) 3926 238 (201) 9 (13.2) 2142 64.1 (144) –239 to 367
Dentist 374 (358) 49 (67.1) 18,326 309 (318) 40 (58.8) 12,360 65.3 (71.8) –77.5 to 208
Optician 37.2 (25.6) 25 (34.2) 930 43.1 (56.0) 23 (33.8) 991 –5.85 (12.7) –31.9 to 20.2
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Resource
Trial arm
Difference (£)StepUp BeatIt
Mean cost (£) (SD)
Used by,
n (%)
Total cost
(£) Mean cost (£) (SD)
Used by,
n (%)
Total cost
(£) Mean (SE) 95% CI
Audiologist 100 (28.3) 2 (2.7) 200 45.0 (27.4) 4 (5.9) 180 55.0 (24.2) –48.8 to 159
Chiropodist 35.9 (22.1) 25 (34.2) 898 30.3 (19.4) 24 (35.3) 727 5.67 (5.93) –6.26 to 17.6
Employment services/job centre 398 (668) 5 (6.8) 1990 1459 (2186) 7 (10.3) 10,213 –1061 (879) –3112 (990)
Total community cost (mean for
complete cases) (£)
10,759,452 (15,822) 884,952 (15,512)
Medication
Prescribed medication 866 (1489) 66 (90.4) 57,156 1002 (2029) 64 (94.1) 64,128 –136 (308) –748 to 475
‘Use when necessary’ 21.6 (26.6) 19 (26.0) 410 6.76 (11.8) 19 (27.9) 128 14.9 (6.67) 1.14 to 28.6
OTC 193 (182) 3 (4.1) 579 14.4 (13.9) 6 (8.8) 86 179 (105.0) –270 to 629
Total medication cost (mean for
complete cases) (£)
58,145 (807) 64,343 (862)
Intervention costs
Supervisor costs 143 (136) 72 (98.6) 10,296 225 (183) 65 (95.6) 14,625 –82.0 (27.8) –137 to –27.0
Therapist costs 566 (256) 73 (10) 41,318 1058 (484) 67 (98.5) 70,886 –491 (66) –623 to –360
Therapist training 279 (0) 73 (100) 20,367 462 (0) 68 (100) 31,416 –183 (0) N/A
Materials 41.25 (0) 73 (100) 3011 59.1 (0) 68 (100) 4019 –183 (0) N/A
Total intervention cost (mean for
complete cases) (£)
74,992 (1050) 120,946 (1788)
N/A, not applicable.
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TABLE 53 Mean resource use for participants using resources for 4 months prior to baseline
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Daytime activities
Day centre
Weeks attended 14.9 (3.93) 10 (13.7) 15.3 (2.69) 13 (19.1) –0.408 (1.45) –3.49 to 2.68
Mean hours per week 18.4 (8.14) 10 (13.7) 20.8 (11.61) 13 (19.1) –2.46 (4.12) –11.0 to 6.12
Sheltered work
Weeks attended 16 (N/A) 1 (1.4) 16 (0) 2 (2.9) 0 (N/A) N/A
Mean hours per week 35 (N/A) 1 (1.4) 21.5 (9.19) 2 (2.9) 13.5 (0) N/A
Voluntary work
Weeks attended 12.7 (6.25) 18 (24.7) 13.6 (4.87) 13 (19.1) –0.893 (2.0) –4.98 to 3.20
Mean hours per week 4.69 (5.99) 18 (24.7) 5.31 (4.12) 13 (19.1) –0.613 (1.82) –4.33 to 3.10
Adult education
Weeks attended 15.4 (1.81) 7 (9.6) 8.71 (5.62) 7 (10.3) 6.71 (2.23) 1.47 to 12.0
Mean hours per week 4.93 (2.32) 7 (9.6) 8.57 (10.9) 7 (10.3) –3.64 (4.22) –13.8 to 6.48
Drop-in centre
Weeks attended 16 (0.577) 3 (4.1) 17 (N/A) 1 (1.5) –1.0 (N/A) N/A
Mean hours per week 4.17 (2.75) 3 (4.1) 9 (N/A) 1 (1.5) –4.83 (N/A) N/A
Social club
Weeks attended 13.1 (5.67) 23 (31.5) 13.4 (5.56) 22 (32.4) –0.322 (1.67) –3.70 to 3.06
Mean hours per week 3.28 (2.01) 23 (31.5) 3.32 (1.96) 22 (32.4) –0.036 (0.591) –1.23 to 1.16
Learning disabilities centre
Weeks attended 13.6 (5.37) 5 (6.8) 0 (0) 0 (0) N/A N/A
Mean hours per week 17.2 (13.9) 5 (6.8) 0 (0) 0 (0) N/A N/A
Hospital services – number of contacts
Psychiatric intensive care
ward
0 (0) 0 (0) 0 (0) 0 (0) N/A N/A
Acute psychiatric ward 122 (N/A) 1 (1.4) 0 (0) 0 (0) 122 (N/A) N/A
Psychiatric rehabilitation
ward
0 (0) 0 (0) 10 (N/A) 1 (1.5) –10 (N/A) N/A
General medical ward 6.67 (8.14) 3 (4.1) 2.25 (0.5) 4 (5.9) 4.42 (4.71) –15.7 to 24.6
Other specialties 3.5 (2.12) 2 (2.7) 0 (0) 0 (0) 3.5 (N/A) N/A
Day hospital 1 (N/A) 1 (1.4) 1 (N/A) 1 (1.5) 0 (N/A) N/A
Psychiatric outpatient visit 2 (N/A) 2 (2.7) 1 (N/A) 3 (4.4) 1 (0) N/A
Other hospital outpatient
visit
5.31 (11.2) 13 (17.8) 2.94 (3.55) 16 (23.5) 2.37 (3.23) –4.55 to 9.30
A&E visit 1.56 (1.01) 9 (12.3) 1 (0) 7 (10.3) 0.556 (0.338) –0.224 to 1.33
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TABLE 53 Mean resource use for participants using resources for 4 months prior to baseline (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Community based
Community psychiatrist
Contacts 1.77 (1.07) 26 (35.6) 2.43 (2.17) 28 (41.2) –0.660 (0.460) –1.59 to 0.271
Mean duration of
contact (minutes)
38.7 (19.5) 26 (35.6) 47.5 (23.9) 28 (41.2) –8.85 (5.91) –20.7 to 3.02
Psychologist
Contacts 5.41 (8.14) 17 (23.3) 5.14 (6.68) 14 (20.6) 0.269 (2.66) –5.17 to 5.71
Mean duration of
contact (minutes)
58.2 (25.4) 17 (23.3) 47.9 (15.4) 14 (20.6) 10.4 (7.40) –4.82 to 25.6
GP
Contacts 3.17 (3.40) 48 (65.8) 3.07 (2.33) 46 (67.6) 0.101 (0.600) –1.09 to 1.29
Mean duration of
contact (minutes)
11.07 (0) 48 (65.8) 11.07 (0) 46 (67.6) 0 (N/A) N/A
Community psychiatric nurse
Contacts 5.25 (3.20) 4 (5.5) 8.20 (5.85) 5 (7.4) –2.95 (3.07) –10.3 to 4.45
Mean duration of
contact (minutes)
45.0 (17.3) 4 (5.5) 50.0 (14.1) 5 (7.4) –5.0 (10.7) –31.4 to 21.4
Learning disability nurse
Contacts 5.91 (4.84) 32 (43.8) 6.21 (5.76) 24 (35.3) –0.302 (1.45) –3.23 to 2.63
Mean duration of
contact (minutes)
55.6 (29.7) 32 (43.8) 54.6 (26.8) 24 (35.3) 1.04 (7.58) –14.2 to 16.2
Other community nurse
Contacts 28.8 (66.5) 12 (16.4) 3.27 (4.71) 11 (16.2) 25.6 (19.3) –16.8 to 67.9
Mean duration of
contact (minutes)
23.8 (19.2) 12 (16.4) 27.3 (18.4) 11 (16.2) –3.52 (7.83) –19.8 to 12.8
Community mental health team member
Contacts 0 (0) 0 (0) 16.0 (N/A) 1 (1.5) –16.0 (N/A) N/A
Mean duration of
contact (minutes)
0 (0) 0 (0) 60.0 (N/A) 1 (1.5) –60.0 (N/A) N/A
Health-care assistant
Contacts 122.0 (N/A) 1 (1.4) 14.5 (7.78) 2 (2.9) 107.5 (N/A) N/A
Mean duration of
contact (minutes)
1440 (N/A) 1 (1.4) 150 (127) 2 (2.9) 1290 (N/A) N/A
Speech therapist
Contacts 0 (0) 0 (0) 1.0 (N/A) 1 (1.5) –1.0 (N/A) N/A
Mean duration of
contact (minutes)
0 (0) 0 (0) 90.0 (N/A) 1 (1.5) –90.0 (N/A) N/A
continued
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TABLE 53 Mean resource use for participants using resources for 4 months prior to baseline (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Physiotherapist
Contacts 6.29 (6.02) 7 (9.6) 4.6 (6.95) 5 (7.4) 1.69 (3.85) –7.21 to 10.6
Mean duration of
contact (minutes)
42.9 (16.0) 7 (9.6) 34.0 (15.2) 5 (7.4) 8.86 (9.10) –11.7 to 29.4
Occupational therapist
Contacts 6.10 (6.40) 10 (13.7) 5.40 (6.58) 5 (7.4) 0.70 (3.57) –7.56 to 8.96
Mean duration of
contact (minutes)
64.5 (44.7) 10 (13.7) 51.0 (13.4) 5 (7.4) 13.5 (15.4) –20.1 to 47.1
Art/drama/music therapist
Contacts 0 (0) 0 (0) 8.0 (N/A) 1 (1.5) –8.0 (N/A) N/A
Mean duration of
contact (minutes)
0 (0) 0 (0) 60.0 (N/A) 1 (1.5) –60.0 (N/A) N/A
Alternative therapist
Contacts 0 (0) 0 (0) 1 (N/A) 2 (2.9) –1 (N/A) N/A
Mean duration of
contact (minutes)
0 (0) 0 (0) 60.0 (42.4) 2 (2.9) –60.0 (N/A) N/A
Social worker/care manager
Contacts 3.16 (4.08) 32 (43.8) 3.72 (4.12) 25 (36.8) –0.564 (1.09) –2.76 to 1.63
Mean duration of
contact (minutes)
49.8 (20.8) 32 (43.8) 51.5 (14.8) 25 (36.8) –1.68 (4.725) –11.1 to 7.79
Social work assistant
Contacts 1.0 (N/A) 1 (1.4) 42.0 (N/A) 1 (1.5) –41.0 (N/A) N/A
Mean duration of
contact (minutes)
60.0 (N/A) 1 (1.4) 90.0 (N/A) 1 (1.5) –30.0 (N/A) N/A
Home help/home care worker
Contacts 80.3 (53.1) 23 (31.5) 84.3 (57.1) 24 (35.3) –4.07 (16.01) –36.5 to 28.3
Mean duration of
contact (minutes)
408 (449) 23 (31.5) 366 (439) 24 (35.3) 41.8 (130) –219 to 303
Advocate/counsellor
Contacts 5.30 (6.36) 10 (13.7) 4.67 (5.89) 9 (13.2) 0.633 (2.81) –5.30 to 6.57
Mean duration of
contact (minutes)
62.0 (23.9) 10 (13.7) 66.7 (46.9) 9 (13.2) –4.67 (17.4) –42.7 to 33.3
Dentist
Contacts 1.95 (1.81) 37 (50.7) 1.48 (0.770) 25 (36.8) 0.466 (0.335) –0.206 to 1.14
Mean duration of
contact (minutes)
25.3 (19.9) 37 (50.7) 24.2 (22.4) 25 (36.8) 1.07 (5.55) –10.1 to 12.2
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TABLE 53 Mean resource use for participants using resources for 4 months prior to baseline (continued )
Resource
Trial arm
DifferenceStepUp BeatIt
Mean (SD)
Used by,
n (%) Mean (SD)
Used by,
n (%) Mean (SE) 95% CI
Optician
Contacts 1.45 (0.688) 11 (15.1) 1.08 (0.289) 12 (17.6) 0.371 (0.223) –0.111 to 0.853
Mean duration of
contact (minutes)
26.4 (15.2) 11 (15.1) 39.2 (47.5) 12 (17.6) –12.8 (14.4) –43.9 to 18.3
Audiologist
Contacts 4 (N/A) 1 (1.4) 1.75 (1.5) 4 (5.9) 2.25 (N/A) N/A
Mean duration of
contact (minutes)
30.0 (N/A) 1 (1.4) 16.3 (9.46) 4 (5.9) 13.75 (N/A) N/A
Chiropodist
Contacts 1.80 (1.01) 15 (20.5) 2.31 (1.03) 13 (19.1) –0.508 (0.388) –1.31 to 0.291
Mean duration of
contact (minutes)
24.3 (12.8) 15 (20.5) 19.2 (6.07) 13 (19.1) 5.10 (3.71) –2.62 to 12.8
Employment services/job centre
Contacts 5.60 (6.50) 5 (6.8) 6.57 (7.35) 7 (10.3) –0.971 (4.02) –10.0 to 8.07
Mean duration of
contact (minutes)
37.2 (23.0) 5 (6.8) 72.9 (54.4) 7 (10.3) –35.7 (23.0) –88.0 to 16.7
N/A, not applicable.
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TABLE 54 Mean cost for participants using resources for 4 months prior to baseline
Resource
Trial arm
Difference (£)StepUp BeatIt
Mean cost (£)
(SD)
Used by,
n (%)
Total cost
(£)
Mean cost (£)
(SD)
Used by,
n (%)
Total cost
(£) Mean (SE) 95% CI
Daytime activities
Day centre 6694 (3727) 10 (13.7) 66,940 7723 (4912) 13 (19.1) 100,399 –1028 (1801) –4775 to 2718
Sheltered work 4766 (N/A) 1 (1.4) 4766 2927 (1252) 2 (2.9) 5854 1838 (N/A) N/A
Voluntary work 1515 (2443) 18 (24.7) 27,270 1686 (1524) 13 (19.1) 21,918 –171 (714) –1633 to 1291
Adult education 1623 (775) 7 (9.6) 11,361 1482 (1423) 7 (10.3) 10,374 141 (613) –1239 to 1521
Drop-in centre 757 (468) 3 (4.1) 2271 1764 (N/A) 1 (1.5) 1764 –1007 (N/A) N/A
Social club 548 (460) 23 (31.5) 12,604 551 (432) 22 (32.4) 12,122 –2.65 (133) –271 to 266
Learning disabilities centre 6550 (5676) 5 (6.8) 32,750 0 (0) 0 (0) 0 N/A N/A
Total daytime cost (mean for complete cases) (£) 157,962 (2323) 152,431 (2628)
Hospital based
Psychiatric intensive care ward 0 (0) 0 (0) 0 0 (0) 0 (0) 0 N/A N/A
Acute psychiatric ward 39,284 (N/A) 1 (1.4) 39,284 0 (0) 0 (0) 0 39,284 (N/A) N/A
Psychiatric rehabilitation ward 0 (0) 0 (0) 0 2960 (N/A) 1 (1.5) 2960 –2960 (N/A) N/A
General medical ward 1733 (2118) 3 (4.1) 5199 585 (130) 4 (5.9) 2340 1148 (1224) –4091 to 6388
Other specialities 966 (585) 2 (2.7) 1932 0 (0) 0 (0) 0 966 (N/A) N/A
Day hospital 157 (N/A) 1 (1.4) 157 157 (N/A) 1 (1.5) 157 0 (N/A) N/A
Psychiatric outpatient visit 344 (0) 2 (2.7) 688 172 (0) 3 (4.4) 516 172 (0) N/A
Other hospital outpatient visit 881 (1858) 13 (17.8) 11,453 488 (589) 16 (23.5) 7808 393 (536) –756 to 1543
A&E visit 193 (125) 9 (12.3) 1737 124 (0) 7 (10.3) 868 69 (42) –28 to 166
Total hospital cost (mean for complete cases) (£) 60,450 (889) 14,649 (252)
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Resource
Trial arm
Difference (£)StepUp BeatIt
Mean cost (£)
(SD)
Used by,
n (%)
Total cost
(£)
Mean cost (£)
(SD)
Used by,
n (%)
Total cost
(£) Mean (SE) 95% CI
Community based
Community psychiatrist 431 (364) 26 (35.6) 11,206 672 (746) 28 (41.2) 18,816 –241 (158) –560 to 78.7
Psychologist 477 (725) 17 (23.3) 8109 392 (542) 14 (20.6) 5488 84.6 (228) –382 to 551
GP 142 (186) 48 (65.8) 6816 120 (91.6) 46 (67.6) 5520 21.2 (30.1) –38.9 to 81.2
Community psychiatric nurse 385 (293) 4 (5.5) 1540 741 (620) 5 (7.4) 3705 –357 (313) –1126 to 412
Learning disability nurse 610 (909) 32 (43.8) 19,520 549 (605) 24 (35.3) 13,176 61 (203) –345 to 468
Other community nurse 433 (530) 12 (16.4) 5196 194 (396) 11 (16.2) 2134 239 (194) –166 to 643
Community mental health team member 0 (0) 0 (0) 0 1589 (N/A) 1 (1.5) 1589 –1589 (N/A) N/A
Health-care assistant 73,493 (N/A) 1 (1.4) 73,493 1117 (1260) 2 (2.9) 2234 72,376 (N/A) N/A
Speech therapist 0 (0) 0 (0) 0 72.0 (N/A) 1 (1.5) 72 –72.0 (N/A) N/A
Physiotherapist 185 (157) 7 (9.6) 1295 84.7 (98.3) 5 (7.4) 424 100 (74.0) –64.9 to 265
Occupational therapist 458 (752) 10 (13.7) 4580 209 (234) 5 (7.4) 1045 249 (260) –318 to 815
Art/drama/music therapist 0 (0) 0 (0) 0 367 (N/A) 1 (1.5) 367 –367 (N/A) N/A
Alternative therapist 0 (0) 0 (0) 0 46.4 (31.6) 2 (2.9) 93 –46.4 (N/A) N/A
Social worker/care manager 253 (382) 32 (43.8) 8096 292 (348) 25 (36.8) 7300 –38.5 (97.0) –233 to 156
Social work assistant 36.0 (N/A) 1 (1.4) 36 2269 (N/A) 1 (1.5) 2269 –2233 (N/A) N/A
Home help/home care worker 12,540 (18,071) 23 (31.5) 288,420 12,530 (17,642) 24 (35.3) 300,720 9.85 (5212) –10,489 to 10,509
Advocate/counsellor 262 (320) 10 (13.7) 2620 243 (316) 9 (13.2) 2187 19.7 (145) –288 to 328
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TABLE 54 Mean cost for participants using resources for 4 months prior to baseline (continued )
Resource
Trial arm
Difference (£)StepUp BeatIt
Mean cost (£)
(SD)
Used by,
n (%)
Total cost
(£)
Mean cost (£)
(SD)
Used by,
n (%)
Total cost
(£) Mean (SE) 95% CI
Dentist 289 (306) 37 (50.7) 10,693 254 (417) 25 (36.8) 6350 35.3 (97.3) –161 to 232
Optician 31.1 (23.6) 11 (15.1) 342 30.4 (35.4) 12 (17.6) 364 0.71 (12.4) –25.3 to 26.7
Audiologist 90.4 (N/A) 1 (1.4) 90 17.9 (10.4) 4 (5.9) 72 72.5 (N/A) N/A
Chiropodist 16.4 (12.1) 15 (20.5) 246 17.7 (9.56) 13 (19.1) 230 –1.29 (4.09) –9.71 to 7.12
Employment services/job centre 124 (91.8) 5 (6.8) 620 862 (1302) 7 (10.3) 6034 –738 (494) –1943 to 467
Total community cost (mean for complete cases) (£) 442,919 (6513) 380,189 (6450)
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Appendix 4 Qualitative interview schedules
Interview schedule for supporter interviews
l What were their initial expectations, beliefs and emotions about the intervention?
l What can they remember about the intervention and what they did in the sessions (and between
the sessions)?
¢ Materials (activity diaries, etc.).
¢ Activities in sessions.
¢ Homework tasks.
¢ Formulation and final booklets.
l Aspects of intervention found most helpful.
l Aspects of intervention found least helpful.
l What they learned about depression and how to support people with depressive symptoms?
l Did their involvement in sessions change their confidence about supporting their relative/client?
l Did their involvement in sessions change how they support their relative/client?
l Process issues:
¢ relationship with therapist
¢ joint working with client and therapist
¢ continuity across sessions
¢ a sense of whether or not the intervention was sufficiently tailored to the individual.
l Perceived changes for client, if any, as a consequence of the therapy:
¢ their feelings
¢ their ability to cope/sense of self-efficacy
¢ engagement with the world – in terms of activities and social relationships.
l Perceived changes for the supporter in terms of:
¢ their relationship with their relative/client
¢ their confidence in supporting their relative/client
¢ how they support their relative/client
¢ the support person’s QoL.
l How could the intervention be improved?
l Do they think the intervention is suitable for other clients?
l What has happened since the therapy finished?
¢ building on any progress made/or going backwards
¢ continuing any aspect of the therapeutic work
¢ other life changes linked to the initial therapy.
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Interview schedule for participants with learning disabilities
I am going to ask you some questions about the psychological therapy you are receiving through the
meetings with <insert the name of therapist>. There are no right answers to these questions and different
people might say different things. I would like you to think about these sessions and how it feels for you.
Warm-up questions/establishing presence of alliance
l You are seeing <insert the name of therapist> to help you with some problems. How do you feel these
sessions are going?
l Tell me about what happens during these sessions.
l What have you done together/talked about that has really helped you feel better?
l Is there anything about these sessions that has not helped you or made you feel worse?
Goals
l What do you hope to get out of your sessions with <insert the name of therapist>? What would you
like to get better? What would you like to be able to do after these sessions finish?
Example prompts
l What does <insert the name of therapist> want you to be able to do after these sessions?
l How did you decide what you wanted to get out of sessions? Was this the best thing?
l Have there been any differences between what <insert the name of therapist> wants you to get out of
sessions and what you want? What was it like to agree/disagree? What did you think about this? How
did this feel?
l Was what you wanted listened to by <insert the name of therapist>? Did you listen to what they
thought? How did this feel?
Tasks
l Tell me about the kinds of things you do/tasks you do when you meet with <insert the name of
therapist>? How do you decide what kinds of tasks you will do?
Example prompts
l What tasks have been good? How have they helped you?
l Was there any task that was not helpful or did not feel good? Why did it not help?
l Do you understand why you talk about certain issues/do certain tasks?
l Did you get control over the tasks you do? If yes, what was this like?
l If no, what was it like to be told by <insert the name of therapist> what tasks you would do?
Bond
l Can you tell me about what <insert the name of therapist> is like? How do you feel when you meet
with them?
Example prompts
l How do you get on with <insert the name of therapist>?
l What qualities do you think makes a therapist be able to help someone in therapy?
l What is it like speaking to <insert the name of therapist> about your problems? Can you trust them?
l What things help you to feel relaxed talking to them?
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l What would make it hard to talk to them about your problems? Have there been times you did not
want to go to sessions?
l Do you think they can help you with your problems? Why/why not?
l How do you think they feel about meeting with you? Do you think they care about how you are
getting on?
(When appropriate, photographs and drawings can be used by the interviewer to help illustrate the
questions and stimulate discussion.)
Interview schedule for therapist focus groups
l What were their initial expectations, beliefs and emotions about the intervention?
l Views of the therapy training.
l Understanding and views of the behavioural activation model.
l Views about the manual and different materials and exercises:
¢ materials (activity diaries etc.)
¢ activities in sessions
¢ homework tasks
¢ formulation and final booklets.
l View about working with clients to overcome barriers to change and the challenges they faced
with this.
l Aspects of intervention that they thought the clients and support persons found most helpful
and engaging.
l Aspects of intervention that they thought the clients and support persons found least helpful
or engaging.
l Process issues:
¢ relationship with therapist
¢ joint working with client and therapist
¢ continuity across sessions
¢ a sense of whether or not it was possible to tailor the intervention to the individual’s particular
difficulties and life circumstances.
l Perceived changes for client, if any, as a consequence of the therapy:
¢ their feelings
¢ their ability to cope/sense of self-efficacy
¢ engagement with the world in terms of activities and social relationships.
l Perceived changes for the support person in terms of:
¢ their relationship with their relative/client
¢ their confidence in supporting their relative/client
¢ how they support their relative/client
¢ the support person’s QoL.
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l Therapist views of supervision:
¢ What have been the most helpful aspects of supervision?
¢ What has been least helpful about supervision?
¢ How could the supervision be improved?
l If they delivered the therapy to more than one client, how did their approach and confidence change
over time?
l Overall, what, if anything, do they think they have gained from being a therapist in the study?
l In their view, what could be done to improve the intervention?
l What clients, if any, do they think the intervention is suitable for?
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
130

Part of the NIHR Journals Library 
www.journalslibrary.nihr.ac.uk
Published by the NIHR Journals Library
This report presents independent research funded by the 
National Institute for Health Research (NIHR). The views 
expressed are those of the author(s) and not necessarily 
those of the NHS, the NIHR or the Department of Health
EME
HS&DR
HTA
PGfAR
PHR
